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Abstract 
The debates surrounding male circumcision and HIV prevention have been diverse ranging 
from religious, medical, ethical, cultural, political and financial. The arguments have been 
complex and varied depending on what academic and medical discipline one prescribes to and 
furthermore one‘s ideology of the epidemic in sub-Saharan Africa. This research will explain 
why on March 28, 2007 WHO and UNAIDS endorsed male circumcision as a public health 
initiative for HIV prevention in sub-Saharan Africa. By understanding how WHO and 
UNAIDS assessed and evaluated the evidence, it may clarify if all or some of the debates and 
concerns associated with male circumcision and HIV prevention were justified and warrant 
further analysis. Furthermore, the research may provide insight into how male circumcision 
will affect the universal fight towards improving overall population health in Africa.  
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Chapter One: Introduction 
1. Background 
It was 1981 when the world was first introduced to AIDS, a disease that accounts for 
approximately 2.5 million new HIV infections and 2 million deaths annually.
1
 During the last 
27 years, HIV/AIDS has shown no mercy attacking those populations most vulnerable to 
poverty and disease, resulting in more than 25 million deaths.  The region most affected by 
the epidemic has been sub-Saharan Africa with an estimated 22 million people living with the 
disease and 1.6 million dying each year.
2
  At present 68% of all new HIV infections and 76% 
of all HIV/AIDS related deaths recorded globally are from sub-Saharan Africa, and 
predominately associated with heterosexual relationships.
3
   
Over the last decade, the world has witnessed significant advancements in the amount and 
types of research targeted at HIV and AIDS. Donor funding has increased dramatically, 
accessibility to antiretroviral therapy has improved for marginalized groups, and public 
consciousness has grown through global HIV awareness programs. Furthermore, political 
leaders, celebrities, and corporations now lend a voice to the cause.  
Some of the progress made in sub-Saharan Africa can in part be attributed to the 
establishment of UNAIDS, an international humanitarian agency formed under the resolution 
of the United Nations Economic and Social Council in 1994 and made operational in 1996. 
UNAIDS‘ mandate has been to coordinate and support the efforts of the 10 UN co-sponsors4 
and to assist governments, civil society, donors and those living with HIV/AIDS by 
educating, mobilizing and monitoring the necessary resources to combat the disease. 
Furthermore in June 2001 and 2006 the United Nations General Assembly put forth 
resolutions for the ‗Declaration of Commitment on HIV/AIDS‘ and ‗Political Declaration on 
HIV/AIDS‘. The resolutions were based on the principle that the epidemic ―constitutes a 
global emergency and one of the most formidable challenges to human life and dignity, as 
well as to the effective enjoyment of human rights, which undermines social and economic 
development throughout the world and affects all levels of society – national, community, 
                                                 
1 UNAIDS and WHO 2007:1. AIDS epidemic update 
2 Ibid:7. 
3 Ibid:6. 
4 UNAIDS cosponsors are UNHCR, UNICEF, WFP, UNDP, UNFPA, UNODC, ILO, UNESCO, WHO and the World Bank; UNAIDS 
2007. Overview brochure. 
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family and individual.‖5 These resolutions started a framework to develop a long-term 
political and international commitment towards the epidemic. 
UNAIDS in many ways became the most visible international mainstream voice for AIDS. 
Cautiously explaining the moral obligation to assist those who were unable to gain access to 
knowledge or treatment due to their governments‘ lack of political will and/or because social 
and economic determinants hindered their ability to act. UNAIDS legacy of advocacy, may 
be seen today when observing the quantity of daily international and local media coverage 
given to topics relating to AIDS and furthermore evident in the amount of financial resources 
made available. In 2007 UNAIDS reported that their funding increased by 30% with the 
majority (70%) of the annual resources being donated by the Netherlands, Norway, Sweden, 
United Kingdom and the United States, which underscores UNAIDS ability to garner support 
for the fight against AIDS.
6
 In total, international aid has grown to approximately United 
States Dollar (USD) 10 billion annually compared to USD 300 million in 1996, which can 
largely be attributed to UNAIDS and their 10 co-sponsors and partners.
7
 
The other organization that has played a pivotal role in assisting the health sector in sub-
Saharan Africa has been the World Health Organization (WHO). As the world‘s recognized 
authority on international health and one of the 10 co-sponsors of UNAIDS, its mandate has 
been to lead the UN health sector‘s response to the AIDS epidemic.8 Some of WHO‘s key 
responsibilities in relations to the health sector in sub-Saharan Africa include: assisting the 
Ministries‘ of Health (MoH) with guidance on any evidence-based science relating to 
HIV/AIDS, providing support and technical assistance for scaling up interventions to prevent, 
care, treat and support individuals at risk or living with HIV/AIDS, assisting policy-makers in 
building a framework for assessing and strengthening their health strategies relating to HIV - 
such as health promotion and health safety standards and lastly providing support on capacity 
building and training for health sector workers.
9
  
However dramatic the achievements and contributions WHO and UNAIDS have made 
towards furthering the progress of HIV/AIDS in sub-Saharan Africa, the discouraging news 
                                                 
5 United Nations 2001:1.S-62/2 Declaration of commitment on HIV/AIDS; United Nations 2006. 60/262 Political declaration on HIV/AIDS. 
6 UNAIDS 2007:33. Annual report: Knowing your epidemic. 
7 UNAIDS 2008:1. Progress in AIDS response but still a long way from meeting global target; UNAIDS 2008:1. Global AIDS epidemic far 
from over. 
8 UNAIDS 2008. www.uanids.org/en/cosponsors WHO-World Health Organization; WHO 2008. www.who.int about us. 
9 WHO 2008. www.who.int about us. 
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remains, there still has not been a significant reduction in HIV incidence
10
rates.
11
 
Furthermore, the Global HIV Prevention Working Group in 2007 reported that the 
heightened global focus on providing access to treatments for AIDS adversely distracted 
attention away from HIV prevention efforts.
12
  The President of the United Nations General 
Assembly, H.E. Srgjan Kerim recently reiterated this assertion when he stated in his June 12, 
2008 statement at the UN General Assembly High Level Meeting on AIDS ―for every two 
people that begin HIV treatment there are five new HIV/AIDS infections.‖13 This statement 
in conjunction with the acknowledgement that vaccine trials have had limited success re-
emphasized the urgency to implement and scale up successful HIV prevention methods. For 
it would seem improbable that the world has the capacity to fund or manage widespread 
distribution of medical treatments if new HIV infections continued at the pace H.E. Srgjan 
Kerim outlined. 
WHO and UNAIDS argued in 2006 that those most vulnerable to HIV have had limited 
access to prevention strategies due to the fact that several policy-makers have chosen to 
refrain from implementing methods that have been proven to be effective.
14
 However, AIDS 
activists and researchers have argued that the lack of improvement in reducing HIV incidence 
rates has been in part due to the excessive focus and funding placed on of the Western 
world‘s ABC (Abstinence, Be faithful, and use Condoms) behaviour change program.15  
Nonetheless after 27 years of experience, whether due to the lack of political will or 
ineffective prevention strategies, the following findings are dismal and of grave concern, if 
prevention remains the only known cure for HIV. Only 12% of men and 10% of women in 
sub-Saharan Africa know their HIV status, men‘s condom use and acceptance levels remain 
extremely low for the magnitude of the epidemic.
16
 Women condoms remain in short supply 
with almost non-existent usage rates and still only 31% of HIV-infected pregnant women 
                                                 
10 HIV incidence (sometimes referred to as cumulative incidence) is the number of new cases arising in a given period in a specified 
population. UNAIDS normally refers to the number of people (of all ages) or children (0–14 years) who have become infected during the 
past year. UNAIDS 2008. Terminology Guidelines. 
11 Connor, Steve and Chris Green 2008. Is it time to give up the search for an Aids vaccine?; Santini, Jean-Louis 2008. Researchers 
despondent as AIDS vaccine still out of reach; USA Today 2008. Experts: Africa AIDS funds wasted; UNAIDS 2005:53. AIDS in Africa: 
Three scenarios to 2025. 
12 Global HIV Prevention Working Group 2007:1. Bringing HIV prevention to scale: an urgent global priority. 
13 United Nations 2008:4. Closing of the high-level meeting on HIV/AIDS, statement by H.E. Srgjan Kerim. 
14 UNAIDS and WHO 2006:124. Report on the global AIDS epidemic: A UNAIDS 10th anniversary special edition.  
15 Potts, Malcolm et al. 2008. Reassessing HIV prevention; Epstein, Helen 2007: The invisible cure; Whiteside, Alan 2008. HIV/AIDS: A 
very short introduction. 
16 Global HIV Prevention Working Group 2007:2. Bringing HIV prevention to scale: an urgent global priority cited from WHO, UNICEF, 
and UNAIDS 2007, Towards universal access: Scaling up priority HIV/AIDS interventions in the health sector. 
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receive antiretroviral prophylaxis to prevent mother-to-child transmission.
17
 These factors 
may underscore why 90% of all children infected with HIV live in sub-Saharan Africa and 
how 420,000 children became newly infected with HIV in 2007.
18
 
The prevention findings outlined above highlight the assertions for why there has been a 
growing urgency for accelerating National HIV prevention campaigns in vulnerable regions 
and the need for providing universal access programs that include prevention, treatment, care 
and support.
19
 An example of this movement towards targeting prevention can be observed in 
South Africa. Where a country many have found to be evasive or cautious in their approach 
to HIV/AIDS, unequivocally defined Accelerated Comprehensive HIV Prevention Programs 
as a strategic priority in their 2006/07 South African National Healthcare Plan.
20
 In part, 
South Africa‘s efforts can underscore the growing anxiety surrounding the belief that 
countries and donors cannot rely on treatment alone and therefore the need to strengthen and 
maintain HIV prevention strategies must remain a complementary goal. 
Brazil, Thailand and Uganda all were recognized for their early successes in reversing the 
spread of HIV and AIDS. These stories have been well documented and highlighted how 
HIV prevention works when there was strong political leadership sending an ongoing 
message of awareness and prevention.
21
 However, the recent reversals witnessed in some of 
Uganda and Thailand‘s gains can only support the evidence, which claims HIV prevention 
efforts need consistent and well funded prevention strategies, defined by a country‘ unique 
epidemic and available resources.
22
  
In response to the evidence and concerns regarding new HIV infections, WHO and UNAIDS 
stated, ―prevention must be greatly prioritized in the response to AIDS and efforts are being 
made to find new prevention technologies to bolster the package of already know effective 
prevention methods.‖23 Potential new prevention methods discussed by the Global HIV 
Prevention Group in 2006 were female microbicides, HIV vaccines, male circumcision, pre-
exposure prophylaxis with antiretroviral medication, herpes suppressive therapy and cervical 
                                                 
17 UNICEF, UNAIDS and WHO 2008:1. Children and AIDS: Second stocktaking report, actions and progress, fast facts. 
18 Ibid:1. 
19 WHO/AFRO 2006. The year to accelerate HIV Prevention in Africa; UNAIDS 2007. Practical guidelines for intensifying HIV prevention: 
Towards universal access; United Nations 2008:8. Declaration of commitment on HIV/AIDS and political declaration on HIV/AIDS: 
midway to the millennium development goals. 
20 South Africa Department of Health 2006. Annual National Health Plan 2006/07. 
21 UNAIDS and WHO 2006: 124. Report on the global AIDS epidemic: A UNAIDS 10th anniversary special edition. 
22 UNAIDS 2007:5. UNAIDS Annual Report: Knowing your epidemic; United Nations 2008:8. Declaration of commitment on HIV/AIDS 
and political declaration on HIV/AIDS: midway to the millennium development goals. 
23 WHO and UNAIDS 2007:2. New data on male circumcision and HIV prevention: Policy and programme implications. 
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barrier methods, many of which had trials pending or were currently in progress.
24
 However, 
by 2008 the overwhelming majority of those trials were stopped for lack of efficacy, which 
sent a disappointing message to many in the AIDS community.
25
 The only prevention method 
that showed strong evidence based outcomes was male circumcision.  
Male circumcision occurs when the foreskin of a man‘s penis has been fully or partially 
removed. This procedure had been discussed as a possible medical intervention for HIV 
prevention for at least 15 years, due to numerous ecological and observational studies 
showing an association between male circumcision and the reduced risk of HIV infection in 
men.
26
 Although the body of research had been significant, numerous critics argued the 
evidence demonstrated only an association between male circumcision and HIV, because the 
majority of the studies could not account for possible confounding factors such as religion, 
culture, and behaviour.
27
 Thus, in order to validate the previous findings, researchers at the 
start of the 21
st
 century planned and designed three randomized controlled trials (RCT‘s) to 
evaluate the effect of male circumcision on HIV infections. 
At the end of 2006, the three RCT‘s on male circumcision were all officially terminated, each 
having been stopped early by their respective data safety monitoring boards (DSMB) because 
interim findings showed that the group of men circumcised had a significantly lower rate of 
HIV infections than the group not circumcised.  The three trials were conducted in Rakai, 
Uganda, Kisumu, Kenya and Orange Farm, South Africa. The final research findings 
demonstrated that there was a 51% to 60% reduction in the risk of men becoming infected 
with HIV during vaginal intercourse if they were circumcised.
28
    
In direct response to the research findings presented from the Kenya and Uganda RCT‘s 
media, academic researchers, medical and humanitarian communities shifted their attentions 
to the how and why‘s of male circumcision and the feasibility and acceptability of using it as 
a tool for HIV prevention is sub-Saharan Africa.  With the renewed focus and emphasis on 
                                                 
24 WHO and UNAIDS 2007:3. New data on male circumcision and HIV prevention: Policy and programme implications; Global HIV 
Prevention Working Group 2006:2. New approaches to HIV prevention: Accelerating research and ensuring future access. 
25 WHO, UNAIDS and UNICEF 2008: Towards universal access: scaling up priority HIV/AIDS interventions in the health sector; Timberg, 
Craig 2007. The rethink of AIDS policies. 
26 Siegfried, N. et al. 2003. Male circumcision for prevention of heterosexual acquisition of HIV in men; Gray, Ronald et al. 2007. Male 
circumcision for HIV prevention in young men in Rakai, Uganda: a randomized controlled trial. 
27 Howe, R.S. Van 1999:8. Circumcision and HIV infection: Review of the literature and meta-analysis; Siegfried, N. et al. 2003. Male 
circumcision for prevention of heterosexual acquisition of HIV in men. 
28 Auvert, Bertran et al. 2005 Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk; Gray, 
Ronald et al. 2007. Male circumcision for HIV prevention in young men in Rakai, Uganda: a randomized controlled trial; Bailey, Robert 
et al. 2007. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomized controlled trial. 
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accelerating and providing comprehensive HIV prevention strategies and the reportedly low 
percentages of circumcised men in many parts of sub-Saharan Africa WHO and UNAIDS 
took immediate action to evaluate and confirm the findings on male circumcision. They 
initiated a review of the trials and any other relevant evidence surrounding male 
circumcision, with the objective to discuss policy and programme implications and to make 
recommendations regarding public health issues.
29
 
On March 28, 2007 WHO and UNAIDS published their recommendations from the 
international consultation that convened on March 6-8, 2007 in Montreux Switzerland. Their 
findings supported the evidence put forth from the three medical trials. Male circumcision 
was recognized as ―an efficacious intervention for HIV prevention.‖30 Furthermore, they 
asserted, ―the three randomized controlled trials showed that male circumcision performed by 
well-trained medical professionals was safe and reduced the risk of acquiring HIV infection 
by approximately 60%.‖31 Modeling forecasts were utilized to determine where the 
intervention would have the greatest benefit, they concluded it was regions with hyper-
endemics,
32
 and less than 20% of its men circumcised.
33
 Based on those assumptions male 
circumcision was targeted for countries in sub-Saharan Africa and predominantly in the sub-
region of Southern Africa. Thereafter the statements made by WHO and UNAIDS, were 
reported by numerous international media sources emphasizing the impact mass male 
circumcision programs would have on reducing the amount of new infections in African 
countries.  
During this same time period AIDS Vaccine Advocacy Coalition, UCLA AIDS Policy 
Development Center, WHO and UNAIDS all documented significant social and behavioral 
factors that could impede the effectiveness of male circumcision as a public health prevention 
strategy for HIV. The areas that posed the greatest concern were the messaging of 
circumcision, social and economic factors, cultural implications, human rights, legal and 
ethical implications, consequences relating to unskilled professionals and inadequate physical 
infrastructures and lastly the effect on women.  
                                                 
29 WHO and UNAIDS 2007:2. New data on male circumcision and HIV prevention: Policy and programme implications. 
30 Ibid:3. 
31 Ibid:3. 
32 Hyper-endemics are HIV prevalence in the general population exceeds 15%. 
33 WHO and UNAIDS 2007:7. New data on male circumcision and HIV prevention: Policy and programme implications. 
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Although there were calls for additional research on the social, behavioural and economic 
effects of male circumcision, it had a minimal impact on the growing momentum for 
implementing and funding male circumcision at a public health level. On August 20, 2007, 
US Secretary Mike Leavitt announced that The President‘s Emergency Plan for AIDS Relief 
(PEPFAR) would start funding male circumcision programs in some African countries in an 
effort to reduce the spread of HIV.
34
 Furthermore, in September 2007, Rwanda‘s Health 
Ministry officially announced the launch of a mass male circumcision campaign, with the 
initial rollout targeting the army, police, and university students.
35
  Additionally some 
countries made plans for widespread male circumcision programs and started to initiate 
guidance through establishing National Policy Programs for Male Circumcision, such as: 
Zimbabwe, Mozambique, Tanzania, Kenya, Swaziland and Malawi.
36
 
Interestingly in response to the male circumcision research conducted in his country, 
President Yoweri Museveni of Uganda argued that he feared his country could regress in HIV 
prevention if people do not comprehend that circumcision was not a cure.  Emphatically 
President Museveni stated ―These days, there are many confusing messages: one of them is 
that if you are circumcised, you are less likely to catch AIDS even if you behave recklessly – 
now what sort of message is that?‖37 The President surmised that the outcome sends the 
wrong message and creates apathy.
 38
 Furthermore, Museveni stated, ―I am worried that HIV 
infection rates have started to rise, and people think that HIV is no longer there. The way we 
controlled AIDS was because of an unequivocal message that there is a sickness, which is not 
curable, you get it through sex, and when you get it, you die. Therefore, avoid all risky sexual 
behaviours.‖39  
The debates concerning male circumcision have taken on many diverse points of view from 
religious, medical, ethical, cultural, political and financial. The arguments have been complex 
and varied depending on what academic and medical discipline one prescribes and 
furthermore ones ideology of the epidemic in sub-Saharan Africa. In seeking to understand 
the debates surrounding male circumcision it was evident that to have any clarity on the 
significance of the arguments one needed to understand the substantive factors that 
                                                 
34 Timberg, Craig 2007. Anti-AIDS program to fund circumcision. 
35 Musoni, Edwin 2007. Rwanda: Government readies for mass male circumcision. 
36 News24.com 2007. SA needs mass circumcision.  
37 IRIN PlusNEWS 2007.  UGANDA: Findings on circumcision my derail HIV/AIDS fight-President.  
38 IRIN PlusNEWS 2007.  UGANDA: Findings on circumcision my derail HIV/AIDS fight-President.  
39 Ibid:1.IRIN PlusNEWS 2007. UGANDA: Findings on circumcision my derail HIV/AIDS fight-President. 
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influenced and compelled WHO and UNAIDS to endorse male circumcision at the time they 
did.  
2. Research Question 
Why did the WHO and UNAIDS endorse male circumcision as a public health initiative for 
HIV prevention in sub-Saharan Africa? 
Hypothesis 
WHO and UNAIDS decision was in direct response to the increasing rates of HIV incidence 
in sub-Saharan Africa and their knowledge that HIV prevention efforts focused on 
behavioural modification have  not produced the results experts projected, even when African 
governments supported and endorsed prevention. 
3. Aims of Research 
 Clarify what WHO and UNAIDS function is in relation to HIV prevention in sub-
Saharan Africa. 
 Critically analyze the factors that have influenced WHO and UNAIDS to support 
male circumcision as a public health initiative. 
 Explain how WHO and UNAIDS utilized their historical findings on why social and 
behaviour factors hinder HIV prevention in sub-Saharan Africa when evaluating the 
effectiveness of male circumcision.  
 Examine the views of HIV/AIDS and male circumcision experts and organizations, 
relating to how they interpreted why WHO and UNAIDS made their 
recommendations for male circumcision in sub-Saharan Africa. 
 Explore how WHO and UNAIDS assessed the impact of male circumcision on 
women. 
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4. Rationale 
In recent years, it has been stated that the sub-Saharan Africa‘s AIDS epidemic has reached a 
level of ―maturity‖,40 however the region remains the worst affected area in the world. We 
have seen Botswana and Uganda, two countries who have benefited from state support and 
leading international AIDS initiatives, struggle to combat the deadly epidemic. Moreover, 
evidence shows the significant gains in providing ARV services has not resulted in a 
substantial reduction in new HIV infections.
41
 
These discouraging observations can only re-emphasize the need for promoting prevention 
methods that could have an immediate impact on reducing the transmission of HIV while still 
having a lasting effect towards combating the overall epidemic. Thus, when we witness the 
two most recognizable AIDS and health organizations in the world, making commanding 
endorsements to have male circumcision incorporated into public health HIV prevention 
strategies we should be compelled to question and understand why and how they made their 
recommendations. Furthermore, through knowing why they made a confident endorsement 
for male circumcision, we might gain insight into how their approach towards HIV 
prevention will influence the immediate and future direction of HIV/AIDS in Africa. 
In addition by seeking to clarify the process WHO and UNAIDS undertook to evaluate male 
circumcision, it would seem appropriate to question why male circumcision has been 
endorsed and how it will affect the universal fight towards improving overall population 
health in Africa with the limited infrastructures, budgets and human resources available for 
healthcare. The research may also provide a perspective for learning how WHO and 
UNAIDS evaluate and balance funding, research and policy actions when making 
recommendations.  
Lastly, the researcher hopes the outcomes of this research will further the debates 
surrounding how best to utilize behavioural and social factors in assessing, evaluating and 
understanding the overall effectiveness a biomedical intervention will have on a disease that‘s 
―social‖ in nature. 
                                                 
40 Maturity – the high levels of reporting deaths and new infections has leveled off 
41 Global HIV Prevention Working Group 2007:1. Bringing HIV prevention to scale: an urgent global priority, cited from WHO, UNICEF, 
and UNAIDS 2007. Towards universal access: scaling up priority HIV/AIDS interventions in the health sector; United Nations 2008:4. 
Closing of the high-level meeting on HIV/AIDS, statement by H.E. Srgjan Kerim. 
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5. Research Design & Methodology 
Intrinsic to the research question and the aims put forth in this study was the need to explain 
how WHO and UNAIDS processed, analyzed and formulated ideas and strategies when 
presented with information on male circumcision. The design strategy that provided the most 
appropriate means for collecting, interpreting and reporting the data necessary to answer the 
research question was a qualitative method of research. Strauss and Corbin defined 
qualitative research, as ―any kind of research that produces findings not arrived at by means 
of statistical procedures or other means of quantification.‖42   
The approach used for presenting the final findings of this research was the synchronic style 
of reporting defined by Weiss as a report that achieves coherence without a focus on time; the 
structure was based on presenting the report using significant sectors, which flow in a logical 
sequence.
43
 The researcher used this principle of design to present the complexity of factors 
surrounding male circumcision and HIV prevention into an integrated logical cohesive story 
by categorizing the data. 
5.1. Data-Collection 
The goal at this stage of the research was to gather and organize various types of empirical 
evidence for analysis and review. There are various methods and techniques of observation 
available to facilitate the collecting of data, such as, document analysis, interviewing, surveys 
and ethnography.
44
  The two methods of collection that were best suited to address the aims 
of this study were Document Analysis and Semi-Structured Interviews. 
Document Analysis 
The key pieces of literature analyzed were: WHO and UNAIDS position papers on male 
circumcision, HIV prevention and gender in sub-Saharan Africa, the general periodicals and 
research focused on male circumcision and HIV prevention, biomedical influences on 
HIV/AIDS, WHO and UNAIDS position papers aimed at understanding HIV prevention in 
sub-Saharan Africa, the politics and power of AIDS and lastly the historical findings on why 
                                                 
42 Strauss, Anselm and Juliet Corbin 1990:17. ―Basic considerations‖ in Basics of qualitative research: grounded theory procedures and 
techniques. 
43 Weiss, Robert 1995:44. Learning from strangers: the art and method of qualitative interview studies. 
44 Mouton, Johann 2006. Understanding social research. 
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women are disadvantage to men in sub-Saharan Africa. The majority of the documents were 
obtained through utilizing the University of Witwatersrand library, Yahoo‘s World Wide 
Web search engine and through reviewing the bibliographies of previous literature. 
The collection of documents and their subsequent analysis was a critical factor in determining 
the most relevant questions for the interviews and for deciding which candidates were the 
most ideal to request participation. The researcher reviewed and analyzed key pieces of 
literature before conducting the interviews. This strategy helped to structure and organize the 
interviews into a clear and concise format, thus maximizing the time of the participants and 
researcher. 
During the interviews, it became immediately evident to the researcher that the majority of 
the literature reviewed up to this point had a perspective that supported male circumcision 
and furthermore the authors of these documents consistently referenced each other‘s work. At 
this stage of the research, it became apparent that additional efforts were needed to expand 
the scope of documents reviewed. After taking recommendations from participants the 
researcher engaged in a new document collection search by using new key words and authors 
to locate additional views and knowledge. The literature included content on clinical trials, 
religion and culture of male circumcision, neonatal circumcision, policy and health in Africa, 
ethics, women and male circumcision and the views of leaders from UNAIDS and WHO. 
Furthermore, it was discovered after conducting some of the interviews with WHO and 
UNAIDS that a more rigorous evaluation of their respective organizations was needed. Thus, 
a second analysis of WHO and UNAIDS  male circumcision documents transpired, and 
included: regional consultation on male circumcision and HIV prevention (Nairobi, 
November 20-21, 2006), strategies and approaches to male circumcision programming 
(Geneva, December 5-6, 2006), perspectives from social science on male circumcision for 
HIV prevention (Durban, January 18-19, 2007) and the UN Work Plan for Male 
Circumcision. Furthermore a review of both organizations websites and their respective 
literature on male circumcision was conducted, and lastly an examination was undertaken to 
locate any male circumcision research authored or co-authored by WHO and UNAIDS 
employees. 
In addition to collecting additional data on male circumcision from WHO and UNAIDS it 
also became imperative to understand their leaderships ideology and strategies. Lastly, a 
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search was completed to locate how previous biomedical interventions such as mother-to-
child transmission and ARV programs were documented and if there was guidance for 
biomedical trials. 
The data that was collected and analyzed during the second phase was then utilized as a 
foundation for the interviews with Catherin Hankins, UNAIDS Chief Scientific Adviser and 
Kevin De Cock, WHO Director of HIV/AIDS Division. Furthermore, the data was used as 
the basis for the follow-up questions, which were sent to UNAIDS at the completion of all 
the interviews, it should be noted the researcher requested the participation of Dr. Peter Piot, 
UNAIDS Executive Director, however based on to his schedule he declined. 
Semi-Structured Interview 
The semi-structure interview was the method used to collect primary data needed to 
accomplish the aims of this research. The semi-structured style provided the framework 
needed to ask well-defined guiding questions while still providing for the flexibility to ask 
questions as the interview progressed.   
By choosing the semi-structured style of interview, the risk of producing biased assumptions 
was reduced by enabling the researcher to ask additional questions. Likewise, the defined 
group of guiding questions provided the foundation for allowing a comparative analysis of 
the data collected from the interviews. See Appendix A for a list of guiding questions utilized 
during this research. 
The critical criteria for selecting the sample were expert knowledge surrounding the debates 
on male circumcision, the respondents influence on creating policies for HIV prevention 
programs, and lastly availability and willingness to participate. The master list of possible 
respondents was originally developed by reviewing the documents published on the male 
circumcision; the United Nations task forces that cover topics on HIV/AIDS, education and 
gender; all media accounts; the websites of sub-Saharan Africa countries specific to the 
Ministry of Health and HIV/AIDS; and the employees of UNAIDS and WHO that cover the 
region of Southern Africa.   
To achieve the aims outlined for this study it was necessary to construct two groups of 
potential respondents, see Appendix B for list of participants. 
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Group 1 
Group 1 comprised employees from WHO and UNAIDS or one of its 10 co-sponsors. The 
selection criterion was based on their experience in one or all of the following topics: 
involvement in the creation of the male circumcision positioning document, an understanding 
of gender and HIV/AIDS, and/or expertise in the field of HIV prevention in sub-Saharan 
Africa. The initial contact was made with senior management, to ensure that all ethical 
considerations were adhered to and the proper political etiquette was followed.  
Group 1 had 6 completed interviews, versus the 8 forecasted. This in many ways appeared to 
be based on the two organizations‘ structure of referring any requests relating to male 
circumcision back to the key players responsible for managing the program at WHO and 
UNAIDS. From the researchers perspective unless additional participants had opposing views 
a greater number of respondent did not appear likely of furthering the quality of this research. 
Group 2 
Group 2 included experts from NGO‘s, universities, governments and medical practitioners 
and will be referred to as ‗experts‘. The selection criterion was based on their experience and 
reputation in one or all of the following topics: experience in the medical field of male 
circumcision, an understanding of gender and HIV/AIDS, and expert familiarity with HIV 
prevention in sub-Saharan Africa. Participants from Group 2 were contacted in the following 
order, trial researchers, South Africa experts, Governments, and international experts.  
Group 2 had 21 completed interviews, which was consistent with the original objective of the 
research set at achieving between 20 to 25 interviews. Another objective the researcher had 
for Group 2 was to achieve a broad scope of representation; the aim was to have at least 15 
unique organizations, at the conclusion of the interviews 20 unique organizations were 
represented. In addition to the respondents originally selected, the snowball technique of 
sampling was successfully used to broaden the diversity of opinions amongst participants. 
The interviews occurred from March 19, 2008 and ended May 9, 2008, 27 interviews were 
completed in total.  Group 1, ‗WHO and UNAIDS‘ had 6 participants their respective 
residential locations were: 3 Switzerland and 3 South Africa. Group 2, ‗experts‘ had 21 
participants and their respective residential locations were 11 South Africa, 6 United States, 1 
Kenya, 1 Zambia, 1 Australia, and 1 France.  
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The interviews that were completed with a face-to-face format were done so at four major 
urban locations in South Africa: Durban, Cape Town, Johannesburg and Pretoria. The 
remaining interviews were conducted via telephone. Within Group 1 ‗WHO and UNAIDS‘: 2 
interviews were conducted via telephone, and 4 in person, and within Group 2 ‗experts‘: 9 
interviews were conducted via telephone, and 12 in person. 
Each interview was scheduled for 45 minutes and the shortest was 35 minutes, the longest 
lasting 1 hour 30 minutes, and the majority lasting 50 minutes. Only one interview was not 
completed in full due to scheduling issues. No follow-up interviews were conducted and 
when clarification of interview content was required, the researcher contacted the participant 
through email. The researcher tape-recorded all interviews except for three, which were not 
recorded due to poor site or time constraints. To assist in the transcribing of the interviews 
the researcher hired a transcription services for 19 of the interviews. 
5.2. Data-Analysis and Reporting 
This phase of the research focused on utilizing the most appropriate data analysis techniques 
for producing an unbiased explanation and/or conclusion to the research.  As outlined 
previously a qualitative method of data analysis was utilized to analyze the data gathered 
through interviews and document analysis. Utilizing the principles outlined by Weiss, the 
strategy best suited to report the data collected in this research was an issue-focused and 
concrete approach to the analysis, including a comparison between WHO and UNAIDS, and 
the expert‘s data. 
Weiss explained four distinct analytic processes involved in producing issue-focused analysis 
in relations to interview material they are coding, sorting, local integration and inclusive 
integration.
45
 These principles of issue-focused analysis were the framework for analyzing 
and reporting the data collected in this research. The final report was presented in a 
synchronic structure, focused on presenting the findings in a logical method using sectors.  
The data-analysis phase occurred simultaneously with the data-collection phase, which 
assisted the researcher in reducing the overall time required to complete the study.   
  
                                                 
45 Weiss, Robert 1995:154. Learning from strangers: The art and method of qualitative interview studies. 
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5.3. Limitations 
The complexity of the debates surrounding male circumcision created the greatest challenge 
within the context of this research. The expertise required from epidemiology, social science, 
cultural and religious practices relating to male circumcision, the medical procedures for 
male circumcision, neonatal circumcision, HIV prevention programs and strategies, the 
epidemic in sub-Saharan Africa, public health policies, biomedical critiques, psychology, 
behavioural science, RCT‘s, ethics, healthcare in less developed regions, gender and the 
politics and power of HIV/AIDS were a few but not limited in scope. Additionally, it could 
be argued that by not having the necessary education and specialization in the respective 
fields the researcher‘s ability to comprehend or assimilate the findings could be viewed as a 
limitation. 
In recognizing the research was qualitative in nature the evidence gathered from the 
interviews may not reflect the opinion of the organization they represent or it may also be 
their policy not to voice opinions, thus there was the limitation of biased or extenuating 
factors which could have influenced individual‘s responses. 
This research was limited by the constraints of having to consolidate the extensive breadth of 
knowledge into a format and timeframe suitable for a Master Degree. Furthermore, the 
inability to engage views and opinions from MoH‘s could be viewed as a weakness. 
5.4. Ethical Considerations 
One of the goals of this research was to conduct a study that was objective and sensitive to 
the participant‘s rights, while still ensuring the final findings were accurate, reliable and 
unbiased. Furthermore, it should be stated that this research did not involve any vulnerable 
persons, groups or populations. 
Interviews 
In accordance with following the ethical standards outlined by the University of the 
Witwatersrand, the researcher ensured all potential respondents were aware of their 
responsibilities, rights, and obligations before participating in this research. The following 
events occurred during the interview phase, which provided the framework required to ensure 
all ethical requirements were achieved when planning and conducting the interviews. 
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Introduction 
Each potential respondent was notified of the research through email and where necessary a 
follow-up phone call or email occurred, see Appendix C for a copy of the letter sent. The 
introduction and follow-up conversations included outlining the scope of the research and the 
estimated time forecasted to conduct the interviews. Furthermore, a letter from the 
researcher‘s advisor was included in the original invite to assist with ensuring the validity and 
relevance of the research.  
If a potential respondent confirmed they were unavailable the researcher most often sent a 
thank you note for their consideration and when no response was received the researcher 
followed-up 2 to 3 additional times by telephone or email and upon no response from the 
potential respondent the researcher would deemed them not interested in participating. 
The Interview 
Before an interview started, the researcher asked each participant if the conversation could be 
recorded and inquired into their preference on how to be referenced (cited) within the 
research, anonymous or with their professional title and respective organization. The 
researcher proceeded by outlining that any quotes or references utilized in published research 
would be submitted to them for approval and furthermore if they did not want to answer any 
questions during the interview that was their choice.  
All participants allowed the researcher to reference their participation and 5 respondents 
asked for specific quotes to be regarded as anonymous. 
Document Analysis 
Throughout the research, various public and private documents were utilized to enhance or 
confirm the research findings.  To ensure the documents were protected and referenced in an 
ethical and unbiased method the following guiding principles were used throughout the 
research: 
 Ensure all documents presented in the in-text and references were accurately 
acknowledged through the Chicago (history) Style of citation. 
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 Receive written or verbal confirmation from any organization that provided private 
documents and adhere to all confidentiality requirements placed on such documents. 
 Protect all interview transcripts during and after submitting the final research. 
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Chapter Two: Literature Review 
1. Background 
The key literature used to critically explain WHO and UNAIDS‘ decision to endorse male 
circumcision as a public health initiative in sub-Saharan Africa included the politics of 
HIV/AIDS, medicine and HIV/AIDS, public health and policy, and barriers to greater 
equality for women. 
2. Politics of HIV/AIDS 
In seeking to explain why WHO and UNAIDS made various decisions relating to their 
endorsement for male circumcision the researcher chose to engage some of the most recent 
literature that described the various ways HIV/AIDS stakeholders have influenced and 
challenged AIDS policymaking in Africa.  It was also important to examine how the 
structures of international and local stakeholders promote or impede mutual collaboration 
when developing and implementing AIDS policies.  
Patterson argued that there were four key factors that have influenced AIDS policymaking in 
Africa: democratic transitions, donors, the state, and civil society.
46
  In her opinion, the 
―variation in state development, the unevenness of democracy, the tenuous power of civil 
society and the uncertain outcomes of donor programs causes the AIDS fight to be 
insufficiently institutionalized into African politics.‖47 Patterson defined the 
―institutionalizing of AIDS‖ as an approach which viewed decision making as a long term 
accountable process that recognized all key stakeholders (donors, state, civil society and 
those infected) as supportive partners in the struggle to combat AIDS. She further asserted 
that institutionalizing the AIDS fights would change the short-term humanitarian perception 
that AIDS was an emergency to solve, to one that was centered on the long-term ideology of 
the disease.
48
 The author maintained that leaders needed to address the inequality of power 
and representation that existed in AIDS decision-making if there was to be an environment 
where AIDS policies and programs were defined and managed on the principles of 
                                                 
46 Patterson, Amy 2006:1. The politics of AIDS in Africa.  
47 Ibid:1. 
48 Ibid:2. 
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sustainability and accountability.
49
 Patterson believed the ideal way to address the inequality 
in power and representation was through empowering civil societies with the means to 
engage in substantive policy discussions.
50
  
De Waal contended that AIDS organizations and activists have shaped the character and 
structure of the AIDS response through promoting a human rights and voluntary participation 
based approach.
51
 He explained how the powerful international AIDS organizations have the 
potential to utilize their influence on local African communities either through 
communicating positive or negative strategies when responding to the epidemic. He 
discussed how international AIDS activists and donors have the power to utilize their 
collective voices and funds to raise awareness and give support to marginalized 
communities.
52
 Conversely, De Waal warned that the same international AIDS community 
have also shown the capacity to solidify into an ―introverted bureaucracy that soldiers on, 
pushing certain formulae on African societies‖, resulting in policies and programs that 
become inadequate or inappropriate for combating the AIDS epidemic.
53
  
According to De Waal, institutional and political interests have driven the AIDS strategies in 
sub-Saharan Africa.
54
 To support his assertion De Waal discussed how AIDS policies and 
national plans have not been translated or implemented into sustainable and effective 
community based programs.
55
  De Waal blamed this lack of action on the fact that ―African 
rulers, with a sound appreciation of how power functions, know that they won‘t be removed 
from office or even face political threats on account of AIDS.‖56 Furthermore, De Waal 
argued that the chronic nature of HIV/AIDS allowed politicians in countries where there have 
been term limits to avoid the long-term implications and responsibility for managing the 
epidemic.
57
 For AIDS experts have agreed that the delayed diagnosis of the disease from 
infection to illness (approximately 8 years) has provided leaders with a mechanism for 
justifying the resources allocated to the economy, crime, war, and poverty.
58
  
                                                 
49 Patterson, Amy 2006:18. The politics of AIDS in Africa. 
50 Ibid:18. 
51 De Waal, Alex 2006:121. AIDS and power. 
52 Ibid:121. 
53 Ibid:121. 
54 Ibid:123.  
55 Ibid:2. 
56 Ibid:2. 
57 Ibid. 
58 Patterson, Amy 2006:18. The politics of AIDS in Africa; De Waal, Alex 2006. AIDS and power. 
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Beside the fact, political leaders have had little economic incentive to support pervasive 
HIV/AIDS efforts; De Waal believed inertia was also caused by the absence of political 
leaders constituents demanding action.
59
  When recognizing many of the economic and social 
conditions that shape life in sub-Saharan countries are immediate in nature, it becomes 
obvious for one to understand why the majority of politicians and their constituencies still 
cannot justify putting AIDS at the top of the political agenda.  
In responding to the evidence that the AIDS epidemic has not adversely affected sub-Saharan 
Africa economies, Whiteside recently raised an opposing and moral view to the dilemma.  He 
expressed his concern that there may be situations where individuals are dying unnoticed due 
to their lack of contributions to the national economy.
60
 By examining Whiteside‘s concern, 
we can begin to develop a sense of awareness to the complexity and challenges governments 
face when aiming to balance human rights, politics, economic growth and AIDS.
61
 
Whiteside also gave insight into the possible shift that may be happening in African politics 
and AIDS. This shift was in response to the number of politicians that have died from the 
disease, which has resulted in loss of intellectual capital and growing financial costs 
associated with re-election campaigns.
62
 Thus, he concluded these financial and productivity 
losses might influence political leaders to take a more active role in the management of 
AIDS.  
The literature on politics and AIDS starts to explain why organizations like WHO and 
UNAIDS might take an active role in developing and endorsing strategies that could possibly 
facilitate governments towards action.  The historical difficulty of organizing and 
coordinating AIDS stakeholders towards a unified direction offers an insight into the 
challenges and politics of establishing a cohesive and unbiased response to AIDS. The 
literature also sheds light on the potential influence and power international organizations 
could use to assist those communities most vulnerable, especially when governments and 
their constituencies may be absent or enable to provide support. Each one of these viewpoints 
starts the process towards explaining why certain actions were taken by WHO and UNAIDS 
during the evaluation and endorsement for male circumcision. 
                                                 
59 DeWaal, Alex 2006. AIDS and power. 
60 Whiteside, Alan 2008:93. HIV/AIDS: A very short introduction. 
61 Ibid:93. 
62 Ibid:94. 
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3. Medicine and HIV/AIDS  
To explain why WHO and UNAIDS proceeded with evaluating male circumcision in the 
manner they did, the researcher had to establish the prevailing and historical framework used 
to manage HIV/AIDS. Upon concluding, the prevailing ideologies were established through a 
medical lens, the researcher examined literature to understand how this discipline might have 
influenced WHO and UNAIDS and their consultative process.   
Response to HIV/AIDS 
Panem outlined three stages that commonly occur when managing a new epidemic.
63
 The 
stages were defined as follows, ―the initial period always is characterized by unknowns. A 
second period begins when effective medical treatment or prevention becomes available. A 
third period, devoted to fine-tuning prevention and intervention, follows.‖64 Each one of these 
stages relied heavily on the medical network of scientists, researchers and public health 
institutions that managed the definition of the disease, the cure of the disease and the 
appropriate education and intervention strategies to prevent the disease. Another key 
principle outlined in Panem‘s work was the understanding that AIDS was discovered and 
defined by Western medical institutions, which influenced how each stage of the epidemic 
was developed. The characteristics of the Western epidemic at that time were homosexual 
intercourse, drug users, and unsafe medical practices.
65
  
Panem‘s thesis relied heavily on the bureaucracy of AIDS and defining the types of 
institutions that manage epidemics classified as a health emergency. Her work focused on 
two agencies the National Institutes of Health (NIH) and the Center for Disease Control 
(CDC), her rationale was premised on the fact that these organizations had directed the 
largest portion of the initial response.
66
 Furthermore, Panem maintained that the inability of 
the different agencies to effectively communicate ―exacerbated the effort to manage the 
AIDS epidemic.‖67 In addition to her concerns relating to NIH and CDC she explained how 
the biomedical research establishment ―was criticized for slowness in its response to the crisis 
                                                 
63 Panem, Sandra 1988:2. The AIDS bureaucracy. 
64 Ibid:2. 
65 Ibid:2, 18-22. 
66 Ibid:4.  
67 Ibid:5.  
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and for reliance on a peer review system whose incentives may encourage personal ambition 
at the expense of the overall scientific effort.‖68   
Twenty years later when Whiteside discussed the characteristics of the African AIDS 
epidemic, he described many of the same bureaucratic challenges Panem witnessed in 1988. 
For each emphasized the role of Western science and institutions, and both described the 
preoccupation with finding a medical vaccine.
69
 The types of institutions varied over the 
twenty-year period, however the common characteristic remained, they were all founded in 
the science of biology and medicine.  In recent years, there has been a concrete effort to 
expand the scope of contributors, for example economics and development; however, the 
response, people, skills, resources and management of AIDS has remained a product of 
public health and medicine.  
Each of these factors assists in clarifying and understanding of how AIDS had been directed 
and managed in Africa. For the literature has positioned that the knowledge, power, and 
expertise on AIDS was originally constructed from Western medical structures, which 
subsequently influenced decisions on research, media and the overall management of the 
disease.
 70
 Furthermore, the literature has established that the management of AIDS was 
grounded in the doctrine of medicine and public health. Schneider explained in the 
Introduction to Public Health the differences between medicine and public health; this was 
helpful in categorizing the literature and debates relating to male circumcision. 
While medicine is concerned with individual patients, public health regards the community as 
its patient, trying to improve the health of that population. Medicine focuses on healing 
patients who are ill. Public health focuses on preventing illness.
71
 
Critique of the Biomedicine 
This section will engage literature that critiques the science of medicine, with special 
emphasis on understanding how these views, attitudes and opinions may have shaped and 
influenced the discourse on male circumcision. The literature on the biomedical model of 
health was broad in scope, although the field comprised mainly of the methods and principles 
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70 Ibid:4. 
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established in biological sciences.
72
 There were various definitions of biomedical provided 
however, for this study the researcher will rely on the characteristics Annandale outlined in 
the Sociology of Health and Medicine, which in her opinion was one of the universal 
definitions of biomedicine.  
The three characteristics of biomedicine defined by Annandale included the reductivist 
approach, the doctrine of specific aetiology and the claim to scientific neutrality.
73
 The 
reductivist approach ―assumes that health and disease are natural phenomena which exist in 
the individual body, rather than in the interaction of the individual and the social world‖.74 
The doctrine of specific aetiology was seen as an outcome of the reductivist approach, which 
Rene Dubos defined in the 1960s while seeking to explain the movement from viewing 
disease as the result of an imbalance between a sick person and their environment to a 
perspective in which a disease was caused by an identifiable micro-organisms (germs, 
parasites, bacteria, etc).
75
 Lastly, scientific neutrality Annandale defined, as ―medicine can be 
rational, objective and value-free, treating each individual according to their need and 
irrespective of any sense of moral work.‖76  
In the context of HIV prevention the most commonly used biomedical intervention to date 
has been the condom, ―a barrier method that stops live virus from touching the genital 
mucosa, the treatment of other sexually transmitted diseases (STDs) that are cofactors for 
HIV transmission.‖77 The second most discussed biomedical intervention in AIDS was 
ARV‘s - a drug used to prolong life and may indirectly assist with preventing future HIV 
infections. The literature reviewed on medicine and prevention, supports the claims that male 
circumcision was a biomedical intervention and of which was surgical in nature. These 
definitions justify the rationale and need to explore the literature on the critiques of 
biomedicine in order to explain and understand why WHO and UNAIDS made their 
recommendations. The analysis of biomedicine was as vast and complex as the definition; 
therefore, to address the aims of this study the critiques will include the models perceived 
                                                 
72 Blaxter, Mildred 2005:11. Key concepts health. 
73 Annandale, Ellen 1998:6. The sociology of health and medicine. 
74 Ibid:6. 
75 Ibid:6; Blaxter, Mildred 2005:11. Key concepts of health. 
76 Ibid:7. 
77 Gibney, Laura et al. 1999:2. Preventing HIV in developing countries, cited from Zenilman, JM et al. 1995. Condom use to prevent 
incidence STD: The validity of self-reported condom use. 
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inflexibility and adaptability, notion of neutrality, male dominance and the authority over 
research and media. 
Inflexibility and Adaptability  
Gerhardt writings on the criticisms of biomedicine discussed how Rene Dubos believed the 
rigidity of biomedicine hindered its ability to address many of the illnesses and diseases 
present today.
78
  Dubos criticism emphasized medicines need to be more adaptable and aware 
of  how  people‘s environments affect their health which meant medicine needed to be more 
willing to adapt and explore new socially appropriate solutions to manage health and 
illnesses.
79
   In seeking to express his concern that medicine was to focused on the micro-
organisms that caused a disease Dubos stated ―to ward off disease or recover health, men as a 
rule find it easier to depend on healers than to attempt the more difficult task of living 
wisely.‖80 
An example of Dubos suggestions was explored by Campbell where she described the 
challenges her team encountered when implementing and evaluating HIV prevention 
programs in the mining town Summertown, South Africa. The author‘s research focused 
heavily on promoting the biomedical intervention known as condoms with the supporting 
safe sex education. However, she argued the program failed due to their inability to change 
the societal and cultural norms. Furthermore, she discussed how the studies prevention efforts 
were repeatedly undermined by the poverty and gender inequalities that plagued the 
community.
81
 Campbell explained in detail how these factors facilitated HIV infections and 
weakened the projects prevention efforts and its ability to produce positive outcomes.
82
  
Scientific Neutrality 
The critiques on scientific neutrality focused on whether medicine remains neutral when its 
practices have been fully established and ingrained as a construct of society as a whole. 
Blaxter argued, ―It cannot be neutral, for there are wider social, political and cultural forces 
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dictating how it does its work and how the unhealthy are dealt with.‖83 In the context of 
HIV/AIDS, scientific neutrality becomes ever more complex for the social, political and 
cultural factors of local communities cannot be viewed in isolation from the international 
medical ideologies and cultures that have influenced and funded a large portion of AIDS 
programs in sub-Saharan Africa. 
Male Dominance 
The feminist critiques of the biomedical model argued that medicine was an extension of the 
generalized societal roles that influenced women and viewed gender as biological in nature.
84
 
Blaxter argued in Key concepts of Health that the rationale behind the feminist‘s negative 
view of biomedicine was the fact women‘s health had been constructed by the male-
dominated medical profession.
85
  Thus, feminist believed this presence of male authority 
provided the framework to manipulate how health roles and problems were defined and 
managed for women.
86
  Another perspective of the feminist critiques came from Lupton‘s 
work in Foucault and the medicalisation critique.  She argued feminist ―have viewed the 
medical profession as a largely patriarchal institution that used definitions of illness and 
disease to maintain the relative inequality of women by drawing attention to their weakness 
and susceptibility to illnesses.‖87  
The feminist perspectives may help to explain some of the assumptions and statements issued 
on the concerns and affects male circumcision might have on women‘s health. Another 
theoretical concept used to understand and clarify WHO and UNAIDS actions relating to 
women were the principles of gender mainstreaming. Gender mainstreaming was defined by 
UNDP as ―taking account of gender relations in all policy, programme, administrative and 
financial activities and organizational procedures. It comprises two processes, (a) being 
informed about relevant gender issues and (b) incorporating this information into our 
work.‖88  By analyzing how gender mainstreaming principles were incorporated into the 
research, planning and evaluations of male circumcision, we can possibly gain insight into 
the how gender and patriarchal factors influenced WHO and UNAIDS recommendations. 
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Research, Media and Messaging 
The final critique of the biomedical model was framed in the perceived dominance and 
legitimacy of biomedical research compared to other sciences. One of most notable critiques 
of medicine and research comes from Cochrane, he believed medicine relied too heavily on 
untested assumptions and advocated for a greater use of RCT‘s when evaluating medical 
procedures.
89
  Experts have concluded that Cochrane wanted to see medicine implemented 
only after appropriated RCT‘s and cost-benefit analysis were conducted.90  By utilizing such 
an approach it would improve the ―effectiveness and efficiency‖ of medical interventions 
while reducing financial waste and improving patient care.
91
 
In the context of AIDS research, the field has been predominantly led by biology and 
medicine with the majority of funds allocated to biomedical research. De Waal argued that a 
growing challenge within the context of AIDS was ―the premature policy consensus based on 
poor evidence and analysis‖ and how biomedicine has dominated research agendas.92 This 
imbalance in funding and research may be attributed to the medical structures that have 
historically directed the AIDS epidemic. 
Another critique of biomedical research was its tendency to not address or confront the 
unique needs and conditions of the female population. Specific to the AIDS epidemic, 
Lorraine Sherr, asserted if the epidemic affects women differently than there should be a 
corresponding level of analysis targeted at understanding these differences.
93
 To explain the 
perceived bias, Levine, Travers and Bennett argued ―the view of the male body as the norm 
assumes that gender is not a crucial variable (except for exclusionary purposes), and 
consequently the knowledge base regarding HIV/AIDS is almost exclusively based on male-
derived data.‖94 Evidence shows there has been significant gains in providing a more gender 
balanced view of research, however feminists believe the challenge remains embedded in the 
historical structures of female health, which have been predominately constructed by men.  
Panem focused a significant part of her book on how biomedical research institutions 
influenced and directed AIDS research. Three key players emerged from her narrative on 
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biomedical research first, public health institutions and most notably NIH, second the medical 
universities and lastly private or not-for-profit foundations.
 95
 In addition to the key research 
institutions she highlighted the various sources of funding that has dominated AIDS research, 
they were, lobbying, special interest groups and foundations, with a large part of US federal 
funds disbursed through NIH.
96
 Interestingly Panem‘s account of the key stakeholders in 
AIDS research and funding in 1988 appears relevant today when considering the various 
actors involved in the decisions relating to the research, funding and planning of the trials and 
UN work plan for male circumcision were from these disciplines. 
Another concept presented by Panem was how biomedical research was positioned in the 
media. The public most often learns about biomedical research through radio, television, 
newspapers, weekly magazines, science magazines, and the internet. Panem discussed how in 
the early 1980s the media was continuously challenged by having to accurately communicate 
research findings and policy implications to a public that was largely unaware and/or often 
already misinformed about AIDS.
97
 She further discussed how at the start of the AIDS 
epidemic media sources were often criticized for underplaying AIDS, providing false 
information and in some cases creating public anxiety.
98
 The following statement from 
Panem draws attention to the importance of context and meaning when releasing information 
to the public. 
First, the simplification of technical material as it goes through the media from presentation to 
the public can result in its complete distortion. Second, matters that appear neutral to 
scientists may have highly offensive connotations to one segment of the public or another, 
including the groups at highest risk. And, third, professional medical literature is read by a 
wider audience then it is aimed for – a readership that may easily lose sight of important 
caveats like ‗maybe‘ and ‗possibly‘.99 
The use of caveats can be witnessed in the concerns relating to the messaging of male 
circumcision especially around the definition of ‗partial‘ protection. According to Panem, 
there was also a need to recognize the potential for biased reporting; first, she highlighted the 
fact that health organizations have the natural desire to design health messages in such a 
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manner that it will have an impact on public health. Secondly, she discussed how the media's 
preconceived ideals and beliefs could influence what they write, which affects how the public 
interprets and acts on AIDS stories and news.
100
  
Witte and colleagues supported many of Panem views in Effective Health Risk Messages, 
where they argued, ―Because individuals make so many decisions based on their emotions, 
instead of logic, it is useful to look into the research on how emotional, persuasive messages 
work.‖101 The authors explained how the majority of successful health messaging campaigns 
have been designed on ―fear appeals‖, or they aroused fear by utilizing persuasive messages 
to gain compliance. They provided examples of how media utilized horrific drunk driving 
advertisements to instill fear into school students, in hopes to stop children from drinking and 
driving. These ―fear appeals‖ were also witnessed in the Presidents of Uganda‘s statements 
(chapter 1), when he discussed his concerns on the mixed messaging of male circumcision 
and HIV prevention. Furthermore, when President Museveni stated, ―the way we controlled 
AIDS, was because of an unequivocal message that there is a sickness which is not curable, 
you get it through sex, and when you get it you die. Therefore, avoid all risky sexual 
behaviours.‖102 In this example the President was delivering an explicit fear message, defined 
as ―it is so clearly stated, there is no doubt to its meaning.‖103  Implicit fear messages ―are 
thought to be understood from the context of the message, although they are not clearly 
expressed.‖104  The authors believed that explicit fear messages work better than implicit, for 
the reason that people most often do not draw out the conclusion from implicit 
messages.
105The authors discussed that an important component of successful ―fear appeal‖ 
messaging campaigns was premised on utilizing the appropriate culturally based 
colloquialisms, which Panem earlier discussed as caveats. 
Panem‘s writings also drew attention to the system and use of medical experts, and how they 
influence the public, media and policymakers‘ perceptions of AIDS.106 In her opinion, this 
―star status‖ (expert) was often undeserving and unfounded.107  When considering the status 
of an expert Panem discussed how lay people most often did not distinguish between medical 
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expertise, thus giving all MD‘s equal status independent of their training in AIDS, public 
health or epidemiology.
108
 In her view ―when expert opinion contradicts the government‘s 
position, public skepticism and confusion result.‖109 Panem‘s observations relating to the 
media will assist in explaining some of the findings relating to the messaging of male 
circumcision and how certain events relating to WHO and UNAIDS announcements were 
managed and reported to the media.  Furthermore, how these media stories influenced AIDS 
professionals and the public‘s responses, actions, and decisions relating to the information 
reported on male circumcision. 
Nettleton and colleagues argued that the explosion of data on the internet has allowed 
biomedical establishments to promote their standard of good health as the accepted and 
preferred norm.
110
  For research have shown lay people preferred accessing accurate and 
trustworthy health information through familiar and well-established names in health.
111
  
Furthermore, biomedical sites have the financial advantage to develop user-friendly web sites 
and utilize companies such as Google and Yahoo to locate their organization at the top of 
consumer searches, thus enabling them to extend their message to global audiences.  
Power and Medicine 
To further explore how the biomedical model of healthcare impacts or influences AIDS 
ideologies, policies and programs the study needed to review literature that explains why 
medical establishments have the ability to exert power.  The use of power can be discussed in 
very broad terms throughout all aspects of human existence, economics, culture, education, 
relationships etc. This study will engage literature that discusses how medical power effects 
decision making, provides a sense of empowerment over others, and perpetuates existing 
inequalities. 
Foucault and Medicine 
A number of authors have utilized the Foucauldain framework to examine the influence of 
power in medicine these Foucault‘s critiques will be used to analyze the findings in this 
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study. One important concept of Foucault‘s work in relations to understanding WHO and 
UNAIDS actions, was his analysis of the relationship between power and knowledge. In 
Foucault health and medicine, Turner concluded, ―Foucault saw that power and knowledge 
were always inevitably and inextricably interconnected so that any extension of power 
involved an increase in knowledge and every elaboration of knowledge involved an increase 
in power.‖112 Foucault maintained that power exists ―through the disciplinary practices which 
produce particular individual, institutional and cultural arrangements.‖113 
This specific field of Foucault provides insight into how those with knowledge can influence 
those without knowledge by utilizing their knowledge as power. Foucault argued that the 
entire biomedical model of healthcare was structured within this framework of knowledge 
and power, which consequently influences how the vulnerable populations of society receive 
and view healthcare.
114
 Likewise, the Foucauldain perspective also believed it was 
improbable to simply remove power from the medical profession and hand it over to 
patients.
115
 Lupton explained ―power is not a possession of particular social groups, but is 
relational, a strategy which is invested in and transmitted through all social groups‖, which 
she believed was Foucault‘s method of expressing the collusive nature of power in relation to 
medicine.
116
 The last dimension within Foucault‘s work was his emphasis on how the 
―dispersed nature of power‖ influenced the complex framework of healthcare.117 Lupton 
summarizes Foucault‘s view as follows: 
Foucauldain scholars tend to argue that the clinical gaze is not intentional in terms of 
originating from a particular type of group seeking domination over others. The state is, of 
course, involved in the reproduction of medical dominance, including regulating the 
conditions for the licensing of medical practitioners but there are also other agencies and 
institution involved beyond the state, and indeed the interest of the medical profession and 
those of the state often clash.
118
 
Foucault has often been criticized for his work in medicine because he altered his views and 
thoughts over the years. However, it seems important to note that his later work moved from 
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the institutional view of domination and power to the influence of power on oneself and 
others, thus maybe the concept of power relations.
119
 This view was never explored in depth 
for he died shortly after his initial theoretical findings. However, Foucault‘s work on power 
and its influence cannot go unnoticed when seeking to explain many of the decisions WHO 
and UNAIDS and others carried out during the evaluations and research on male 
circumcision. 
Lupton argued that Foucault never classified his work as a medicalisation critique and 
furthermore many of his thoughts varied in stance from the orthodox critique of 
medicalisation. Thus, the orthodox critique of medicalisation has been separated from 
Foucault‘s work on power and medicine and follows. 
Medicalisation critique and power 
Another key piece of literature relating to power and medicine was the orthodox 
medicalisation critique developed from the field of sociology of health. The medicalisation 
critique has been regarded as one of the catalysts for drawing attention to possible 
inequalities in medical relationships and within the structures that deliver health care.  Lupton 
maintained that the medicalisation critique was premised on the notion that individuals 
should not be influenced or constrained by the powerful actors within medical disciplines.
120
 
She argued that the proponents of the critique most often take ―an overwhelmingly negative 
view of members of the medical profession, seeing doctors as attempting to enhance their 
position by presenting themselves as possessing the exclusive right to define and treat illness, 
thereby subordinating the opinions and knowledges of lay people.‖121  
Another key concern presented form the medicalisation critique was the difficulty for patients 
to challenge the medical professions opinions or decisions relating to care, for patients most 
often lacked the medical knowledge to engage in such debates.
122
 Lupton described how this 
inherent power within medicine facilitated the mechanism to promote inequality, especially 
for those groups who were already considered disempowered or vulnerable.
 123
 However, 
Lupton believed there was a weakness within the sociological critique for she felt it had not 
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adequately considered how emotions and desires influence and motivate behaviours, which 
can create an environment where there can be a mutual dependency between doctors and 
patients.
124
 
Women and Power within Medicine 
This section of the literature will be brief for the section on barriers to greater equality for 
women will cover many of the theoretical concepts relating to patriarchy, participation and 
inequalities. However, it was important to note the role of power in the debates on health, 
AIDS, and women. The statement made by Travers and Bennett highlights many of the 
challenges. 
Throughout the health care structures, women living with HIV/AIDS experience numerous 
barriers to exercising their power and control. Such practices as excluding women from drug 
trials, inequalities in the power relationship between doctor and client, the gender-defined 
roles that promote compliance and passiveness among women, and the assumption of the 
male norm serve to restrict the choices available to women, and consequently power over 
their health.
125
  
As the statement above concluded, the historical structures of medicine can perpetuate 
inequalities, especially in locations where women already live as subordinates and void of 
power.
126
 It has been widely published that when social structures exclude women from 
participation it disempowers them from effectively communicating their concerns, needs and 
expectations sometimes resulting in programs and policies for women that are male 
engendered or inappropriate. The historical gap in funding, usage, production and promotion 
of male and female condoms may serve as an example of how social and power structures are 
mutually dependent when discussing the issues of women‘s health. 
4. Public Health and Policy 
The primary sources of literature to explain how male circumcision was positioned within the 
context of population health included these themes: priorities of public health and evidence 
based policymaking. The goal of this literature was to explain the purpose of public health, 
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the prevailing practices used to evaluate policy recommendations and furthermore the tools 
used to priorities health interventions. 
Priorities of Public Health 
Recent definitions of public health evolved out of the 1988 report The Future of Public 
Health produced by the US Institute of Medicine. In simple terms public health has been 
established to protect the entire population with ―organized community efforts aimed at the 
prevention of disease and the promotion of health.‖127 The core functions have often been 
defined as the assessment of health, policy development and assurance.
128
  Assessment can be 
defined as the process of collecting, analyzing, and presenting data on a population‘s health. 
The function of policy development ―involves the scientific knowledge to devise a strategic 
approach to improving the community‘s health.‖129 Lastly, assurance as it implies includes 
assuring the appropriate health services are available and accessible to the general population.  
In the context of developing countries, The Global Health Watch Report argued that poverty 
alone does not create poor health, the need to address the power relationship between men 
and women, rich and poor, educated and uneducated; were all critical elements of tackling the 
issues relating to health.
130
 Furthermore, in developing countries where political and 
economic structures ―reinforce unfair advantages and widen socio-economic disparities‖ 
health services have often been crippled.
131
 This dynamic coupled with the limited resources, 
infrastructures, and budgets to deliver public health can result in an environment where 
political and economic agendas set the priorities of health.  
Schneider argued that little movement occurs in public health without the involvement of 
government, it has been their role to approve or deny the interventions and recommendations 
presented by their health experts.
132
 She explained that politics usually enters at the policy 
development and assurance phases since the responsibility for funding, and how much was 
determined during this time. Many in the medical field have contested this political 
                                                 
127 Schneider, Mary-Jane 2004:5. Introduction to public health, cited from Institute of Medicine, Future of public health: 1988:40. 
128 Schneider, Mary-Jane 2004:5. Introduction to public health. 
129 Ibid:6.  
130 People‘s Health Movement 2005:4. Global Health Watch. 
131 Ibid:4. 
132 Schneider, Mary-Jane 2004:7. Introduction to public health. 
37 
 
involvement, instead of viewing it as a critical component of democratic governance; they 
argue that governments impede the decision-making process.
133
 
She further argued that one of the main duties of public health was to develop and implement 
interventions in order to prevent the undesirable health outcomes that facilitated the need for 
the intervention. Schneider presented a five step approach that public health experts 
commonly use to define health problems in communities. They were (1) define the problem, 
(2) identify the risk factors (3) develop and test community level interventions (4) 
implementation of the interventions and (5) monitor the overall effectiveness of the 
intervention.
134
 
The literature showed that epidemiology was the dominant science used by public health to 
investigate disease. Schneider defined epidemiology as a method ―used to investigate causes 
of disease, to identify trends in disease occurrence that may influence the need for medical 
and public health services, and to evaluate the effectiveness of medical and public health 
interventions.‖135 Conversely, she discussed the concerns relating to the sciences 
susceptibility to various errors, she argued, ―epidemiology cannot prove cause and effect.‖136 
However, in her opinion the fact that observational studies do not have the same 
susceptibility to potentially harm people unlike clinical trials, she concluded even with its 
flaws epidemiology remains a necessity for the basic science of public health.
137
 In the 
context of AIDS, Priorities in Health argued that guidelines relating to endorsing appropriate 
HIV prevention and treatment strategies to date have been largely influenced by the 
epidemiological profiles of countries.
138
 
In addition to the statistical findings computed from epidemiology studies, public health 
officials rely heavily on statistics to assess the public needs and to evaluate the progress of 
population level health. For example, figures on cause of death, mortality, births, and 
occurrences of infectious disease can all be used to guide public health responses. 
When establishing how interventions should be prioritized, public health utilizes tools such as 
cost benefit analysis and other methods to inform the decision-making process. From The 
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World Bank perspective priorities in health have been clearly defined, first ―identify the cost-
effective interventions for those diseases that impose the largest burdens around the globe or 
in target regions or populations that exhibit grave need or inequity and determine how to 
deliver these interventions effectively, efficiently, and equitably.‖139 Furthermore, they went 
on to explain how many interventions can be effective, however it is the combination of 
knowledge and economic cost effectiveness, which determine which interventions can have 
the greatest impact with a given level of resource commitment. The World Bank definition of 
cost effectiveness analysis was the tool used ―for weighing different costs and health 
outcomes when policy-makers have to make resource allocation decisions.
140
 
The cost effective analysis of interventions in developing countries can be critical in 
mobilizing solutions that are inexpensive and can result in reducing disease burden. The 
World Bank reasoned that the cost effectiveness of an intervention was one factor in working 
towards providing policy guidance, other factors such as prevailing burden of diseases, the 
existing coverage and lastly the capacity of the health system.
141
 Furthermore they believed 
the relative costs to determine which combination of interventions would yield the greatest 
improvements in health was critical for making the best use of public funds.
142
  In discussing 
the nature of collective analysis, The World Bank mentioned factors such as; ranking the 
interventions in broad categories, how would statistics vary in different demographic areas, 
does the interventions address the major sources of disease burden, and the feasibility - based 
on resources and experience.
143
  
Risk assessment was a second important tool that public health officials have utilized for 
assessing population level health. Schneider defined risk assessment as a formal process that 
―identifies events and exposures that may be harmful to humans and estimates the 
probabilities of their occurrence as well as the extent of harm they may cause.‖144 
Researchers have classified how a person perceives risk from two perspectives ―dreadness‖ – 
the more dread the less acceptable, and ―knowability‖ – a person‘s known risks were 
considered the more acceptable.
 145
 Researchers argue that sometimes people‘s perception of 
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risk conflict with the scientific assessment of the risk. Based on that false dynamic Schneider 
argued that sometimes public health in efforts to protect the population could require risk 
assessment, especially in the context of injurious behaviour.
146
 When analyzing all these 
components for assessing population health we can begin to develop a sense of why 
―scientific knowledge alone does not determine which interventions will have the most 
impact.‖147 
In addition to the literature discussed the WHO‘s white paper on the Strategies and 
Approaches for Male Circumcision Programming clarified some of the attitudes WHO had 
towards the complexity of implementing male circumcision.
148
 In response to the possible 
rollout of male circumcision, WHO stated, ―perhaps the most critical lesson we have learnt 
about introduction of a new clinical procedure, method or technology, is that it is more than 
just the innovation itself. Other health systems issues need to be considered and 
addressed.‖149 The paper also supported the widely held concern for implementing 
interventions in public health settings where resources are limited. They provided examples 
of various interventions that had been introduced on a wide scale in the developing world, 
such as clinical contraceptives and other reproduction health technologies.
150
 WHO argued 
that the lessons they had gained from the introduction and scale-up of reproductive health 
technologies demonstrated that ―inadequate attention to introduction may lead to a host of 
problems.‖151  
The following potential barriers were highlighted by WHO as obstacles to effective 
implementations: poor quality services resulting in post-procedure infections; inadequate 
counseling resulting in uniformed decision making (coercion in the worst case scenario); poor 
communication strategies and inadequate counseling leading to confusion and 
misunderstanding; low use due to poor reputation of the services or inadequate availability of 
access; cultural or religious-based opposition from, for example the community, political or 
religious leaders, and service providers; and services were not sustainable in terms of 
coverage and / or quality.
152
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The literature on public health established the framework to understand how male 
circumcision was located within this context. Through understanding how public health 
officials utilize statistical data to assess the impact of an intervention on population level 
health we can begin to explain some of the  arguments associated with  male circumcision 
and mass population roll outs. 
Evidence based Policymaking 
The concept of ‗evidence based‘ emerged in the 1990s, when researchers pondered if 
medicine needed to be evidence based, shouldn‘t health policies be developed on this same 
principle.
153
 The framework of evidence-based research has grown steadily as a standard 
within the context of Africa public health policies. Bowen and Zwi outlined in their research 
that the ―theory on translation of research findings into policy and practice, and on 
knowledge utilization, offers only part of the solution to this complex task.‖154 The 
complexity of policymaking challenges the assumptions that evidence based research will 
result in effective policy action. The scope of literature relating to evidence based research 
and policymaking was broad and has been situated without various models which included 
rationalist, implied, knowledge-driven, problem-solving, interactive, political, enlightenment, 
and tactical model to name a few.
155
 
Black, Bowen and Zwi each highlighted how the external factors such as politics, social, 
funding, bias, personal values and relationships, influence policymakers and their actions.
156
 
Black argued if researchers seek to gain a greater influence over policy decisions they needed 
to have a more substantial understanding of the policy process, funding sources and how they 
should engage collaboratively with policy-makers.
157
 Furthermore, he viewed the 
involvement of policy-makers in the ―conceptualization and conduct of the research‖ as 
critical elements to increasing the probability of turning evidence based research into 
effective policymaking.
158
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5. Barriers to Greater Equality for Women  
The issues surrounding women draws special attention based on the historical vulnerability of 
women in sub-Saharan Africa. Currently 61% of those living with HIV are women and in 
some Southern Africa countries, that number remains higher.
159
 Furthermore, women 
typically have had to bear a significant portion of the emotional and financial burdens 
associated with the care or death of a child or family member infected with AIDS.
160
 
UNICEF reported that in 2007 sub-Saharan Africa had 420,000 children newly infected with 
HIV and 290,000 died of AIDS.
161
  
Recent evidence has shown that young women between the ages of 15-24, represent 
approximately two thirds of all people newly living with HIV in developing countries 
―making them the most-affected group in the world.‖162 Additionally UNICEF presented that 
in 2007 that 15-24 year olds were responsible for approximately 40% of all new infections in 
the category defined as adults - 15 and above.
163
 The figures relating to the age group 15-24 
maintain importance for experts argued the number of new HIV infections in this age range 
most accurately predicts the state of the epidemic.
164
 
During the 2008 United Nations General Assembly High Level meeting on the status of 
AIDS, Executive Director Dr. Peter Piot insisted, ―it is time now to speak out and take 
concrete action to address gender inequality and special vulnerabilities of women.‖165 Hence, 
to understand how UNAIDS and WHO assessed the affect mass male circumcision would 
have on women‘s health, rights, and choices, the researcher utilized literature that discussed 
societal inequalities, barriers to participation and how the framework of universal citizenship 
can restrain oppressed or vulnerable populations from accessing the privileges of citizenship. 
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Patriarchy 
It has been widely acknowledged, ―that patriarchal social structures have historically and 
systematically excluded women from those aspects of society that are responsible for 
leadership, policy information, resource allocation and decision making.‖166 Pateman argued 
that the historical power relationships that limit women went beyond colonialism in scope; 
she believed it was a direct outcome of the social contract that was based on a fraternal pact 
that constituted civil society as a patriarchal or masculine order.
167
 Feminist have agreed that 
the traditional patriarchy of our fathers has been transformed into the fraternal modern 
patriarchy of civil society. However, the ability to develop a modern political theory that 
incorporates both the feminine and masculine individuality into political and civil life 
remains a challenge.
168
  
Pateman further argued that it was not only the patriarchal foundations of the social contract 
that limited freedoms it was a condition of the sexual contract, which was the subjection of 
women.
169
  Pateman described the original pact as a sexual as well as a social contract that 
established men‘s political right over women and sexual in the sense of establishing orderly 
access by men to women‘s bodies. This historical subjection of women as property has 
developed into a legacy of male dominance over women‘s bodies and rights. Within the 
Africa context the evidence of such beliefs of dominance over women‘s bodies and rights are 
witnessed in the Marriage Act Policies that define women as property and allows the man 
rights to sex.  The subjection of women policies have been further perpetuated in the tribal 
Customary Law practices found in many African countries. Pateman argued that unless this 
legacy of subjection of women as bodies for sex and viewed as a male-right was restructured, 
women would never gain full citizenship rights.
170
 Pateman's writings also reflected on the 
challenges and accountability of whether it was possible to change the structures that existed 
within modern politics, and if modified would it positively influence women rights.  
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Citizenship 
The modern political and academic definition of universal citizenship has been constructed 
on the principles of inclusion and participation for everyone in public life premised on 
establishing the universal point of view.
171
 Young argued that ―the assumed link between 
citizenship for everyone, on the one hand, and the two other senses of citizenship – having a 
common life with and being treated in the same way as the other citizens – on the other, is 
itself a problem.‖172 Young discussed how oppressed groups were concerned with the 
universality of citizenship being understood as the ‗same‘ in the majority view, for their 
unique differences were the defining characteristics that viewed them as ‗different‘ in the first 
account.
173
 These observations of Young‘s assisted with providing a framework to understand 
many of the challenges relating to women and participation, especially when seeking to 
explain some the events that transpired during the evaluation of male circumcision. 
In many countries, laws have provided full citizenship to all; however, the societal structures 
and beliefs that are embedded in their civil societies hinder those who are oppressed from 
fully accessing citizenship rights.  The movement towards democracy in many sub-Saharan 
countries provided those who had been marginalized with a sense of hope, a belief that 
winning full citizenship status - equal political and civil rights would lead to their freedom 
and equality.
174
 However, time has shown full citizenship by law does not equate into full 
agency to those rights, ―social movements of oppressed and excluded groups have recently 
asked why extension of equal citizenship rights has not led to social justice and equality.‖175 
When looking to gain an understanding of what factors within a society limit the 
effectiveness of laws for full citizenship rights we can look to Young‘s definition of 
oppression, this clearly establishes a framework for understanding the conditions which 
create and perpetuate inequalities:  
(1) the benefits of their work or energy go to others without those others reciprocally 
benefiting them (exploitation); (2) they are excluded from participation in major social 
activities, which in our society means primarily a workplace (marginalization); (3) they 
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live and work under the authority of others and have little work autonomy and authority 
over others themselves (powerless); (4) as a group they are stereotyped at the same time 
that their experience and situation is invisible in the society in general and they have little 
opportunity and little audience for the expression of experience and perspective on sol 
events (cultural imperialism); (5) group members suffer random violence and harassment 
motivated by group hatred or fear.
176
  
 
These factors help to articulate the social and cultural influences that contribute to oppression 
and limit a society‘s ability to have its citizens practice the laws defined by their Nation. 
Young argued that the ―inclusion and participation of everyone in public discussion and 
decision-making requires mechanisms for group representation, where differences in 
capacities, culture, values, and behavioral styles can be put forth without judgment or 
discrimination.
177
 The challenge with changing this idealist version of democracy was in part 
historical, since the classical period our civil society theories of contracts have been defined 
on a masculine experience, non-emotional, dispassionate, and universal in values and 
norms.
178
 Again, one may question if the unraveling of these patriarchal foundations can 
realistically be accomplished.  
The debates on gaining full citizen rights has led many to believe that social and economic 
equality must be achieved before political equality can be instituted, while others argue that it 
takes both including a substantial change to the representation in the political spheres to 
promote policy changes. However, within both arguments those that are oppressed still have 
limited capabilities in accessing their full citizenship rights based on their inability to have a 
voice and their limited powers to influence or change the majority view. A significant amount 
of literature highlights the underlining historical factors that define why oppression exists, 
however, there are few antidotes for how to change a legacy of cultural and institutional 
structures that influence and perpetuate inequalities. 
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Equality for Women 
In the last 25 years living conditions for many people residing in sub-Saharan Africa have 
improved dramatically based on investments put forth to improve practical needs.
179
 However 
former President Paul Wolfowitz, of the World Bank argued, ―income levels do not measure 
accurately levels of development or reflect social or geographical inequalities‖ highlighting 
the enormous challenge women face in gaining equality in Africa.
180
 Nussbaum argued ―it is 
very clear that there are dramatic cultural and societal differences and that the life of a female 
individual is from birth shaped by social expectations and norms regarding femaleness‖, 
which influences both men and women‘s actions and choices.‖181 Nussbaum suggestions can 
be observed in the awareness that sub-Saharan Africa women remain the population most at 
risk for contracting diseases such as AIDS, malaria, TB and  cholera
182
and traditionally 
retained the responsibility of care when illnesses or deaths occurs in the family.
183
 Nettleton 
supported Nussbaum argument when she discussed how poor health and inequalities were 
often associated with men who live with a constant lack of empowerment, feeling of 
inadequacy, and a fatalist view developed from living in conditions where life expectancy 
and employment remain low.
184
 
In Botswana‘s 2004 MDG Status Report the authors argued, ―that over the past two decades 
substantive areas of life, including control of productive resources have improved in 
Botswana, however even when legislation may be gender neutral, traditional and institutional 
cultures perpetuate practices that disadvantage women in relation to men.‖185Botswana‘s 
government publicly recognised the ―substantive challenge lies in bridging the gap between 
progressive policy and legislative reforms on the one hand and traditional and deep-seated 
institutional cultures that stand in the way of equal rights of citizenship for men and women 
on the other.‖186 The key challenge therefore becomes transformations, the ability to change 
culture, individuals, institutions, socio-economic disparities and society for the in betterment 
of all.
187
  Furthermore, in various parts of sub-Saharan Africa tribal customary laws and 
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actions have in many cases perpetuated inequalities towards women even when adequate civil 
laws, state laws and policies have been put into practice to protect women‘s rights.188 
In aiming to understanding how these debates surrounding culture influences inequalities and 
HIV/AIDS, we can look to former President of Botswana, Fetus Mogae 2006 State of the 
Nation speech. The President passionately expressed his concern with the number of cases 
reported on male deviant behaviour; he explained how alcohol abuse was in part responsible 
for the increased rates of violence against women, unnecessary rapes, passion killings and 
infections of HIV/AIDS.
189
 The President vehemently stated this behaviour was harmful to 
society and needed to stop.
190
   
With the increased concern that HIV/AIDS has become feminized in sub-Saharan Africa, it 
could be argued that these casualties will continue to affect societies as a whole if socio-
economic environments and polices cannot be implemented or targeted at improving the 
well-being of those most vulnerable to infection.
191
 Recently, a renewed emphasis has been 
placed on the need to change deep rooted cultural and societal norms if women are to achieve 
equality and thereafter prevail over HIV/AIDS, which questions where male circumcision 
will fit within this context.
192
 
Representation and Participation 
In looking for solutions to improve equality within developing countries, it was understood 
that through gaining a greater diversity of representation in governments and civil society it 
would promote and transform the male patriarchal class of politics into one that was more 
representative of the overall society‘s needs and interests.193 Feminists argued that greater 
representations of woman would influence the policies and rights for women based on 
common interests.  
Anne Phillips outlined the following four positions as the primary arguments put forth for 
justifying increasing the levels of women in elected office. 
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There are those that dwell on the role model successful women politicians offer; those that 
appeal to principles of justice between the sexes; those that identify particular interests of 
women that would otherwise be overlooked; and those that point towards a revitalised 
democracy that bridges the gap between representation and participation.
194
  
This rapid movement towards representation in African countries has been in contrast to the 
Scandinavian and Northern European countries who achieved significant participation over 
an 80-year period through slow and continuous social and civil movements. Hassim and 
Goetz questioned how the rapid and significant rise in women in African parliament 
correlated to effective gender policies and have their voices been representative of woman as 
a collective whole.
195
 In support of this apparent paradox Bauer and Britton stated, ―Bringing 
women into national office does not necessarily translate into a consistent voice for women‘s 
rights.‖196Furthermore they went on to argue that in most cases where electoral quotas have 
influenced minority representation the participation has been limited in voice due to the 
majority rule influence that dominants most political structures of democracy.
197
 
Bauer and Britton further explained how ―legislating policy is a necessary but not sufficient 
condition for ensuring the adequate implementation of polices to advance the status and 
position of women.‖198 The authors provided an example of where in Rwanda women held a 
48.8% representation in government, which at the time was the largest percentage in the 
world, however many questioned if these women were able to effectively exert power 
independent of their male majority leadership. For there were reports that a land draft policy 
developed by women MP‘s for expanding women‘s ownership and inheritance rights was 
modified and limited in scope by the male ruling party,
199
 resulting in a final land policy 
reform act that was male engendered. This example demonstrates the challenges that women 
of affluence have in gaining agency for it has been argued that in sub-Saharan Africa politics, 
women in government have often been associated with the male political leaders and in many 
cases serve more as a ―first lady‖ rather than an independent representative.200  This common 
occurrence in politics underscores the difficulty that women of poverty and marginalized 
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groups have in being heard or represented by women in politics.
201
 Bauer and Britton 
concluded that women may represent women in politics however, their ability to advance the 
status and position of gender issues in society as a whole has been limited due to their 
inability to act independent of political pressures of the majority party.
202
 Goetz and Hassim 
provided a perspective from South Africa, where they saw a growing dissociation between 
the women in government and those in civil society based on a perception of elitism and the 
beliefs that MP‘s do not understand or care about the needs of the common women.203  With 
male circumcision positioned as masculine and cultural, one would have to question how 
women MP‘s might pressure the majority rule on the subject of male circumcision, especially 
if he was circumcised. 
 
It is clear that women have been represented in many sub-Saharan African governments, 
however their ability to act appears to be limited based on the historical power structures that 
persist in African cultures.  Pateman argued that if change was to occur in participation and 
democracy then ―it is clear that if women are to be citizens as women, as autonomous, equal, 
yet sexually different beings from men, democratic theory and practice has to undergo a 
radical transformation.‖204 Pateman‘s assists in framing another disappointing and consistent 
occurrence in governments the practice of absorbing powerful women and women‘s 
organizations into their own formal governmental parties, where the majority rule can 
steadily diminish their voices and powers to influence policy and their society.
205
 
The literature also drew attention to an emerging perspective that equality agendas need to 
broaden their scope form health, welfare and education to including strategies that address 
gender inequalities related to equity distribution, economics of reproduction and the role of 
women in development planning and implementation.
206
 Pearson explained how there needed 
to be a refocus on the material inequalities and on social policies of redistribution, she wanted 
to see more effective feminist political action that would drive policies for reducing the 
marginalization and subordination of women.
207
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Conclusion 
The literature on patriarchy, citizenship, gender equalities and representation provided a 
means to explore why women remain the most vulnerable population for HIV infections in 
Africa. However, on a broader scale the content established the framework to explain why 
certain decisions were made relating to male circumcision and women. Furthermore, as the 
literature discussed many of the existing patriarchal cultures and structures that exist today in 
politics and society‘s in sub-Saharan Africa limit a woman‘s ability to influence change. This 
challenge was expressed by Hassim, who argued ―that a strong notion of equality would rest 
on the extent to which overall poverty is reduced, the degree to which women have autonomy 
and are able to make choices free of the constraints of care work within families and 
communities, as well as free of the pressure to remain in oppressive and violent relationships 
and the extent to which women feel safe in society.‖208 Hassim‘s argument exposes a 
weakness in the literature, if social, political and sexual relationships hinder a women‘s 
ability to feel safe, what would give her the power to act or engage in constructive debates on 
male circumcision, especially in the instances where the media and AIDS agencies have 
already had an opportunity to influence her partner(s).  
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Chapter Three: HIV prevention and Male Circumcision 
In seeking to explain the question and aims related to why WHO and UNAIDS endorsed 
male circumcision as a public health initiative for HIV prevention in sub-Saharan Africa the 
researcher needed to position male circumcision into the overall framework of HIV 
prevention. By understanding how HIV prevention efforts have been historically managed 
and implemented in sub-Saharan Africa we can begin to establish how male circumcision 
was situated within this context. 
The second key component to explaining why WHO and UNAIDS made their endorsement 
was achieved through constructing a historical timeline comprising the significant milestones 
up to the point of WHO and UNAIDS recommendation. The objective of this research was 
not to analyze or debate the medical efficacy of male circumcision. Thus, the timeline 
focused on reporting the processes and methods used to establish how male circumcision was 
evaluated and positioned. This process provided a structure to determine and evaluate how 
the events and decisions WHO and UNAIDS commenced influenced the timing, urgency and 
support for the endorsement. 
1. Historical perspective of HIV prevention in sub-Saharan Africa 
The literature review of HIV prevention assists in clarifying the research aim targeted at 
understanding how WHO and UNAIDS used historical factors to weigh the evidence on male 
circumcision. The literature strongly suggests that the prevailing response for managing HIV 
prevention in sub-Saharan Africa has been from the perspective of an ‗emergency‘.209 The 
most common strategies that were discussed for promoting HIV prevention were: firstly, 
changing individual behaviour through the ABC approach of prevention, which was marketed 
by community and national AIDS campaigns; and, secondly, from a biomedical approach of 
providing treatment, which would consequentially reduce the spread of HIV by counseling 
ARV patients on testing and safe sex practices during consultations.  
Although, prevention efforts have emphasized and promoted the individual behaviour change 
concept, the strategy has been highly contested by many AIDS experts. Mary Crewe, 
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Executive Director of Pretoria University‘s Centre for Study of AIDS, shared her thoughts 
―everybody keeps on saying let‘s reinforce the ABC message and let‘s make its stronger 
because it isn‘t working, surely the question, is why isn‘t it working, rather than saying we 
need to reinforce it.‖210 David Harrison, Executive Director of Love Life, expressed his 
concerns with the strategy, ―there is far too much of a preoccupation with the mechanics of 
transmission of HIV transmission and not enough focus on the dynamics of transmission.‖211  
Historically, prevention efforts have been delivered with short term messaging campaigns, 
with the expectation that individuals would uniformly change their behaviour irrespective of 
their community, economic status, and education.
212
 The following comment taken from the 
UNAIDS Africa 2025 project helps to underscore the complexity surrounding HIV 
prevention, the authors stated ―transmission of HIV happens because of the choices that 
individuals perceive they have-or do not have-and the actions they take as a result.‖213 
Warren Parker, Executive Director of CADRE provided his insights, ―interventions have to 
be behavioural and in relation to who people have sex with and when, in other words in 
relation to relationships, a lot of the emphasis on interventions has been on the intricacies of 
sexual behaviour and not the dynamics of sexual relationships.‖214   These statements serve as 
an example of the historical preoccupation with individual and sexual behaviour change 
irrespective of the context of social, behavioral, and economic factors. 
Some of the key strategies relating to HIV prevention efforts in sub-Saharan Africa were 
discussed at the Southern Africa Development Committee (SADC) Expert Think Tank 
Meeting on HIV prevention in Southern Africa held on May 10-12, 2006 in Maseru, Lesotho 
with 38 participants, 33 of which resided in African countries.
215
 The objective of the Expert 
Think Tank was to reflect and expand upon the key drivers of the epidemic in the SADC sub-
region. Think Tank participants concluded that the key drivers of the epidemic were ―high 
levels of multiple and concurrent sexual partnerships by men and women with insufficient 
consistent, correct condom use, combined with low levels of male circumcision.‖216 
Additionally, attitudes and behaviours, intergenerational sex (5 year age gap), violence, 
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stigma, lack of openness, untreated sexually transmitted infections (STI‘s) and lack of 
condom usage in long-term concurrent partnerships were all presented as key but secondary 
drivers of the epidemic. Thought was also given to defining social and structural drivers of 
the epidemic, which were gender inequality, women‘s vulnerability to HIV, cultural 
influences on gender relationships and high mobility.
217
 
The Expert Think Tank meeting concluded by outlining the HIV prevention strategies that 
should be given priority. The priorities were: reduction in multiple and concurrent partners; 
preparing for the possible roll out of male circumcision; address the responsibility and 
involvement of the male in relations to sexual and reproductive health; improve condom 
usage and with consistent and proper use; and lastly continued programming focused on 
delaying sexual debut within the context of condom programming and reduced 
partnerships.
218
 UNAIDS Regional Adviser for HIV prevention in Eastern and Southern 
Africa, Tomas Lundstrom reflected on the importance of the Think Tank meeting, 
We had a think tank meeting in 2006 and it felt like for the first time people really started 
looking at what‘s really driving this epidemic. Only when you do that you can actually try to 
find the programs to actually prevent HIV infection. I think a lot of the research is needed but 
there are a lot of things we already know but we are still not moving. I think HIV prevention 
is mainly driven by the gender imbalance we talk about gender, inequality for a number of  
years but it is not tackled, at all, because we have a fundamental resistant of actually doing it. 
We do not need any more evidence saying that gender is driving the epidemic, or we high 
levels of multiply concurrent partners, but it‘s how we tackle it, its deep down roots in the 
culture and everything and it‘s so difficult to deal with and I am afraid we don‘t change that 
by more evidence or more research.
219
 
The literature that covered the subject of successful HIV prevention programs in the context 
of sub-Saharan Africa focused predominantly on one country, Uganda and it‘s early 
successes with the ‗zero grazing‘ program.220 The program resulted in a significant reduction 
in HIV prevalence
221
 in the 1980s and 1990s and defined Uganda as a model AIDS success 
story. The ‗zero grazing‘ prevention campaign was led by President Museveni and was based 
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on the principle of staying faithful; however, if you choose to engage in additional partners 
stay close to home and use condoms.  The other significant component of the campaigns 
success was the President‘s unique ability to tailor his message of prevention depending on 
the audience he was addressing.
222
  
The literature covering Uganda also tended to focus on academics‘ assumptions that when 
Uganda moved to the United States‘ ABC campaign, which focused heavily on abstinence, 
President Museveni‘s messaging strategy moved away from the principles of ‗zero grazing‘ 
which caused many of the gains in the epidemic to diminish.
223
  However, others have 
suggested that the results were likely due to the political unrest at the time, the highly 
questionable prevalence statistics and if the concepts of ‗zero grazing‘ would have the same 
effect on today‘s youths.224 Uganda‘s story can be seen as an example of the how the lack of 
concrete measurable outcomes hinders prevention strategies and creates doubt and 
uncertainty.  
Countries such as Kenya, Tanzania, and Zimbabwe have also experienced ups and downs in 
their respective epidemics, however there was minimal literature on the programs utilized 
during these periods and the reasons for the variations in outcomes.
225
 The literature has 
established a trend for relying on Uganda‘s early successes; this reliance can be observed in 
Daniel Halperin, Senior Researcher Scientist and Lecturer, Harvard University statement on 
the outcomes from the 2005 SADC Think Tank meeting. Halperin surmised: 
SADC has officially endorsed the position that they have to focus, or in that region they need 
to focus, on various things, but the main priority needs to be on encouraging behaviour 
change especially on reducing the levels of multiple and concurrent sexual partnerships and 
also on scaling up male circumcision. Whether they actually implement and do this is another 
question of course, but that is what they are saying they are going to do, and part of that is 
based on the experience of Uganda, where HIV has gone down.
226
 
The success story of Uganda can also be replaced with the negative influences of corruption 
and AIDS, which was not unique to Uganda, it was a disappointing issue that many sub-
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Saharan countries needed to confront.
227
 Corruption created a greater awareness for 
accountability and created a movement towards stronger management and financial processes 
to ensure those who need help were the ones benefiting from donor support.
228
 
Funding has grown significantly from approximately USD 300 million in 1996 to USD 10 
billion in 2007. However, the allocation towards prevention programs and research on related 
topics has been substantially less than its peer program of treatment. Programs such as The 
United States Presidents Emergency Plan for AIDS Relief (PEPFAR) have been heavily 
weighed and executed on set amounts to be allocated towards the treatment and science of 
AIDS.
229
 The criteria for distribution of donor funding has also appeared to benefit treatment 
programs, for allocations have been linked to ideology of prevention methods (religion, 
abstinence, etc) and approved as vertical programs. Robert Bailey, Professor, University of 
Illinois Chicago shared his opinion on the challenges of donors and prevention in Africa, he 
remarked: 
The greatest challenge in prevention is getting countries and donor agencies to put more 
resources into prevention and to come up with an integrated approach to prevention, not a 
vertical program.   Donors now tend to have their favorite intervention and to want to fund 
that intervention, but not a full package of intervention.  I think the challenge has been to get 
countries to come up with plans that then sort of force donors into a much more integrated 
approach and to want to put more funding into prevention, hopefully not sacrificing care and 
treatment, but given prevention a higher priority. That is the biggest challenge at this point.   
As I have said, we cannot treat our way out of this epidemic so the most effective approach is 
to try to prevent new infections, in the long run that is cost effective and it is going to save us 
money and ultimately lives.
230
  
He also argued that ―HIV prevention measures have really been dictated from Western 
culture, from the big donors and from the multilateral, multinational agencies and many of 
the prevention strategies have not come from the communities themselves‖, which has 
established a top down approach versus the bottom up approach that originates from the 
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community. 231 Thus, in 2006 when evidence showed that for approximately every two people 
that began ARV treatment, five new people became infected with HIV,
232
 it was of no 
surprise to many that the focus on treatment programs and poorly managed prevention efforts 
had contributed to this predicament.
233
 
The literature revealed that the most common obstacles in addressing why HIV prevention 
efforts had lagged in comparison to treatment were: individuals did not modify their 
behaviour; governments lack of incentives or risk to confront the epidemic and/or the delay in 
acknowledging the epidemic existed; the concentration on and belief that a vaccine was 
achievable; the assumption that treatment would contribute to altering the course of the 
epidemic and lastly stigma.
234
 One of the most significant arguments put forth by academics 
in understanding the framework of why individuals and societies deny knowledge was 
developed by Stan Cohen.
235
 Cohen outlines three type of denial; ―‗literal‘ people simply 
refuse to accept what is happening, ‗interpretative‘ in which the basic outline of events is 
acknowledged but the patterns and meanings are disputed, ‗implicatory‘ denial in which 
people absolve themselves of responsibility for what has happened.‖236 The next two 
compelling quotes provided insight into the drivers and difficulty of overcoming denial 
within African communities. Glenda Gray, Executive Director HIVSA, provided the first 
narrative: 
As far as the previous generation or generations are concerned, behaviour change is erratic, 
condom use is erratic and people do not perceive themselves to be at risk.  And so they never 
think they are going to get infected and so they never ever really do effective prevention.  
There is competing risks, you are unemployed, you are hungry, you could be killed in a car 
accident or shot or hijacked and so the competing risks of death are far more real than an 
abstract reason or cause of dying in 10 years time, so those are also the kind of issues, so I am 
going to die tomorrow so why should I worry about 10 years.  I think we need to look at the 
next generation to see whether the experiences they had will change the way they do things.
237
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The second quote was in response to the empirical evidence gathered from a 2005 National 
Survey conducted in South Africa by the Human Sciences Research Council (HSRC), Social 
Aspects of HIV/AIDS & Health Programme.  Leickness Simbayi, Executive Director 
provided this narrative: 
Even in this day and age, there are some people who still do not believe that they are at risk of 
HIV infection, coupled with the fact that very few people have tested and know their status. 
We conducted anonymous testing, we go to people‘s homes ask them to participate in a 
survey, we don‘t take down their names, we just know their sex, their race and where they are 
so we have an idea of geographical location whether it is urban, rural, formal or informal. In 
that study, which is now being used to estimate national prevalence in the country about half 
the people we found to be HIV positive, when asked the question whether they thought they 
are at risk of becoming infected, they actually believed they were not.  I am saying they were 
actually already infected.  Now that says something about the problem.  At least the half that 
believe that they are at risk maybe they are doing something, whereas the other half that are 
already infected and do not believe they are at risk are carrying on behaving as if they are not 
at risk, that is their perception.  So their behaviour probably is in line with that perception, so 
they are probably not taking precautions whatsoever.
238
 
In addition to Gray and Simbayi accounts of the presence of denial, Campbell also argued in 
her research on the mining town in Summertown South Africa, that the lack of community 
support and denial of the gender inequalities was a major contributing factor to understanding 
why the HIV prevention program conducted and researched in that community failed.
239
 
Campbell, further underscored the need for greater community involvement if individual 
behaviour, values, and beliefs were to be altered for the long-term; she reasoned that there 
was a needed for corporations, community leaders, and families to support and encourage 
change.
240
 
Corporations, governments, and major international humanitarian agencies have most often 
executed and implemented the HIV prevention programs offered at a population wide level in 
sub-Saharan Africa. While NGO‘s have focused their efforts on treatment, human rights 
advocacy, support, care, and prevention at a community level. Furthermore, the health care 
sector has historically led the majority of AIDS initiatives with a heavy dependency on 
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scientific evidence and funding coming from the Western world, this in part can be attributed 
to the emphasis on ARV treatment and care. This over emphasis on the biomedical approach 
has been widely criticized by many in the field of AIDS; many believe this dominance has 
hindered HIV prevention efforts. Professor Simbayi‘s observation was reflective of those 
who argued for a more neutral approach, he concluded that the biomedical approach has 
―ignored a large body of scientific knowledge about other non medical or basically 
behavioural and social interventions that have been developed primarily by social scientists‖ 
and have often shown more promising hope in the short term.241  
It appears thus far that the most significant broad range action taken towards accelerating 
HIV prevention strategies in sub-Saharan Africa has occurred from the commitments made 
by the UN and its member states. The first commitment was the establishment of The 
Millennium Development Goals (MDG‘s) in 2000, which was followed by a series of time-
bound targets established in the 2001 ‗Declaration of Commitment on HIV/AIDS‘.242 
Thereafter the UN and its member states passed in 2006 the ‗Political Declaration on 
HIV/AIDS‘ which perhaps was regarded as the most significant endorsement given to 
encourage action in relation to HIV prevention efforts. For the ‗Political Declaration on 
HIV/AIDS‘ reconfirmed the time-bound targets passed in 2001 and established a new 
agreement to achieve universal access for HIV prevention, treatment, care and support by the 
year 2010.
243
 
In conclusion, although there has been a very clearly defined model for delivering and 
messaging HIV prevention efforts in sub-Saharan Africa, the consensus on whether this 
approach has been effective remains highly contested.  
Examples of Biomedical Interventions for HIV prevention 
To understand how male circumcision was positioned compared to other HIV prevention 
strategies, it was important to review previous biomedical interventions.  Historically, new 
biomedical interventions have been evaluated and endorsed by WHO and UNAIDS,         
with subsequent normative guidance on how best to implement and market the respective 
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interventions. However, the execution and implementation of the interventions have been left 
to a complex network of government officials, NGO‘s, international funders, academics and 
activist to priorities and implement.  
Two prevention programs that have received recommendations from WHO and UNAIDS are 
the prevention of mother-to-child transmission and co-trimoxazole prophylaxis for HIV-
related infections. Currently, only 31% of HIV-infected pregnant women receiving 
antiretroviral prophylaxis
244
and 90% of all the HIV infections relating to children under the 
age of 15 have come from mother-to-child transmission.
245
 Research has shown that the 
majority of these infections occur during the pregnancy, at delivery or from breastfeeding. 
Data has also shown that more than half of the children infected perinatally die before they 
reached the age of two.
246
 
Secretary-General of the UN, Ban Ki-moon argued in his April 2008 report to the General 
Assembly on the status of AIDS, that ―although the cost-effectiveness of mother-to-child 
HIV transmission prevention programmes was demonstrated in the 1990s, children still 
accounted for one in six new infections in 2007.‖247 UNAIDS provided their first strategic 
guidance on the prevention of mother-to-child transmission in 1999 and WHO convened a 
consultation in December 2001.
248
 Thereafter, WHO and UNICEF convened the first high 
level global partner forum on the prevention of mother-to-child transmission in December of 
2005 with the objective of encouraging scale-up due to the discouraging progress.
249
 In 
follow-up to the 2005 meeting, WHO in November 2007 issued a consensus statement, which 
further emphasized the challenges of scaling up quality, programs for mother-to-child 
transmission services.
250
 
In 2008, the UN reported that developed countries had almost completely eliminated the risk 
of mother-to-child HIV transmission, ―through the implementation of comprehensive 
prevention measures, including primary prevention of HIV infections; fewer unintended 
pregnancies among HIV-positive women; provider-initiated HIV testing and counseling in 
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antenatal settings; timely delivery of antiretroviral prophylactic regimens; and safe infant-
feeding.‖251 In the same UN report, they documented that in 2007 Botswana had achieved a 
91% uptake of mother-to-child services, resulting in only 4 % of children born to HIV 
positive mothers becoming infected with HIV.
252
  The success in Botswana demonstrated that 
HIV interventions with proven effectiveness could work when political will, support and 
financial resources are managed accordingly.
253
 
WHO and UNAIDS made a provisional statements relating to the usage of co-trimoxazole in 
2000 and during 2006 WHO provided further guidance after receiving additional evidence- 
based research supporting the drug‘s efficacy in resource-limited settings.254 In 2007 WHO 
reported that of the 1.5 million children born to pregnant women with HIV, only 4 % initiated 
co-trimoxazole during the first two months of birth.
255
 Furthermore data from RCT‘s and 
observational studies showed the effectiveness of co-trimoxazole in preventing Pneumocystis 
jirovecii pneumonia (PCP)
256
 in infants and reducing morbidity and mortality in children and 
infants living with or exposed to HIV.
257
 In 2008, a study published in Lancet and conducted 
in Uganda further underscored the drug‘s effectiveness by demonstrating ―an 81 % reduction 
in mortality among uninfected children over a 31-month period if their HIV–infected parents 
were receiving antiretroviral therapy and co-trimoxazole preventive therapy.‖258  
From the perspective of prevention it was argued that based on the difficulty of diagnosing 
HIV infections in infants, co-trimoxazole could be beneficial for infants who‘s mothers are 
HIV-positive, it was recommended to start the drug 4-6 weeks after birth and continued until 
the infant is no longer at risk of acquiring HIV.
259
 Furthermore, the treatment has been the 
standard of care for both children exposed to or living with HIV for many years in developed 
countries, however, in sub-Saharan Africa, many countries have included this inexpensive 
drug co-trimoxazole into their national policies but the implementation has been poor.
260
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Reasons given for the minimal coverage were ―lack of national-level guidance to health care 
providers on co-trimoxazole prophylaxis, the lack of opportunities to document its provision 
in registers or child health cards and erratic supply and frequent stock-out of drug.‖261  
Additional prevention statistics on pregnant women and HIV prevention efforts that seemed 
notable were, only 12% of HIV-positive pregnant women were evaluated to determine if they 
were eligible for ARV therapy when attending antenatal care sessions.
262
 Secondly, in 2004, 
only 8% of pregnant women in low and middle-income countries received a HIV test and in 
2007, that number reached 18%.
263
 Lastly, HIV-positive pregnant women receiving 
antiretrovirals to prevent mother-to-child transmission in low and middle income countries 
increased from 9 % in 2004 to 34% in 2007, the universal access goal set for 2010 is 80%. 
AIDS in Africa: Three scenarios to 2025 
In 2005 UNAIDS in conjunction with the support of the African Union initiated a project to 
develop three possible scenarios for how AIDS may exist in Africa by the year 2025.
264
 The 
team comprising of men and women mainly from Africa used their collective experiences 
and knowledge to help guide the making of the scenarios. 
This study decided to utilize the UNAIDS report as a source of knowledge to further clarify 
why HIV prevention strategies and programs have not produced substantive results in sub-
Saharan Africa. The three scenarios will help to broaden and support the HIV prevention 
findings discussed earlier in this chapter. The projects scope was extensive; however, it was 
the content that focused on the key drivers and challenges to overcome AIDS in 2025 that 
helped to establish the popular beliefs, assumptions, and theories relating to Africa and the 
AIDS epidemic. Furthermore as discussed previously, this literature review assisted with 
defining a framework for HIV prevention in sub-Saharan Africa, which allowed the 
researcher to evaluate and position male circumcision within these defined beliefs. 
The three scenarios developed for the project were ‗Traps and legacies: The whirlpool‘ – the 
foundation was based on utilizing current HIV/AIDS trends until 2025. ‗Tough choices: 
Africa takes a stand‘ – this scenario was based on utilizing what had worked thus far, which 
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was based on the principles of Uganda. Lastly, ‗Times of transition: Africa overcomes‘ this 
scenario utilized the framework for universal access – rapidly scaling up comprehensive 
treatment and prevention programs for all.
265
 All three scenarios were based on two key 
assumptions, first AIDS was not a short-term challenge and the disease will exist in 2025, 
and secondly what occurs now will shape how the future will look.
266
  
The project identified five critical drivers that could impede future efforts or if managed 
appropriately would produce successful outcomes. They were ―the growth or erosion of unity 
and integration; the evolution of beliefs, values, and meanings; the leveraging of resources 
and capabilities; the generation and application of knowledge and lastly the distribution of 
power and authority.‖267 
Researchers argued that in the future, those societies that have poor unity would also most 
likely have difficulty in providing comprehensive prevention, care and treatment programs 
for their respective communities or nations.
268
 Furthermore, high levels of inequality, or 
tensions surrounding ethnic and religious beliefs could influence action towards violence, 
which would further impede efforts relating to care, treatment and prevention of HIV/AIDS.  
However, if there was a sense of collective unity within the society efforts would most likely 
result in success.
269
 For example, the project asked, ―will rural communities across Africa 
feel integrated in national development or feel marginalized?‖270  When positioning this 
statement within the context of HIV/AIDS it demonstrates the need to have participation 
from all groups within a society, if a sense of unity remains the goal. 
The driver relating to beliefs, values and meanings was constructed based on the theory that 
one‘s beliefs surrounding religion, sexuality, death, life, morality and values creates and 
influences a person‘s identity. This would consequentially have a positive or negative impact 
on how topics and solutions relating to HIV/AIDS will be perceived and acted upon.
271
 
Providing programs on condom use without the awareness of religious beliefs, marketing 
abstinence without a sense of cultural practices, and offering voluntary HIV testing without 
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acknowledging the social implications, all underscore the importance of recognizing the 
influences that cause a person to act. 
The driver that focused on the leveraging of resources and capabilities emphasized the need 
and concerns for providing funding strategies that were short and long term in nature, while 
managed with a sense of fiscal accountability.
272
 Without adequate sources of funding 
HIV/AIDS programs cannot succeed, however it has also become paramount to produce 
quantifiable outcomes which benefit those most in need. Furthermore, this driver emphasized 
the need to capitalize and maximize the financial recourses available to each community or 
country. 
The next driver was the generation and application of knowledge, which was based on 
interpreting how biomedical, sexual behaviour and people living with AIDS share and apply 
their knowledge to the epidemic. The project emphasized the importance of biomedical 
interventions; however, researchers also argued that the development and uptake of 
successful new technologies does not always ―guarantee their effective deployment.‖273 
Furthermore, this driver highlighted the importance of gaining participation from those living 
with AIDS, with hopes to reduce stigma and bring awareness to the struggles and obstacles of 
those living or dying from the disease. 
Lastly, the distribution of power and authority was identified as a key driver, which focused 
attention on how the use of power and authority can potentially impede the voices and actions 
of vulnerable populations.
274
 Possible sources of authority included governments, donors, 
academics, activists, international AIDS agencies and medical practitioners. The project used 
the distribution and access to AIDS treatments and HIV prevention programs as an example 
to show how power could negatively influence a program.
275
 This highlights the need for 
adequate controls to ensure power does not negatively influence the types of solutions offered 
and furthermore who has access to those services. 
In addition to the drivers outlined above there was another key concept that developed from 
the discussions relating to the Myths and Assumptions of HIV/AIDS.
276
The literature 
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highlighted how the wealth of knowledge and information now available on the epidemic has 
at times made it difficult to ascertain the difference between myths and reality. Interestingly 
within the report, the following myth and corresponding reality were documented. Myth: 
―Providing free and wide access to antiretroviral drugs will undermine prevention efforts. 
Reality: Evidence shows the contrary, e.g., people receiving antiretroviral therapy in Cote 
D‘Ivoire use condoms more frequently than untreated HIV positive people.‖277 This example 
firmly highlights the challenge of communication and the risk of presenting one-line catch 
phrases, for it has now been argued by WHO and UNAIDS that in concept the focus on ARV 
treatments has hindered prevention efforts. 
The last piece of valuable information gathered from the AIDS in Africa document were 
some of the outcomes produced from the final 2025 project. These factors were presented as 
the key components to moving towards a future where Africa overcomes the AIDS epidemic 
irrespective of the three scenarios. Some of the key concepts outlined from the project were: 
―prevention of AIDS fatigue; ensuring the crisis is defined and backed by all players; policies 
should be shape by ensuring the inclusion of local cultures, values, and meanings if results 
are to be effective; the need to reflect on national or international capacities without the 
pressure for results, otherwise it could create an environment where the priorities of stronger 
voices prevail; no magic bullet strategies; there must be a wide range of actors in 
implementing and proposing solutions; comprehensive understanding of social, physiological 
and economic issues that impact women; the necessity to care and provide treatment for 
orphaned children; and lastly a greater understanding of the psychological impact of the 
epidemic.‖278  
If these key components could be overcome, Africa would have a higher likelihood of 
overcoming the epidemic. Even though the list was extensive, the concepts provided the 
researcher with an opportunity to analysis how these principles were used during WHO and 
UNAIDS evaluation of male circumcision. Furthermore the researcher utilized the projects 
overall assumptions and views to explore and analyze how the decisions and actions relating 
to male circumcision were processed compared to the principles defined from the AIDS in 
Africa project.  
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Recent developments in HIV Prevention Efforts 
Recently, significant attention was placed on the current and future state of HIV prevention 
most notably due to the June 10-11, 2008 UN General Assembly High Level Meeting on 
AIDS, which reported on the MDG‘s for 2015 and the universal access goals set for 2010. 
When seeking to locate male circumcision within the overall framework of HIV prevention it 
seemed appropriate to outline the recent developments relating to HIV/AIDS. These findings 
not only help to establish the current priorities and concerns relating to HIV/AIDS, they assist 
in clarifying the challenges and shifts in prevention ideology.  
Some of the key strategic themes that transpired from the UN meeting were the recognition 
that HIV/AIDS was both a public health and development concern, furthermore AIDS should 
be seen as a ―central theme of development efforts.‖279 The epidemic must move from an 
‗emergency‘ response to a phase where we treat AIDS as an ―immediate crisis and as a long-
wave event.‖280 An overwhelming sense that sub-Saharan Africa will probably not treat itself 
out of the epidemic, thus prevention methods proven to be effective must be maximized.
281
 
Lastly the awareness that greater efforts must be made to strengthen public health systems if 
the goal for universal access was to be achieved. 
Other key views taken from the UN meeting were premised on the realization that action was 
needed; having established policies or visions was no longer an acceptable norm. 
Furthermore Dr. Piot, UNAIDS Executive Director argued that in addition to just establishing 
policies, there was a concrete need for action if gender inequalities were to be realistically 
addressed.
282
 There appeared to be a renewed emphasis placed on the need for greater 
collaboration between social science and medical research – with expectations that it would 
help to explain how cultural norms and attitudes increase the risk of infection.
283
 Lastly, 
attention was also drawn to the need for greater protection of health worker and the necessity 
to tackle brain drain - Botswana, for example had lost approximately 17% of its healthcare 
workforce to AIDS between 1999 and 2005.
284
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Secretary-General Ban Ki-moon acknowledged at the UN meeting that there had been 
significant gains in the commitment, will and courage from many Africa leaders. Thereafter, 
he also reminded the assembly that ―serious challenges remain, in several countries; 
prevalence is rising among young people as well as women and girls.‖285 These findings 
outlined by Mr. Ban Ki-moon had also been considered by Whiteside, for he believed that 
there had been a shift in the growing importance and role of African governments in the 
battle to overcome AIDS.
286
 Additionally Whiteside argued that it was not only critical to 
address gender concerns but there was a need for men to actively participate in these debates 
through encouragement and as positive role models.
287
 Whiteside also drew attention to the 
situation where grandmothers and older women were carrying a substantial portion of the 
burden of the epidemic through having to support and care for those infected or orphaned by 
the disease.
288
 
Concerning prevention, there appeared to be a renewed emphasis on providing more effective 
messaging and promotion campaigns tailored to community‘s unique epidemics and for 
rapidly scaling up interventions that are evidence-based. Another key debate that emerged in 
recent literature was the feasibility of utilizing HIV testing and counseling to manage the 
spread of the HIV, for evidence showed that the overwhelming majority of individuals living 
in sub-Saharan Africa still did not know their HIV status 25 years into the epidemic. The last 
significant topic was the growing health risks associated with tuberculosis (TB) and AIDS, 
and the subsequent risk TB poses to the entire population.
289
 
In summary, the recent findings provided an additional source of knowledge to assist in 
explaining how and why recent decisions were made relating to male circumcision. 
Furthermore, by understanding the historical and current perspectives relating to HIV 
prevention in sub-Saharan Africa the researcher can evaluate how the decisions and choices 
relating to male circumcision fit within these points of view. Which also assists with 
explaining why WHO and UNAIDS made their recommendation. 
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2. Timeline of key milestones relating to male circumcision  
The debates surrounding male circumcision and HIV prevention have been a long and 
tenuous process. The catalyst for linking male circumcision with HIV infections developed 
out of the interest to explain why certain regions in Africa, the ―AIDS belt‖,290 had higher 
HIV prevalence than other regions in Africa.
291
 There have been over 37 ecological, cross-
sectional, and cohort studies conducted from 1986 to 2000, with the majority demonstrating 
an inverse correlation between HIV prevalence and male circumcision.
292
 However, the 
significance of the findings had little impact on establishing male circumcision as a 
prevention tool in the 1990s. For questions relating to the accuracy of the statistical data used 
in the studies, researchers‘ methodologies, and the inadequate utilization of confounding 
factors such as religion, culture, and behaviour when analyzing the data caused HIV experts 
to remain cautious and to insist on additional evidence.
293
  
James Ntozi in 1995 argued that moving forward with policy based on observational data 
alone was a risk, he surmised, ―if the experiment fails, Africans are likely to feel abused and 
exploited by scientists who recommended the circumcision policy.‖294 Ntozi also argued that 
any intervention that could help his fellow Africans combat the AIDS epidemic should be 
immediately explored. Hence, Ntozi urged fellow researcher to move forward with 
coordinating controlled experiments based on the hypothesis of male circumcision and HIV 
in Africa.
295
 In spite of the endorsement, it was not until the start of the 21st century when a 
renewed interest in male circumcision and HIV prevention occurred. This was in part 
associated with the growing concerns related to the disappointing state of the HIV/AIDS 
epidemic in sub-Saharan Africa.
296
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Thus at the start of 2000, Weiss and colleagues published a systematic review and meta-
analysis, which included 27 observational studies previously conducted on male circumcision 
and HIV acquisition.
297
 The authors concluded that 21 of the aforementioned studies showed 
men who had been circumcised had an approximately 50% reduced risk of becoming infected 
with HIV than those not circumcised.
298
 Consequently, they argued that there was currently 
enough compelling evidence to associate male circumcision with HIV infections especially in 
areas where HIV prevalence was high. However, the researchers also cautioned that there 
were concerns associated with the intervention, which should be addressed through 
accessibility and feasibility studies. The concerns were increased incidents of risky sexual 
behavior based on the false sense of protection, how and who pays for the service, post 
surgical healing and bleeding complications and questions relating to cultural identity and 
acceptability.
299
 The study concluded that if decision makers required reliable empirical 
evidence then the ideal way forward was to conduct a RCT on how and if male circumcision 
protects against HIV infections.
300
 
During the early part of decade, the field of male circumcision started to mature into a 
defined group of actors. It was common to observe the same authors, academic institutions, 
and AIDS activist when reviewing relevant topics on male circumcision and HIV; familiar 
names were Agot, Auvert, Bailey, Gray, Halperin, Morris, Moses, Serwadda, Wawer and 
Weiss.  This cohesiveness assisted in creating a powerful voice and support network for 
promoting male circumcision. However, activism was not enough to persuade HIV experts 
and public health officials, for they remained cautious and unwilling to implement policies or 
guidance on male circumcision.  
Thus at this stage of the evolution of male circumcision the prevailing consensus was to 
conduct a RCT. Recognizing the need for reliable empirical evidence, three of the principal 
investigators involved in a number of the previous ecological and observational studies 
secured support and funding for three RCT‘s to be performed at different locations in sub-
Saharan Africa. The conclusion that RCT evidence was a critical if not the decisive factor for 
considering male circumcision as a future prevention tool was subsequentially confirmed in 
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the 2003 Cochran Review on male circumcision. The report concluded, ―It would be prudent 
for consumers to await the findings of ongoing randomized trials before deciding on the 
balance between benefits and risks of male circumcision in the context of HIV infection.‖301 
Male Circumcision RCT’s:  South Africa 
The first RCT for male circumcision started recruitment in July 2002 and was stopped in 
mid-April 2005 by the study‘s Data and Safety Monitoring Board (DSMB) based on interim 
findings demonstrating a significant health benefit for the group circumcised.
302
 Subsequently 
the findings were published in October 2005. The study team was led by principal 
investigator Dr. Bertran Auvert of France and supported by the French Agence Nationale de 
Recherches sur le SIDA (ANRS).  This trial was conducted at the site of Orange Farm, a 
semi-urban neighborhood outside of Johannesburg, South Africa. Interestingly the RCT was 
considered the first study that used a surgical procedure to prevent an infectious disease.
303
 
The Orange Farm trial comprised 3274 uncircumcised men ranging from the age of 18 to 24 
who were randomized into two groups.
304
 The control group was not circumcised and 
consisted of 1582 HIV negative men, which had 49 cases of HIV infections during the study 
period. The intervention group consisted of 1546 HIV negative circumcised men, which had 
20 incidences of HIV infections during the study period. The study found that men who were 
circumcised had a 61% protection effect against acquiring HIV compared to those men not 
circumcised.
305
 The authors concluded that in countries where there was a high percentage of 
males not circumcised and high levels of heterosexual related HIV infections, male 
circumcision should be rapidly integrated into public health plans.
306
 
The South Africa study created excitement and contention. Many in the scientific community 
questioned the accuracy of the findings. Their concerns ranged from the investigators‘ 
methodology, the obstacles associated with conducting a RCT that was surgical (participants 
are fully conscious that they have been circumcised), the limited scope and details relating to 
assessing behavioral factors and lastly the consequence of stopping the trial early (the 
findings were short term in nature with no long term protective knowledge).  At this stage, it 
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appeared that the Orange Farm trial had become a source of encouragement for those who 
historically had supported the association between male circumcision and HIV prevention. 
However, the consensus was still for delaying any policy recommendations until the two 
trials being conducted in Kenya and Uganda were concluded. Furthermore, Orange Farm‘s 
principal investigator confirmed this position during an interview from the 3
rd
 IAS 
Conference on HIV Pathogenesis and Treatment when he stated: 
For sure, we have demonstrated that in South Africa and this part of the world, we did see a 
population level reduction of HIV infection in this trial, but we are not ready to use this as a 
prevention method right now. The situation in Africa is quite complex—you‘ve got a lot of 
different cultural situations and it‘s not possible. We also have 2 ongoing trials in Uganda and 
Kenya, and we have to wait for these results to be available in order to understand if this can 
be used as a prevention method.
307  
 
WHO and UN agencies also issued a statement highlighting the positive outcomes of the 
Orange Farm trial, however any future prevention strategies would be subject to the results 
obtain from the Kenya and Uganda male circumcision studies.
308
 
UN Work Plan on Male Circumcision: November 2005 
The UN Work Plan on Male Circumcision was established in the August 2005 timeframe 
with support from the UNAIDS secretariat, WHO, UNICEF, UNFPA, and the World Bank, 
funding assistance was provided by the Bill and Melinda Gates Foundation, US National 
Institutes of Health (NIH), UNAIDS Secretariat and the French Agence Nationale de 
Recherches sur le SIDA.
309
 Each of the funders involved in the UN Work Plan were also 
involved in funding research related to male circumcision and HIV.  
Although the UN was cautious in proceeding towards making guidance or policy 
recommendations, they believed that there was merit in coordinating a UN Work Plan on 
male circumcision. Irrespective of the Kenya and Uganda results, the UN argued that the 
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findings from the Orange Farm trial could lead to an increased demand for safe circumcision 
services, thus the initiation of an action plan seemed prudent and timely.
310
 
The UN Work Plan was focused on developing practices for ensuring safety and establishing 
a policy and programming framework based on sound scientific, ethical and technical 
parameters.
311
 In addition to strengthening existing circumcision services, the plan would 
allow for timely and relevant guidance on male circumcision services upon the completion of 
the RCT‘s in Kenya and Uganda.312  
From July to September 2006, the UN Work Plan group held country level consultations with 
five countries in sub-Saharan Africa (Lesotho, Kenya, Swaziland, Tanzania and Zambia) as 
these countries had shown an interest in learning more about the subject of male circumcision 
and HIV.
313
  The UN group also assisted in coordinating four major consultations on male 
circumcision, which took place from November 2006 to March 2007. 
The literature also highlighted that a second UN Work Plan for male circumcision was 
introduced, the plan was to of have been led by the WHO. The second work plan was 
expected to provide the necessary framework and guidance to assist countries with providing 
safe male circumcision services for their respective populations.
314
However, the researcher 
was unable to locate further information relevant to this second plan, thus further clarification 
was not possible. 
First International Consultation: UNAIDS November 20-21, 2006 - Nairobi 
On November 20-21, 2006, UNAIDS and its partners hosted the first of four consultations on 
male circumcision. The meeting held in Nairobi, Kenya provided participants with a venue to 
openly discuss male circumcision and HIV prevention. The consultation had 50 participants 
with approximately 40% represented from African governments and civil society; the 
remaining attendees came from WHO, UN agencies, international AIDS organization and 
academic institutions. The purpose of the gathering was to initiate progress towards 
developing policies and action plans premised on the assumption that Kenya and Uganda 
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RCT‘s would produce the same results as Orange Farm.315 Furthermore, participants agreed 
that it was an appropriate time to progress from ―learning of the evidence to active planning 
to meet increasing demand for safe male circumcision services.‖316  
The UN argued in the follow-up report that it was a ―country‘s responsibility to act on the 
compelling evidence of the protective effect of male circumcision on HIV infection – 
inaction is unethical for a number of reasons ranging from safety concerns to depriving young 
men of prevention services in high incidence settings, and is therefore not an option.‖317 
Thereafter the UN concluded that if the Kenya and Uganda trials were stopped at the next 
DSMB review (December 13, 2006) the UN would proceed immediately with next steps 
including, scheduling a policy meeting, release of briefing packages, presentation of 
modeling data (i.e. numbers of HIV infections and deaths averted), and lastly normative and 
technical guidance.
318
 Thereafter, the UN set March 2007 as their target date for issuing the 
normative and technical guidance on male circumcision. 
Second International Consultation: WHO December 5-6, 2006 - Geneva 
The next consultation took place two weeks later on December 5-6, 2006, in Geneva 
Switzerland. This meeting was led by WHO representatives and the subjects discussed 
included: the safe delivery of male circumcision services, service strategies located in the 
framework of human rights and ethics, utilization of male circumcision to broaden male 
sexual and reproduction health, and lastly the roles of service providers.
319
 The meeting had 
50 participants as was the case in Nairobi, with approximately 26% from African 
governments and civil society; with the remaining attendees coming from WHO, UN 
agencies, international AIDS organizations and academic institutions. 
Some of the key topics that were discussed during the meeting report included, the 
appropriate strategies for HIV positive men, definition of high risk groups, approach for 
neonates, role of traditional healers and lastly a recommendation that ―non-physician (mid-
level) providers be trained in surgical techniques for male circumcision.‖320 Another key 
issue taken from the Geneva consultation was the emphasis placed on learning from the past 
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to ensure a successful field implementation for male circumcision and HIV prevention. WHO 
supported this position based on citing examples of other family planning and reproductive 
health service programmes that had failed when not adequately prepared to introduce new 
technologies.
321
  
Lastly, the consultation introduced the need for adequate costing and modeling forecasts to 
accurately assess the impact of male circumcision on population level HIV prevalence with 
the associated financial cost for the program. The report went on to highlight how Lesotho, 
Swaziland and Zambia had already started to analyze the potential impact of male 
circumcision on their respective populations.
322
 The expected outputs from the financial 
analysis were the cost of circumcision per individual; the financial resources, required 
number of infections averted, and the cost per infection averted under various scenarios; and 
lastly a report on the status of male circumcision in Lesotho.‖323 
Demand Creation 
One of the key themes that emerged from the literature was the concept of ‗demand‘ this 
word was frequently used in publications and quotes relating to male circumcision and HIV 
prevention. WHO argued in the Geneva meeting report that the principles of demand 
management and demand creation should be recognized when considering roll out strategies 
for male circumcision.
 324
 For if there was demand created for male circumcision, without the 
structures in place to deliver the services it could possibly result in negative outcomes.
325
  
However at the same time ―if only demand management is done, it might for example make 
male circumcision safer, but it would not change the overall circumcision prevalence over 
many years, and therefore would not affect HIV incidence.‖326  
Thus, WHO and the meeting participants concluded that demand creates action, therefore 
when considering male circumcision a ―proactive and reactive approach‖ should be 
considered.
327
  Furthermore, it was concluded, ―that in the absence of real action, the increase 
in male circumcision demand would probably be modest.‖328 This was the case in South 
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Africa, where little demand was created for male circumcision services even with significant 
amounts of media attention reporting on the findings of the Orange Farm trial.
329
However, 
the opposite occurred in Swaziland, here WHO argued that the demand was created because 
of public discussions and engagements on male circumcision
330
 Thus, it was established 
within the meeting report that the role of advocacy was a critical component in creating 
demand and for gaining support for the services required to implement male circumcision 
programs.  The authors of the report also highlighted how if it was not for advocacy efforts, 
ARV treatments would have never been rolled out, furthering the rationale for demand 
creation through advocacy.
331
  
Relating to this topic of demand creation another key document highlighted the emphasis and 
strategy of utilizing demand to advocate male circumcision services. Before the Geneva 
meeting WHO had released a statement with the headline: 
Demand for male circumcision rises in a bid to prevent HIV: Demand for male circumcision 
as a method of combating HIV/AIDS is likely to increase dramatically if the results from two 
studies, in Kenya and Uganda, are positive. Public health experts are warning men, however, 
that circumcision may reduce the risk of HIV infection but it does not provide full 
protection.
332
  
The press release highlighted how the demand for affordable and safe male circumcision 
services was growing and named the following countries in reference Botswana, Lesotho, 
Swaziland, Tanzania, Zambia and South Africa.
333
 The article went on to provide statements 
from African leaders and medical researchers to substantiate the growing excitement for male 
circumcision.
334
 The following were affirmations made: Marwick Khumalo, a Member of 
Parliament (MP) in Swaziland urged his fellow citizens ―All male children should be 
circumcised. To show my seriousness, I have taken all my sons for circumcision.‖335 MP 
Jimmy Angwenui from Kenya pronounced, ―In order to stop the spread of HIV/AIDS male 
circumcision should be made mandatory by the government.‖336  Lastly, Dr. Venter, Clinical 
Director of Reproductive Health and HIV-Research at the University of Witwatersrand 
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advocated ―male circumcision as one of the best protective measures. One of the beauties of 
circumcision is that it is a one-off operation, which takes 16-20 minutes but then has a 
profound effect on the rest of a man‘s life. Whereas to promote condom use or microbicides, 
repeated long-term promotion is needed.‖337 
When considering the overall effectiveness of utilizing male circumcision as a method to 
reduce population level prevalence was premised on a formula that required a rapid scale up 
of circumcised men.
338
 It becomes strikingly obvious the apparent conflict and challenge of 
creating demand while remaining sensitive to culture, religious, gender and societal factors. 
Male Circumcision RCT’s: Uganda and Kenya 
On December 12, 2006, one week after the Geneva consultation and three weeks after the 
Nairobi consultation the DSMB declared that the evidence from the Uganda and Kenya trials 
demonstrated that male circumcision was highly effective and it was unethical to continue 
withholding circumcision from the uncircumcised participants.
339
 The Uganda RCT for male 
circumcision started enrollment in July 2005, and on December 12, 2006, the study was 
stopped early. Findings were published in February 2007. The study team was led by 
principal investigator Dr. Ronald Gray, from Johns Hopkins University, Baltimore, MD USA 
and funded by NIH. Furthermore, the trial was conducted at the site of Rakai, a rural region 
of Uganda.  
The Rakai trial comprised 4966 uncircumcised men ranging from the age 15 to 49 years who 
were randomized into two groups.
340
 The control group was not circumcised and consisted of 
2522 HIV negative men, which had 43 cases of HIV infections during the study period. The 
intervention group consisted of 2474 HIV negative circumcised men, which had 22 
incidences of HIV infections during the study period.
341
 The study‘s authors concluded, 
―male circumcision reduced HIV incidence in men without behavioural disinhibition. 
Circumcision can be recommended for HIV prevention in men.‖342 It was also noted that the 
circumcised group of men had a 51% efficacy protection compared to the group not 
circumcised. 
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The Kenya RCT for male circumcision started enrollment in September 2005, and was 
stopped early on December 12, 2006 by the study‘s DSMB for the interim findings showed a 
substantive health benefit to the group circumcised. The findings were published in February 
2007. The study team was lead by principal investigator Professor Robert C. Bailey 
University of Illinois at Chicago, USA and funded by NIH. The trial was conducted at the site 
of Kisumu; a city located in western Kenya that was mainly comprised of members of the 
Luo culture. In 2003, the MoH reported a HIV prevalence of 25% in Luo women and 18% in 
Luo men.
343
 
The Kisumu trial comprised 2784 uncircumcised men ranging from the age 18 to 24 who 
were randomized into two groups.
344
 The control group was not circumcised and consisted of 
1393 HIV negative men, which had 47 cases of HIV infections during the study period. The 
intervention group consisted of 1391 HIV negative circumcised men, which had 22 
incidences of HIV infections during the study period.
345
 At the conclusion of the study, all 
male participants were immediately circumcised. The trial concluded that male circumcision 
significantly reduced a young man‘s risk of becoming infected with HIV providing a 
protective effect of 53%.
346
 
On December 13, 2006 one day after the trials were closed the sponsoring agent of the Kenya 
and Uganda trials NIH held a telebriefing in the United States. The primary attendees at the 
conference briefing included all primary investigators involved in the Kenya and Uganda 
trials, Dr. Anthony Fauci, Director of National Institute of Allergy and Infectious Diseases of 
the United States National Institutes of Health (NIAID), Kevin De Cock, WHO HIV/AIDS 
Division, Kim Dickson, WHO, and Catherine Hankins, UNAIDS.
347
 The telebriefing 
highlighted the findings of the trials and discussed subjects relating to efficacy, risks, costs 
behavioural modifications, and the role countries must play in rolling out male circumcision.  
Dr. Anthony Fauci during the press conference discussed the impact of male circumcision 
and the forecasts relating to new infections and preventable deaths. However he also urged 
caution when discussing the possible impact of male circumcision he argued that ―you could 
possible avert, you know up to two million infections. But again having said that, I‘d like to 
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please caution the press on this call that we‘ve got to be very careful when you talk about 
mathematical models. OK.‖348 During the briefing the role of donor funding emerged, it was 
highlighted that there was an immediate need to engage donors with the results and to discuss 
possible plans forward, including discussions with PEPFAR and the Global Fund.
349
  
In response to a question on cultural barriers and male circumcision, Kevin De Cock 
discussed the importance of getting the opinions and involvement of communities.
350
 He 
argued that male circumcision was a topic that drew controversy and strong opinions across 
the world, and for that reason it was critical to engage those countries‘s affected by the 
recommendation and to ensure local communities and governments were engage in the 
acceptability of male circumcision.
351
 
Another key discussion related to a question on the risk of men engaging in sex before their 
circumcision wound had fully healed. Dr. Maria Wawer from the Uganda research team 
clarified the findings from the Rakai study; she stated that approximately 10% of the men 
who had engaged in sex before the designated healing period did so just a few days before it 
was considered acceptable. Furthermore, Wawer acknowledged, ―overall, men really did 
comply well.‖ 352  
Interestingly, another clinical trial conducted in Rakai and funded by the Bill and Melinda 
Gates Foundation was notified to stop enrolling participants on December 12, 2006, for the 
study‘s DSMB had ―determined futility with respect to the female HIV outcome.‖353  The 
reason given for stopping enrollment was the study‘s findings showed a significantly higher 
rate of HIV infections in the women partners of HIV-positive men, for couples had resumed 
sex before the recommended healing period.
354
 These findings were not discussed during the 
NIH telebriefing and outside of the NIH online clinical trial database the researcher was 
unable to locate any further confirmation specific to the December 12, 2006 notification date. 
Furthermore, the NIH trial summary stated the DSMB report was defined as closed, thus 
unavailable for the public review. 
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Third International Consultation: UNAIDS and CAPRISA January 18-19, 2007 - 
Durban 
On January 18-19, 2007, the third consultation was organized by UNAIDS and CAPRISA, in 
Durban, South Africa. The event was organized to engage social scientist perspectives on 
male circumcision for HIV prevention and was designed to explore the cultural and social 
implications related to the scale up of male circumcision. The event had about 30 participants 
with approximately 53% from African governments or civil society.
355
 
The limited report from this event highlighted the concern that social science research had not 
been adequately included during the process of evaluating male circumcision. It appeared 
from the summary report that a significant portion of the meeting was focused on discussing 
the reasons for the limited role of social sciences within the debates of HIV prevention. The 
following quote taken from the meeting report assists to clarify these observations ―social 
science seems to have been a somewhat neglected area of science in relation to HIV, in 
contrast to biomedical science.‖356 
In conclusion, the meeting participants identified that there was a need for a greater 
awareness of the contextual issues relating to male circumcision and how these factor may 
vary by society. Furthermore, they recommended that a multi-disciplinary approach should 
be considered when planning male circumcision and HIV prevention programs.
357
 For this 
approach would provide the means to establish participation from a broader range of 
scientific disciplines, which in principle would improved the probability of implementing 
male circumcision programs  that are effective.
358
Lastly, it was argued that there was a need 
to build social science research capacity if serious efforts were to be made to address the 
topics relating to male circumcision and HIV prevention. 
Fourth International Consultation: WHO and UNAIDS March 6-8, 2007 - Montreux 
The final consultation conducted before WHO and UNAIDS made their March 28, 2007 
policy recommendation was held on March 6-8, 2007 in Montreux, Switzerland. The meeting 
was convened approximately 3 months after the first consultation and one month after the 
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findings of the Kenya and Uganda RCT‘s were published.  The number of participants was 
estimated from an interview to be approximately 80 and the types of attendees included 
government, researchers, gender experts, human rights and health advocates, donors, youth 
and implementation partners. The objective of the event was to present the evidence and 
achieve consensus that male circumcision should be recommended as part of an overall 
comprehensive HIV prevention programme. Catherine Hankins, Chief Scientific Officer, 
UNAIDS provided the following account of the Montreux consultation: 
It was done in a meeting with over 80 people.  It was done in a traditional consultation like 
we have all the time that weighs the evidence, the evidence is presented, people argue about 
it, they question the data and then we come up, the meeting comes up with recommendations. 
So in that meeting there were human rights‘ experts, there were gender experts, women‘s 
groups, activists, people with HIV – it was a broad range, we brought everybody who could 
have anything to say into the room including people who were completely opposed to male 
circumcision, totally opposed to it, and it‘s only in doing that, it is not one person that sits 
somewhere and decides something.
359
 
In the meeting report WHO and UNAIDS identified two conditions that would most likely 
need to exist if male circumcision was to be considered as a tool to prevent HIV infections. 
First, the state of the epidemic and second, the number of men circumcised in a region. To 
further clarify their position the following quote was taken from the WHO and UNAIDS 
meeting report, ―the greatest potential public health impact will be in settings where HIV is 
hyper-endemic (HIV prevalence in the general population exceeds 15%), spread 
predominantly through heterosexual transmission, and where a substantial portion of men 
(e.g. greater than 80%) are not circumcised.‖360 In addition to the two conditions just 
discussed, WHO and UNAIDS further clarified that male circumcision would most likely not 
have a significant impact on reducing population level HIV prevalence unless it could be 
scaled up rapidly.
361
 
To assist in providing participants with the relevant knowledge to make an informed decision 
on male circumcision and HIV prevention the consultation provided various forms of 
evidence. Presentations on the efficacy of male circumcision focused primarily on the 
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evidence gathered from the three RCT‘s with support from earlier observational studies. 
Significant emphasis was placed on the acceptability of male circumcision, for it was argued 
that numerous studies had been completed with the majority demonstrating both men and 
women approved of the procedure and would recommend it for their children and partners.  
Lastly, there appeared to be a focus on introducing the modeling data that had been 
completed on the feasibility and cost effectiveness of male circumcision. The cost-
effectiveness studies compared the cost per infection averted to the cost of lifetime ARV 
treatments, and surmised that male circumcision could have substantial cost-benefits.
362 
Furthermore, the modeling forecasts presented at the consultation suggested that, ―universal 
male circumcision in sub-Saharan Africa could prevent 5.7 million new cases of HIV 
infection and 3 million deaths over 20 years.‖363  
Another key event that occurred during the Montreux consultation was the announcement of 
interim results from a study that was also being conducted in Rakai, Uganda.
364
  The research 
was led by principal investigator Maria Wawer from Johns Hopkins University, Baltimore, 
MD USA and funded by the Bill and Melinda Gates Foundation.
365
 The study evaluated the 
effect of male circumcision on HIV-negative women who had HIV-positive male partners, in 
70 couples - the men were circumcised and in 54 couples - the men were not circumcised.
366
 
The six-month review found 11 cases of HIV infections in the female partners of the 70 men 
circumcised and only 4 incidents of HIV infection in the female partners of the 54 men not 
circumcised.
367
   
The Associated Press reported a headline ‗Circumcision may lift HIV risk for women‘, they 
went on to present the preliminary findings from Uganda and highlighted that the increased 
risk to women was as a result of men engaging in sex before the healing period had ended.
368
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The lead investigator remarked, ―We need to err on the side of caution to protect women in 
the context of any future male circumcision programme.‖369  
The study was reported to have been the first clinical trial conducted to produce scientific 
evidence on the effects of male circumcision on their female partners.
370
 Furthermore, the 
findings varied significantly from the previous observational studies completed by Johns 
Hopkins University on male circumcision and its effect on women. For in 2006, a statistical 
review of 300 couples medical records in Uganda resulted in the authors concluding that 
HIV-negative females had a 30% reduced chance of becoming infected with HIV if their 
HIV-positive male partners were circumcised.
371
 
These findings from the Uganda clinical trial were in part supported by the concerns outlined 
in Williams et al. modeling study.
372
 Within the studies, methods and findings section the 
authors argued that male circumcision would increase the proportion of women infected from 
the current 52% to 58% (UNAIDS 2004 statistics).
373
 Furthermore, Catherine Hankins 
UNAIDS also claimed in her published article ―already mathematical modeling suggests that 
in the medium term the proportion of people living with HIV in sub-Saharan Africa who are 
women may rise as male circumcision programmes are scaled up in high HIV prevalence 
settings, due to the lag time for indirect effects for women to be felt.‖374 
The consensus reported from the Montreux consultant in response to the new clinical 
evidence on male circumcision and women‘s HIV risk was - the findings would not impact 
the decision to proceed with male circumcision, however proceed with caution.
375 
The 
following statement by Kevin De Cock was an example of the majority view ―while male 
circumcision has extraordinary potential to prevent HIV infection, these new findings remind 
us that we must proceed with thought and care in developing strategies to explain male 
circumcision in Africa.‖376 
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WHO and UNAIDS March 28, 2007 – Issued Endorsement for Male Circumcision 
Two weeks later on March 28, 2007 a commanding endorsement for male circumcision was 
issued jointly by WHO and UNAIDS, the policy paper reviewed the findings from the trial 
and stated, ―The efficacy of male circumcision in reducing female to male transmission of 
HIV has been proven beyond reasonable doubt. This is an important landmark in the history 
of HIV prevention.‖377  
The report highlighted 11 conclusions and recommendations which were developed from the 
WHO and UNAIDS consultation in March: ―1) The research evidence is compelling, 2) Male 
circumcision does not provide complete protection against HIV, 3) Correct communication 
and messages on male circumcision are critical, 4) The socio-cultural context should inform 
male circumcision programming, 5) Human rights, legal and ethical principle must guide 
service delivery, 6) The gender implications of male circumcision as an HIV prevention 
method must be addressed, 7) Programmes should be targeted to maximize the public health 
benefit, 8) Health services need to be strengthened to increase access to safe male 
circumcision services, 9) Additional resources should be mobilized to finance the expansion 
of safe male circumcision services, 10) Promoting circumcision for HIV-positive men is not 
recommended and 11) research is needed to guide programme implementation.‖378 The 
document provided summary conclusions relating to each of these factors, however the report 
was 10 pages in total, thus it appeared that the endorsement was primarily issued to confirm 
the decisions made from the consultation in March 2007. 
Furthermore, in a press release covering the announcement WHO and UNAIDS emphasized 
the need to incorporate male circumcision into a comprehensive HIV prevention 
package.
379
Significant emphasis was placed on ensuring there was an appropriate messaging 
strategy when rolling out male circumcisions. The rationale was premised on the concern that 
a man would engage in risky sexual behaviours due to a false sense of protection and the 
belief he no longer become infected with HIV, which might undermine the partial benefits of 
male circumcision.
380
 WHO and UNAIDS also presented that experts at the consultation felt 
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it was prudent to try to provide male circumcision services free to the public or at the lowest 
cost possible.
381
 
Lastly, five key areas of additional research were recommended to assist with developing 
further programs, they included: impact on HIV-positive men to women; benefits of male 
circumcision on women‘s health; risk and possible benefits of male circumcision on HIV-
positive men; the effect of male circumcision on homosexual and heterosexual anal 
intercourse; and additional knowledge on the methods, resources and services required to 
produce quality and effective male circumcision programs.
382
  
Conclusion 
The task of establishing a timeline with key milestones provided the researcher with a method 
to gain insight into how each event and decision relating to the endorsement of male 
circumcision transpired.  There has been significant literature narrating the chronological 
history of the scientific evidence supporting male circumcision. However, what was unique 
about this review was the use of data to establish how the processes and decisions relating to 
the science possibly influenced the urgency and veracity of WHO and UNAIDS 
recommendation. 
By evaluating WHO and UNAIDS role within this process the researcher can better evaluate 
how male circumcision was position compared to previous interventions. It also established a 
means to critique WHO and UNAIDS role and authority. Furthermore, it provided the 
evidence to verify statements and claims relating to why certain decisions were made and 
how certain events transpired.  
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Chapter Four: Why did WHO and UNAIDS endorse Male Circumcision 
The data collected from the interviews and documents analysis phase of this research have 
produced the framework for explaining why WHO and UNAIDS endorsed male circumcision 
as a public health initiative for HIV prevention in sub-Saharan Africa. The findings from this 
study showed that the evidence-based research, their consultative process, and the state of 
the epidemic in sub-Saharan Africa collectively constituted the rationale behind why WHO 
and UNAIDS issued an endorsement for male circumcision. Additionally this research will 
argue that the modeling studies were the catalyst and justification for understanding why the 
intervention was promoted as a public health initiative.  
Furthermore, when questioned on the urgency and motivation behind their decisions WHO 
and UNAIDS often responded with a ‗why wait‘ approach. Through defining the principles 
behind this point of view, it provided the means to examine how their ideologies might have 
influenced the process used to evaluate male circumcision.  The following sections will 
provide evidence to support these arguments. 
1. Evidence-based Research  
This research concludes that one of the reasons why WHO and UNAIDS endorsed male 
circumcision as an intervention for HIV prevention in sub-Saharan Africa was the 
comprehensive body of evidence collected over the last 20 years. There were various 
methods of research conducted during this time including, RCT‘s, observational, ecological, 
modeling and acceptability studies. However, the evidence that appeared to have the greatest 
influence on WHO and UNAIDS announcement was the RCT‘s, modeling and acceptability 
studies. When Catherine Hankins UNAIDS Chief Scientific Officer and Associate Director 
Evidence, Monitoring and Policy was asked why they had made their endorsement, she 
stated: 
We do not have another example in HIV prevention, we certainly do not and you would have 
to look pretty far and wide to find something else where you have 20 years of observational 
and ecological data followed by 3 trials not 1. Many people would make a move on 1 trial but 
3 trials, all saying the same thing, incredibly confirmatory of the same findings.
383
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Her view that WHO and UNAIDS had considered a broad range of evidence before making 
their final endorsement was also supported in chapter 3. When responding to why the 
endorsement was made, Professor Robert Bailey the lead principal investigator for the Kenya 
trial provided this assessment of their comprehensive approach,  
Because the evidence is overwhelming.  We have not just the Orange Farm and the Kisumu 
and Rakai trials, which were remarkably consistent in their results and showed a very large 
effect, a 60% effect. We also have over 40 observational studies, we had strong biological 
evidence, in the face of all that evidence, I do not think they had a choice. I think they kind 
of acted slowly, but staring all that evidence in the face, they had no choice but to finally 
declare that male circumcision is effective in reducing HIV incidence.
384
 
Each method will now be discussed to clarify why this study concludes that the RCT‘s, 
modeling and acceptability studies were key components of WHO and UNAIDS decision.   
Randomized controlled trials 
The scope of evidence on male circumcision was comprehensive. However, this study 
suggests that the three RCT‘s forced the change from theory to considering male 
circumcision as an important intervention for HIV prevention.  Matthews defined the RCT 
method of research as an ―experiment performed on human subjects to assess the efficacy of 
a new treatment for some conditions.‖385 The narrative from chapter 3 and the data collected 
from the interviews explain why the RCT‘s were considered a catalyst for proceeding 
forward. 
The most important reason for arguing that the RCT‘s were the factor that moved male 
circumcision from a research to a potential policy agenda was the fact health experts were 
unwilling to proceed without the clinical evidence. Although there was support for male 
circumcision the majority of experts still questioned the historical findings and demanded 
RCT evidence. This view was clarified in chapter 3 and additionally Catherine Hankins 
argued, ―the reason the trials were done was because of the fact that people couldn‘t control 
for confounding variables such as behaviour associated with religion.‖386 
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RCT‘s have achieved elite status in the research fraternity because experts regard them as the 
most reliable and valid form of evidence. Furthermore, when considering the three standards 
of research generalizability, validity, and reliability the RCT‘s basic design takes advantage 
of these principles by limiting the influence of participant‘s behaviour on a study‘s outcome. 
RCT‘s have primarily been used in conducting drug trials where a placebo was administered 
to the control group and the medicine to the intervention group, providing an environment 
where all participants remain unaware of whether they have been given the medicine or the 
placebo.
387
 This lack of knowledge ultimately reduces the effects of behavior on the trials 
outcomes. In the instance of the male circumcision trials the surgical element eliminated the 
ability for ‗procedure anonymity‘ however, the clinical nature of the study was still believed 
to be far more reliable, valid and generalizable then study‘s based on observation or medical 
records.  
The scientific and medical communities have historically classified RCT‘s as the gold 
standard of medical research. Kevin De Cock, Director of WHO HIV/AIDS Division and 
Sibongile Dludlu, Male Circumcision Consultant for UNAIDS verified this view existed 
amongst AIDS professionals when they stressed, ―randomized controlled trials were the gold 
standard‖388 of evidence. Furthermore, expert Warren Parker, Executive Director of CADRE 
remarked, ―when one of these randomized controlled trials comes out, it is supposedly the 
gold standard of evidence.‖389 When Kevin De Cock was asked why they made their 
endorsement, he emphasized many of the characteristics that have made RCT‘s the gold 
standard, 
The fact that three were done and are so consistent in different geographic context, different 
social context and so consistent with the previous data that I think it is very, very persuasive 
and convincing. I think we have adequate data to strongly make those recommendations, 
which it is all about.
390
 
Catherine Hankins earlier discussed that WHO and UNAIDS held off on their endorsement 
until all three trials were completed. The weight they gave to the collective results of the 
RCT‘s was also confirmed when WHO, UN agencies and Bertran Auvert stated at the 
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completion of his Orange Farm trial that any future policy considerations would be subject to 
the results of the Kenya and Uganda male circumcision studies.
391
  
The emphasis given to the three trials consistency and generalizability was unanimously 
supported by all WHO and UNAIDS participants, Catherine Hankins provided an example of 
this passion when she proclaimed the evidence was ―so compelling you do not walk away 
from it, it is unethical to walk away from it.‖392Hankins‘ opinion was also expressed in the 
2006 Nairobi consultation report, where the UN stated that it was a ―country‘s responsibility 
to act on the compelling evidence of the protective effect of male circumcision on HIV 
infection – inaction is unethical for a number of reasons ranging from safety concerns to 
depriving young men of prevention services in high incidence settings, and is therefore not an 
option.‖393 
An important element for constructing the argument that WHO and UNAIDS decision was 
heavily influenced by the RCT evidence was achieved through examining the experts 
responses to why they believed WHO and UNAIDS made the endorsement.  When 
Keymanthri Moodley, Professor at Bioethics Unit Tygerberg Division, was asked why, she 
replied, ―the scientific evidence from all three trials was regarded as reliable, valid, and 
generalizable within the sub-Saharan setting.‖394 Her response was reflective of the majority 
view that the RCT‘s were a decisive factor in explaining why WHO and UNAIDS issued 
their endorsement, irrespective of whether the expert agreed with their decision. Leickness 
Simbayi, Executive Director of HSRC HIV/AIDS & Health Programme, provided another 
perspective, he responded: 
The major reason why they are recommending their position is really having 3 randomized 
controlled trials suggest the efficacy of something, albeit partially, because they say its 60%. 
It is really one of the best news that has come out of prevention research for a long time.  So it 
is the quality of the evidence that is available,  randomized controlled trials are meant to offer 
definitive proof about casual relationships or particularly how effective an intervention is and 
here were 3 RCT‘s which are basically in agreement.395 
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Another aspect of the RCT evidence that drew attention was the efficacy percentage derived 
from each trial. Both WHO and UNAIDS emphasized the efficacy outcomes and furthermore 
reasoned it was equivalent to a vaccine. Kevin De Cock explained why he believed the 
efficacy percentage was important, he stated: 
It is extremely unusual to come up with a once only biomedical – a once only medical 
intervention with 60% efficacy to prevent transmission acquisition in men; it is very unusual 
to come up with something like that in HIV prevention science. I think people are 
underestimating what this actually represents.  If you had a vaccine that had a 60% efficacy 
and we suddenly said, we will give people one dose of a vaccine and this is the reduction of 
HIV incidents you would get – people will say this is extraordinary, this is a major 
advancement.  There has been this skepticism around circumcision because of everything 
around it and what it represents.
396
 
A significant number of the experts also agreed with De Cock‘s opinion that the efficacy 
rating was a scientific accomplishment.  The association to the equivalency of a vaccine was 
not as widely supported; however, there was a group of experts who did share his point of 
view. One of them was Professor Miriam Were, Chairperson of Kenya‘s National AIDS 
Control Council she remarked ―male circumcision reduces the acquisition of HIV by more 
than 60% in otherwise it is as effective as the most effective vaccines.‖397  
Expert concerns were predominately directed at the methodology and accuracy of the RCT 
findings, most often emphasizing the lack of planning, monitoring and reporting of 
participant‘s behaviour. Mary Crewe, Executive Director of the Centre for Study of AIDS 
highlighted several of the concerns, 
I think that the methodology of the trails is extremely flawed.  I think you cannot do those 
kinds of randomized controlled trials on something like circumcision it just does not lend 
itself to that.  We don‘t know enough about those trials, we don‘t know enough about what 
type of men were counseled we don‘t know enough about how the men were recruited we 
don‘t know enough about what kind of messages the men we‘re given. We do not know 
where this alleged demand for circumcision came from that they say these trials created, this 
great demand for circumcision, where did it come from, how was it created.  We do not know 
anything about why the men believed it to be an advantaged to be circumcised, when they still 
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have to use condoms; because it does not prevent infection, it simply lowers your risk. Why 
would men then be circumcised? What was the compelling reason that they gave as to why 
men should be circumcised if it merely lowers your risk, it does not prevent.
398
 
During the interview with the lead principal for the Orange Farm trial, he clarified why some 
concerns may still exist even when conducting research with the gold standard of medical 
science. Dr. Auvert argued that behaviour rarely impacts drug clinical trials, however 
―circumcision of course they knew they were circumcised, so you can imagine that they 
could of changed their behaviour and they reported something different then what they have 
done.‖399 
Another concern expressed by some experts was the need for additional reporting on the 
RCT‘s outcomes and furthermore the resources to gain clarification on such concerns. Anton 
van Niekerk, Professor at the University of Stellenbosch and Director for the Center for 
Applied Ethics shared an example, he remarked: 
One thing about the Orange Farm trial that I do not understand: Why was the six week period 
after the circumcisions took place not taken into consideration in terms of outcomes. One 
would have thought that because people were very strongly urged to refrain from sexually 
activities six weeks after the circumcisions took place that could well have had a significant 
influence on the reduced rates of infections. I have asked this question to many people, 
nobody seemed to come up with an answer, and it was not discussed in the literature I read.
400 
 
One of the themes that emerged out of the experts concerns was this balance between the 
need for excitement and a sense of realism, this distinction was captured in Professor van 
Niekerk reflection on the importance of the RCT findings. The Professor said:   
Look, I think those trials yielded significant information and I think one must act on that 
information. What is not negotiable is you make the recommendation with full counseling as 
to the complete picture, so people get a very, very well informed look, in the long run, this is 
a preventive measure but it is not full proof.
 401
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In summary, WHO and UNAIDS considered the entire body of scientific evidence on male 
circumcision as instrumental in their overall analysis. Furthermore, the historical pessimism 
to proceed with policy discussions based on observation and ecological evidence alone was 
clearly documented in chapter 3 and supported by the interviews. In addition Cochrane 
explained the rationale behind the medical pessimism and highlighted that when used 
appropriately RCT‘s and cost-benefit analysis can improve the ―effectiveness and efficiency‖ 
of medical interventions.
402
 Thus, in conclusion the reason male circumcision transitioned 
from a research agenda to a policy agenda was the consistent and collective outcomes of 
three RCT‘s.  
Modeling 
This study has now shown that one of the pivotal reasons for understanding why WHO and 
UNAIDS initiated a process to evaluate male circumcision as a possible public health 
intervention for HIV prevention was the validity, consistency and reliability of the RCT 
evidence. This section will explain why the RCT evidence in isolation lacked the power to 
justify male circumcision as a public health initiative. The RCT‘s could kick off action but it 
took a far more complex analysis to justify a massive rollout at a population level.  
At the start of this chapter, it was argued that the modeling evidence was the catalyst behind 
why WHO and UNAIDS recommendation was targeted at the public health establishments of 
sub-Saharan Africa. To rationalize this argument we must first establish the intent behind 
WHO and UNAIDS endorsement. The objective stated in the March 28, 2007 WHO and 
UNAIDS endorsement document, was to provide ―policy and programme implications and to 
make recommendations regarding public health issues,‖ and male circumcision.403 WHO 
supported this stated objective during an interview, they argued, ―the intent is to provide 
information to countries so that they can make their policies and programming 
accordingly.‖404 
When experts were asked what was the intent behind WHO and UNAIDS endorsement it 
evoked various responses, however the dominant  response  emphasized  policy guidance that 
was premised on the assumption that ―they [WHO and UNAIDS] would like to see national 
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scale circumcision programs in countries that are heavily affected.‖405 Some of the confusion 
experts expressed relating to the actual intent of WHO and UNAIDS endorsement was 
reflected in two of the National AIDS Councils interviews. The following statements were 
provided in response to the question: What do you believe was WHO and UNAIDS intent 
in relation to male circumcision and policy? Dr. Ben Chirwa, Director General of Zambia 
National AIDS Council replied:  
Policy is a strong word, in fact, it has confused a lot of people, because when you say policy 
it is a government intent, which is not a specific specialty activity, it is a broad government 
intent of action for many years to come.  So, for us we use policy with caution.  What we 
are talking about are basic guidelines, maybe that is a caution I would like to give even to 
you, because immediately you start talking about circumcision policy you are giving broad 
and very strong intention to circumcision.
406
 
Professor Miriam Were, Chairperson of Kenya‘s National AIDS Control Council, provided 
an alternative response to the same question, she remarked: 
I think it is for every country to make their policy and so that it becomes relevant, I think 
that is the intention. Hopefully, we in Africa hope that they will support us in doing this. 
How will the global community respond to this challenge by helping Africa to strengthen 
systems, I see it as a challenge to all of us rather than just WHO and UNAIDS.
407
 
Once clarifying the endorsement was viewed as a public health initiative, we can begin to 
explain how modeling studies influenced various elements of WHO and UNAIDS 
recommendation. The literature review on public health discussed the rationale behind why 
modeling tools such as cost benefit analysis and other statistical methods have been used to 
inform decision-makers. Both Schneider and The World Bank argued that the only way to 
analyze the potential impact on population health and the corresponding justification for that 
expense was through statistical modeling. Therefore whether male circumcision was ―worth 
pursuing at a public level was really driven by modeling.‖408 
The timeline of male circumcision key milestones (chapter 3) highlighted how modeling was 
used to forecast the potential number of saved lives and adverted deaths. Williams and 
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colleagues modeling forecast suggested that, ―universal male circumcision in sub-Saharan 
Africa could prevent 5.7 million new cases of HIV infection and 3 million deaths over 20 
years.‖409The outputs from these forms of models (most significantly the 2006 Williams and 
colleagues study) provided WHO and UNAIDS with the data needed to establish the 
framework to define where male circumcision would have the greatest impact on reducing 
population level infection rates. They concluded that if there was to be a significant impact on 
reducing new HIV infections the intervention would need to be scaled up rapidly; and in 
locations with hyper-epidemics and low levels of circumcision.
410
  
The Williams and colleagues paper drew significant attention from the media. The majority 
of press coverage, which transpired between the NIH teleconference and Montreux 
consultation, consistently referenced their projected number of saved lives and adverted 
infections statistics. Another key component of their modeling findings centered on the 
extensive period of time that it would take before population level benefits might be incurred.  
Warren Parker, Executive Director of CADRE provided a critique of the modeling process,   
I saw the most appalling modeling going on around circumcision, which implied this sort of 
massive impact usually done by economic models, which have absolutely no idea of the 
complexity of the context.  With that said, I think the WHO report by Williams raised as an 
important point that it is a 20 to 30 year project and not a quick fix.  At the time it came out, it 
contradicted many of the sorts of glory parades around this intervention.  They were 
predicting massive impact much sooner.
411
 
Dr. Salim Abdool Karim, Executive Director of CAPRISA who participated in the Montreux 
consultation and hosted the Social Sciences consultation in Durban with UNAIDS, discussed 
the importance of William and colleagues modeling projections. He, as did Parker pondered 
if and how the projections could be achieved at a population level. He stated: 
Well there is no question that it [male circumcision] is effective, it is a question of whether it 
actually turns the epidemic, as we are hoping it to and I do not think it is going to do that, 
because I do not think we will be able to get it out - implement it in the scale required to have 
an impact. That is not to say it does not work at an individual level, if I am circumcised I am 
less at risk, we are not talking about an individual level, we are talking about population level. 
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To turn an epidemic at a population level you really have to do this to a very large scale. If 
you take South Africa, where 34% of men are already circumcised, that means we need to get 
another 50 to 60% of men circumcised.
412
  
WHO and UNAIDS agreed with Dr. Abdool Karim and argued that individual benefits might 
occur in the short term, however to impact population level infections it would take a massive 
scale up. In their Montreux recommendation paper, they detailed the complexity of achieving 
population level impact through the prioritization of various groups. They provided these 
scenarios ―boys and young men before sexual debut are a relatively easy group to reach but 
measurable impact is not likely to be realized for over 10 years; if older boys and men up to 
the age 30 years are prioritized a more rapid effect can be expected. Circumcision of 
neonates, in whom the procedure is simpler and less risky, can be considered as a longer-term 
strategy to promote circumcision in the general population, but impact of this strategy on 
HIV incidence would not be expected for at least 20 years.‖413 
The interviews provided additional evidence that WHO and UNAIDS placed significant 
importance on the need for a rapid scale up of male circumcision if the forecasts to reduce 
HIV infections were to be achieved. Kevin De Cock when asked: Do you believe strongly 
that in 10 years from now that male circumcision will make a quantifiable and identifiable 
reduction in HIV infections? He stated, ―Only if it is scaled up to very high levels.‖414 
UNAIDS response to the issues of scale up remained consistent with De Cock‘s point of 
view, Catherine Hankins explained: 
If scaled up was slow you would not get the effects you would get if scale up was fast, and 
that is because there are indirect effects for women being less likely to encounter an HIV 
positive partner.  So if you scale up very, very slowly and get to a target in 2015 as opposed 
to scaling up quickly and reaching your target in 2015 you get way more effectiveness if you 
do it faster. The limiting factor is as you say it is safety, making sure people are adequately 
trained and so on and so forth.
415
 
The complexity of the balance between safety and having an impact on future HIV infections 
was expressed when WHO discussed possible roll out strategies for male circumcision, WHO 
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argued ―if only demand management is done, it might for example make male circumcision 
safer, but it would not change the overall circumcision prevalence over many years, and 
therefore would not affect HIV incidence.‖416Furthermore Sibongile Dludlu, UNAIDS 
Consultant for Male Circumcision added that the rate of scale up should not be at the cost of 
―encouraging stigma and discrimination‖ she asserted that this was not how the intervention 
was being put across and she did not think that this was how male circumcision should be 
scaled up.
417
 
One of the most highly contested debates involving the scale up of circumcision was the 
inclusion of infants. Kevin De Cock argued, ―We need to change societal norms to move 
towards infant circumcision, because infant circumcision is easier, it is less of a big deal and 
also it means eventually you will end up with higher levels of circumcision across a society 
and it will become the normal thing to be or to have.‖418  Some experts agreed with De 
Cock‘s suggestion, premised on the awareness that a rapid scale up was required to achieve 
any measurable impact. Glenda Gray, HIVSA, Executive Director stated: 
Despite the fact that you do need a military operation and you need skills and healthcare 
workers to roll it out.  We should be looking at ways of being able to roll it out in an easy 
fashion, like one should consider infant male circumcision, which is much easier than adult 
male circumcision.
419
 
As mentioned previously the issues relating to infant circumcision have resulted in some 
heated debates, which at times casted a negative light on WHO and UNAIDS strategies. The 
following observation given by George Denniston, President of Doctors Opposing 
Circumcision should serve as example of some of the doubts and bewilderment that exists 
surrounding neonates, male circumcision and HIV: 
It is very important to know that there is a not a single national medical organization in the 
entire world including Israel and other Muslim countries that approve of routine infant 
circumcision and the reason they don‘t, my God, it‘s because there is no reason for it and 
nobody has the gall to go against that fact.
420
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In addition to the concerns raised by Dr. George Denniston, he and others questioned how 
three RCT‘s on young and middle age men resulted in an endorsement for infant 
circumcision. The literature on evidence-based research, along with WHO and UNAIDS 
own assertions that policy should be based on solid evidence, does cause one to question 
the rationale behind this decision. Furthermore as discussed at the start of this section WHO 
and UNAIDS argued that neonates would have the slowest impact on the reduction of new 
HIV infections.
421
 Daniel Sidler, a Pediatric Surgeon for Tygerberg Children‘s Hospital in 
Cape Town South Africa shared his frustration:  
At the moment, I am in a situation where I really puzzled with what is going on.  I am sure 
that most of the people have good intentions; they are trying to prevent as many people 
from acquiring HIV/AIDS.  We all want that, but one just does not understand how this has 
got anything to do with neonates. If I have a position, a clear cut position it is that neonatal 
circumcision is definitely not a tool for HIV/AIDS prevention. What adult men do with their 
genitals and their foreskin to prevent HIV/AIDS that is their own decision, as long as they get 
the information and they are not pushed to do it for whatever purposes. For example in 
Rwanda, I suppose you cannot make a career if you are not circumcised in the army, I have 
no problem with that.
422
  
The last concern expressed in the context of neonates was the potential burden it would have 
on the currently resourced constrained medical establishments of sub-Saharan Africa. Dr. 
Sidler expressed his apprehension ―if I would have to now do neonatal circumcisions on top 
of everything it would just not be possible.‖423 Dr. Sidler shared his concerns with respect to 
neonates, however the majority of experts also questioned if the weak healthcare 
infrastructures in sub-Saharan Africa could deliver safe and massive scale ups of male 
circumcision in the general population. Professor Simbayi shared his view: 
In terms of capacity of health systems, already even without HIV the health systems in 
many of these countries are basically struggling, they do not have the capacity and they do 
not have enough manpower for human resources just to deal with the diseases that were 
there previously. Now if you throw HIV/AIDS on top of that it is also really affecting how 
the system functions, not only by drawing in critical resources that are needed to address 
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other issues. But really, when it comes to there not being enough medical health providers 
that presents another challenge.
424
 
To address the issues of resource constraints, WHO, UNAIDS and male circumcision 
supporters recommended training nurses, clinical workers, flying in international doctors, 
and/or teaching traditional healers how to perform safe and proper male circumcisions.
425
 
As discussed earlier, Professor Were alluded to another key influential element of modeling, 
when she discussed the hope that WHO, UNAIDS and the international community would 
support Kenya‘s efforts in rolling out male circumcision programs. Another example, which 
demonstrates how modeling projections influenced the need for financial support was 
observed in the international movement towards publicly affirming funds for male 
circumcision. In 2006, The National Edition of the New York Times reported that Dr. 
Richard G. A. Feachem the Executive Director of the Global Fund to Fight AIDS, 
Tuberculosis and Malaria, stated ―I think it‘s a very likely that our technical panel would 
approve it [male circumcision].‖426 A second quote from the same article reported that Dr. 
Mark Dybul, the Executive Director of PEPFAR stated, they would ―support implementation 
of safe medical male circumcision for H.I.V./AIDS prevention‖ if WHO recommended the 
intervention.427  
The donor examples and the demand creation and demand management strategies outlined in 
chapter 3, both  demonstrate how modeling influenced WHO and UNAIDS actions and 
priorities. Maybe the most salient account of how modeling, donors and male circumcision 
were closely coupled came from the Montreux consultation. Attendee Dr. Abdool Karim 
explained: 
Well the policy was really directed at three key role players, first governments to make it 
available in the public sector. The second is to aid organizations and NGO‘s to do this, so for 
example at the meeting in Montreux the person from PEPFAR was there and she said if this 
group, you people, you guys are the experts here, there were about 120 odd people at this 
meeting, you guys tell the world you think this should be done, PEPFAR is going to provide 
the money to do it.  They made that very clear and they are evidence based, the evidence is 
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compelling they will implement.
428
 [Interview interrupted by cell call third role player not 
discussed]. 
The last impact of modeling was taken from the same Williams and colleagues study that 
appeared to influence many of WHO and UNAIDS strategies. In the studies methods and 
findings section on page 1, the authors argued that male circumcision would increase the 
proportion of women infected from 52% to 58%, base on 2004 UNAIDS figures.
429
 
Furthermore, Catherine Hankins drew attention to Williams and colleagues findings in her 
published article, where she remarked, ―already mathematical modeling suggests that in the 
medium term the proportion of people living with HIV in sub-Saharan Africa who are women 
may rise as male circumcision programmes are scaled up in high HIV prevalence settings, 
due to the lag time for indirect effects for women to be felt.‖430 
Views, which supported some of the modeling suggestions that woman may not benefit or 
might possibly be at greater risk, were situated within the framework that ―women are the 
most at risk and infected people‖431in Africa. Leickness Simbayi, argued ―if one looks at the 
epidemiological profile, infection levels are quite high among young women between 20 and 
30, if the idea let‘s say is to circumcise youth now. These young women are having sex with 
older men, at least some of them, so it will really take a generation before we reap any 
benefits from this intervention.‖432   
Dr. Abdool Karim discussed his views on women and male circumcision: 
It is very clear to me that if you want to have an impact on the epidemic in Southern Africa 
circumcision is not your high priority, the epidemic in sub-Saharan Africa needs something to 
reduce transmission in young women, circumcision does nothing for that, there is no direct 
benefit of circumcision for young women. What we need is a vaccine or microbicides, we 
need something to empower women, and circumcision does not do that.
433
 
Warren Parker provided another supporting point of view: 
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I don‘t think they [WHO and UNAIDS] perhaps significantly emphasized the limitation of 
circumcision and for me the HIV epidemic is largely and predominantly an epidemic of 
women in Southern Africa and something like circumcision isn‘t likely to have a significant 
impact on the epidemic in the foreseeable future. I think UNAIDS and WHO both did this as 
contextualized as something that is maybe a 20 or 30 year intervention and not an intervention 
that is going to achieve massive changes now.
434
 
Additional evidence that may support the Williams and colleagues concerns included, today 
61% of people living with HIV in sub-Saharan Africa are women and young women between 
the ages of 15-24 are three times more likely to become infected with HIV irrespective of 
circumcision rates. Furthermore, recent evidence has shown that young women between 15-
24 years represent approximately two thirds of all people newly living with HIV in 
developing countries ―making them the most-affected group in the world.‖435  
Warren Parker expressed an opinion on why women remain the most at risk population. He 
states, ―I think there has been very little recognition that we need to focus on the 
epidemiology of the disease and understand it to know its dimensions, particularly understand 
the risk, it is important to address the questions related to why females are so 
disproportionately affected.‖436 Professor Moodley argued that the patriarchal society was 
one of the obstacles to prevention and provided an example of how ―condom usage is 
frowned upon and women are largely unable to negotiate safe sex for themselves‖437 
demonstrating how patriarchal beliefs may influence AIDS.  In 2006 UNAIDS suggested that 
effective HIV prevention for women should include: ―easy access to HIV prevention service 
and commodities, intensified research efforts to develop new prevention methods that women 
can control, policy reforms to reduce women‘s vulnerability to HIV infection, and longer-
term efforts to develop new gender norms and influence the behaviour and attitudes of men 
and boys.‖438  
WHO and UNAIDS decision to endorse male circumcision suggests they opposed Williams 
and colleagues findings but the evidence also showed that they collectively expressed 
concern over the potential risks to women. Nonetheless, the consensus remained that any 
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additional research would be addressed after the endorsement; a WHO respondent discussed 
their assessment of the concerns relating to women: 
We looked at the evidence that we had at the time, which in the time that we had, was quite 
constrained, and the evidence we had was not a lot. Based on that we are looking to have a 
whole consultation that will actually look at this in more detail and make some clear 
recommendations as to what needs to be done whilst programs are scaled up.
439 
Kevin De Cock shared his perspective on women and male circumcision. 
Gender issues, I am not sure I entirely get them. The gender dimensions of this are very real, 
but there, but I personally view them as potentially downstream rather than from the very 
active male circumcision itself, but what is the question?  We have an intervention, it is what 
it is, and we shouldn‘t use it because of this, like I said it is very unusual to get a 60% efficacy 
with a biomedical intervention. The last time we had something, I think this is probably the 
most important development in prevention science since the introduction of interventions for 
mother to child transmission.  It‘s at that level of importance and it actually interestingly has a 
somewhat similar efficacy to the initial regimen that was studied, for mother to child 
transmission prevention.
440
 
To try to explain WHO and UNAIDS decision to proceed with the endorsement, one could 
rely on the literature that discusses why women have historically been excluded from 
research agendas. Levine, Travers and Bennett argued that some of the perceived bias was 
premised on ―the view of the male body as the norm assumes that gender is not a crucial 
variable (except for exclusionary purposes), and consequently the knowledge base regarding 
HIV/AIDS is almost exclusively based on male-derived data.‖441 The second explanation 
may fall within the context of the biomedical approach that views health and disease as a 
condition that exist in the individual body and of which can be cured by medicine, absent of 
the individual and society. The belief that male circumcision was a biomedical cure, which 
stood apart from ―any sense of moral work‖442could have influenced WHO and UNAIDS to 
proceed with the endorsement. 
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The evidence shows that WHO and UNAIDS appeared to position the Williams and 
colleagues findings as a positive outcome versus a possible risk. The following statements 
made by Catherine Hankins and Kevin De Cock supported this observation: ―the point about 
male circumcision is, the way it is going to have a public health impact is by lowering the 
proportion of men who are infected and there will slowly be a reduction in transmission to 
women‖443 and ―that‘s because there are indirect effects for women of being less likely to 
encounter an HIV positive partner.‖444 Furthermore, this style of messaging was also used in 
the WHO and UNAIDS recommendation document, they stated: 
It is not know whether male circumcision reduces the sexual transmission of HIV from men 
to women. Although a reduction in HIV incidence among men will eventually result in lower 
prevalence in men and therefore less likelihood that women will be exposed to HIV, currently 
there are insufficient data to know whether male circumcision results in a direct reduction of 
transmission from HIV-positive men to women.
445
 
The position of an ‗indirect benefit‘ was a widely held view amongst experts who supported 
male circumcision, Professor Robert Bailey provided a statement that was consistent with 
WHO and UNAIDS opinion: 
If you lower prevalence of HIV in men, you are going to lower the prevalence in women.  
So we can see in modeling and it just makes logical sense that circumcision has the 
potential for reducing HIV prevalence in men by more than 50%.  If you lower the HIV in 
the male population, you are going to be lowering transmission to women and it is going to 
have a very significant effect on women at a population level.
446 
Another example of the ‗indirect benefit‘ was the position that a majority of sub-Saharan men 
do not use condoms now and most likely will not alter that behaviour in the future, thus 
circumcision would help women. Marge Berer in Male Circumcision for HIV Prevention: 
Perspective on Gender and Sexuality suggested that ―there was an unstated assumption in the 
WHO/UNAIDS consultation that unprotected, unsafe sex on the part of men in sub-Saharan 
Africa cannot be changed.‖447 In addition to the indirect benefits, UN and experts referenced 
another study on women and male circumcision, the article UN urges circumcision in AIDS-
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hits southern Africa, published on December 19, 2006 stated, ―one US-Ugandan study found 
male circumcision also reduces infections in female partners by 30 percent.
448
 On December 
14, 2006, New York Times reported, ―Male circumcision also benefits women. For example, 
a study of the medical records of 300 Ugandan couples last year estimated that circumcised 
men infected with H.I.V. were about 30 percent less likely to transmit it to their female 
partners.‖449  One expert discussed the potential risk in having messaging that appears to be 
confusing. They suggested: 
The other thing I think is a potential risk is that, it‘s hard to understand what this all means.  I 
think a lot of people have a misconception that male circumcision has been shown already to 
prevent the risk of women becoming infected.  When that is not what the trials up to date have 
been looking at, they have been looking at the transmission reduction from women to men.
450
 
Explanations for why the media reported the research findings that showed male circumcision 
benefited women‘s health despite the clinical evidence that showed a possible risk to women, 
remain opaque. However Panem‘s accounts on how the media was continuously challenged 
by having to accurately communicate research findings and policy implications to a public 
that was largely unaware and/or often already misinformed about AIDS may partially explain 
some of the confusion.
451
  
It should be noted that in addition to the indirect benefits for women, WHO and UNAIDS 
referenced research that showed male circumcision provided secondary health benefits for 
women irrespective of HIV. Such as, the reduced risks of Chlamydia trachomais infections, 
cervical cancer and urinary tract infections.
452
 
Another key topic in relationship to women was the role of men, a significant number of 
experts argued, ―In sub-Saharan Africa there must be a lot more attention on the role of the 
African men in preventing and reducing the spread of HIV/AIDS.‖453 David Harrison 
explained, ―I think that undoubtedly the position of women in society continues to make our 
work very, very difficult.‖454 He reasoned that ―probably by getting to men more than we 
                                                 
448 Zaheer, Kamil 2006. UN urges circumcision in AIDS-hit southern Africa. 
449 McNeil Jr., Donald. 2006:A21. H.I.V. Risk halved by circumcision, U.S. agency funds: more money is expected. 
450 Anonymous Respondent One. 2008. Interview. 
451 Panem, Sandra 1988:120. The AIDS bureaucracy. 
452 WHO and UNAIDS. 2007:21. Draft Male circumcision: global trends and determinants of prevalence, safety and acceptability; The Body 
Pro 2008. HIV prevention in the developing world: expert panel previews CROI 2008 research. 
453 Were, Miriam April 11, 2008. Kenya's National AIDS Control Council, Chairperson. Interview. 
454 Parker, Warren March 27, 2008. CADRE, Executive Director. Interview. 
101 
 
have done in the past‖ we could possibly assist women.455  This argument rests on the 
hypothesis that the newly circumcised man would alter his behaviour after receiving the 
complementary counseling on safe sex practices, STD‘s, HIV testing, gender violence and 
empowering women. Mary Crewe raised an alternative position, which questioned if clinics 
were the appropriate or ideal location to administer effective HIV prevention programs,  
Everybody talks about the fact that people have turned away from prevention towards 
treatment and care and that the whole testing thing has undermined prevention quite a lot.  I 
think that one of the problems is that people erroneously believe that you can put prevention 
back into the clinic which I don‘t think you can do, so if you had people going for testing they 
would be getting a prevention message that the whole counseling for testing would some way 
act in a way of prevention and I think that turned out not to be the case and I think the clinic 
isn‘t a good place to try to do prevention work. 456 
This study has outlined how modeling shaped the profile for the determination of where male 
circumcision should be rolled out and to whom; established the justification for a rapid and 
massive scale up approach; facilitated the need to solicit international funds and support; and 
compelled activists and the media to promote and create demand. These critical outcomes 
assisted with demonstrating how modeling influenced the planning, marketing and funding of 
male circumcision. Furthermore, the findings explained how modeling studies directed public 
health and policy discourse. The RCT evidence was powerful, however ―scientific knowledge 
alone does not determine which interventions will have the most impact‖457modeling was 
required to determine how and if male circumcision could impact population level infections. 
This section concludes that WHO and UNAIDS endorsed male circumcision as a public 
health initiative because of the modeling evidence. 
Acceptability 
The last major form of evidence-based research that contributed to why WHO and UNAIDS 
endorsed male circumcision was the acceptability of male circumcision. Acceptability studies 
were conducted in various locations in sub-Saharan Africa to assess how traditionally non-
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circumcising communities would respond and whether women would be supportive of the 
procedure for their male partners and children.  
WHO and UNAIDS documents referenced Westercamp and Bailey comprehensive review of 
13 acceptability studies from 9 countries of which 10 included female participants.
458
  The 
review found that ―the median proportion of uncircumcised men willing to become 
circumcised was 65% (range 29-87%).  Sixty nine percent (range 47-79%) of women favored 
circumcision for their partners, and 71% (50-90%) of men and 81% (70-90%) of women 
were willing to circumcise their sons.
‖459
 Furthermore, the authors concluded that based on 
the consistency of the findings across all 9 countries that ―additional acceptability studies that 
pose hypothetical questions to participants are unnecessary.‖460 WHO and UNAIDS 
concluded from the review that, ―the three most salient barriers to the acceptability of male 
circumcision were fear of pain, concerns for safety, and the cost of the procedure.‖461 Other 
key outcomes gathered from the acceptability studies, was the participant‘s desire for the 
procedure to be done by medical practitioners at a public health clinic or hospital, and for a 
minimal cost or free. 
Thereafter this section will demonstrate that the acceptability studies were viewed as another 
important source of evidence that WHO and UNAIDS used to rationalize their endorsement. 
Furthermore WHO and UNAIDS relied on the acceptability findings as a validation of their 
existing points of view and for gaining support from international donors, the public, and 
governments. 
To construct this argument we need to explain why acceptability studies would be important 
to the public, AIDS agencies and governments. During the 2006 NIH teleconference outlined 
in chapter 3, Kevin De Cock responded to questions concerning possible cultural barriers and 
male circumcision.
462
 He discussed the importance of getting the opinions and involvement 
of communities and argued that male circumcision was a topic that drew controversy and 
strong opinions from across the world.
463
 To address the challenges he reasoned it was 
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critical to engage those countries affected by the recommendation and to ensure local 
communities and governments took ownership of male circumcision.
464
 However, Dr. De 
Cock also shared another perspective, he questioned if a person‘s foreskin was more 
important to one‘s identity than having their culture die of AIDS.465 The following statement 
may assist to understand why De Cock believed the foreskin was less important than culture:  
I started off saying, I am just a doctor, my view is perhaps reductionist, and excessively 
biomedical, if you want to talk about cultural attitudes to circumcision of course they are 
important.  We operate in a political and cultural world, but people have to make choices.  I 
mean, is HIV good for your culture?  Is it good to have these astonishing rates of death and 
child mortality and maternal mortality etc. etc. that is what HIV is doing? Robbing your 
particular cultural group of 20 or 30 years of life, is that good for your culture?  So people 
have to make choices.  I think health system issues, personnel, doing it safely, are immensely 
important and worrying – worrying also.  Because it has to be done safely and has to be 
monitored.
466
 
Glenda Gray, an expert in the field of AIDS provided an alternative, but supportive view to 
De Cock‘s argument: 
They [men] need to make the decision themselves; it is cruel to not offer them this 
intervention, because you are going to offend the culture, the religion or the ethnicity of the 
people. It is too difficult, that we don‘t care about offering these interventions to men, 
because we don‘t want to upset the elders or the customs of the country.  I mean I think that is 
ridiculous, because we are going to have the arguments until kingdom come, they will never 
be resolved and we cannot move forward. Why do we care about pussyfooting around culture 
in this issue and not about other issues and so, I think that it is a shame that we are not rolling 
out circumcision faster, it‘s a shame for men in Africa.467 
These views start to demonstrate the contradiction between using acceptability studies to 
inform a decision versus already having a position and using the evidence to retain support. 
To explain why culture remains a concern for HIV/AIDS, Mary Crewe commented, ―I think 
the main obstacles are we do not know how to address things like tradition and culture, we do 
not understand the difference between traditional modernity, we do not understand the very 
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deep forces that work in relations to gender and those kind of things.‖468 Furthermore, Gary 
Dowsett, Deputy Director of Australian Research Centre in Sex, Health & Society argued 
that HIV prevention programs and policies would change considerably if international public 
health organizations had a greater understanding and appreciation of how social and 
contextual factors influence people‘s actions.469 
Some of the concerns experts expressed over the acceptability studies were associated with 
the context of how the questions were constructed and if they adequately illustrated the 
potential risk to men, risk to women and the partial effect of male circumcision. Gary 
Dowsett highlights the difficulty of translating complex subjects into accurate and 
meaningful questions, he explains: 
The complexity of the consequences of circumcision is far too difficult to put in a pamphlet, 
or a small briefing or an informed consent process. You should have a look at what the 
acceptability question was in the Orange Farm trial, but it went something like: if male 
circumcision were shown to be effective in protecting you against HIV transmission, would 
you find it acceptable, would you allow yourself to be circumcised? If that isn‘t a loaded 
question, I do not know what it is. Basically, it says if I can show you that chewing gold is 
going to make you rich, will you chew gold? Of course you will. This is not an acceptability 
question, this is a loaded question. That is an example of how these people think the whole 
process of informed consent and information provision is learned and understood. They were 
talking and explaining to people here some quite complicated stuff, not only simply the 
surgical technique, the post-surgery care that‘s required, the wound care that‘s required, the 
risk for transmission while the wound is not healed-- all the stuff that we know that the trials 
have yet to tell us.
470 
 
Expert Dr. Daniel Sidler provided a similar critique to Dowsett‘s observations, ―What 
information has been given to these Africans and under what pretense were they actually 
willing to circumcise themselves. Particularly people who are not coming from a background 
of circumcising culture.‖471   
Another topic examined was the need to accurately communicate the partial effect of male 
circumcision – the fact one can still get HIV even after circumcision. A significant portion of 
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experts discussed this condition, including how participants were informed of this partial 
effect. Professor Anton van Niekerk, and Mark Heywood, Executive Director AIDS Law 
Program both expressed hesitation with the original hype of male circumcision; they believed 
the messaging had the potential to create a false impression or the perception of a magic 
bullet. 472 Professor Simbayi shared his concerns with the messaging of the partial effect, he 
believed there was a ―potential danger of deemphasizing the partial efficacy or effectiveness 
of the intervention‖ however at the same time he argued that this factor complicated the 
communication with potential recipients because to tell a person an ―intervention is partially 
effective what does that mean.‖473  He also explained how these challenges have impacted 
WHO and UNAIDS, ―in some countries when organizations like UNAIDS and WHO have 
said that this intervention is partially effective some countries have not wanted to hear, 
because they say what are you saying.‖474 The complexity of these issues suggests why 
experts had concerns relating to the types of questions asked in the acceptability studies.  
An example of UNAIDS style of presenting the acceptability study‘s findings came from 
Catherine Hankins, who stated, ―It has become culturally so strong and acceptability studies 
show 70% of women would prefer – this is all hypothetical, but 70% of women in these I 
think 8 countries would prefer their male sexual partners to be circumcised.‖475 The 
acceptability questions for women appeared to predominately focus on their children and 
partner(s), with limited attention placed on a woman‘s health and safety.  This omission may 
pose a concern in light of the findings disclosed from a clinical trial conducted in Rakai, 
which showed an increased risk for women with HIV-positive circumcised male partners if 
they engaged in sex before the man‘s wound had healed; the results of this study were 
outlined in chapter 3.
476
  Professor Moodley shared her concern: 
In one of the trials, it actually showed an increase risk of contracting HIV/AIDS after 
circumcision if men become sexually active prematurely after the circumcision.  I think that is 
something that needs to be addressed in further research and certainly, it needs to be. It points 
to a weakness within a clinical trial where perhaps inadequate counseling was given to men.  
So while we are seeing benefit in terms of prevention in males the actual benefit that goes 
                                                 
472 van Niekerk, Anton April 14, 2008. University of Stellenbosch and Center for Applied Ethics, Professor and Director. Interview; 
Heywood, Mark April 25, 2008. ALP, AIDS Law Program, Executive Director. Interview. 
473 Simbayi, Leickness April 14, 2008 HSRC, Social Aspects of HIV/AIDS & Health Programme, Executive Director. Interview. 
474 Simbayi, Leickness April 14, 2008 HSRC, Social Aspects of HIV/AIDS & Health Programme, Executive Director. Interview. 
475 Hankins, Catherine April 22, 2008. UNAIDS Chief Scientific Officer and Associate Director Evidence, Monitoring and Policy. 
476 Cheng, Maria 2007. Circumcision may lift HIV risk for women; New Scientist Tech. 2007. Male circumcision to fight HIV poses risk to 
women. Roberts, Anne 2007. Male circumcision could increase AIDS risk for female partner: Study. 
106 
 
over to females is not very clear to my knowledge and is worrying if it is going to result in an 
increase risk.
477
 
Additional evidence which may further explain why the Rakai HIV-positive trial raised 
concerns with the scope of the acceptability studies was the data showing that only 13% of 
men in sub-Saharan Africa know their HIV status
478
and HIV testing was not expected to be a 
prerequisite for circumcision. These factors might also question some of the generalizability 
and assumptions derived from the acceptability findings on women.  
To clarify how culture and inequalities could hinder women‘s ability to voice concerns or 
opposing views relating to male circumcision, we can look to Nussbaum‘s explanation that 
―family policy and the nature of the family are an important part of what renders women able, 
or unable, to function productively in the public realm‖ and which could also result in bad 
behavior being insulated or perpetuated in cultures.
479
 When examining the evidence gathered 
on the acceptability and the potential risk of male circumcision on women, Nussbaum‘s 
insights help to explain why women need to be accurately informed of their possible risks.  
Another important concept to consider when discussing risk was the evidence that showed 
that individuals most often do not accurately assess their own risk compared to a scientific 
assessment of the risk.
480
  This would explain why various experts were concerned with the 
reliability of the acceptability studies outcomes and the excessive weight given to these 
findings. 
An example of the difficulty in communicating effective messaging within the complex 
dynamics of culture, sex, gender and male circumcision was conveyed in Catherine Hankins 
narrative on why some men still get HIV, after becoming circumcised, she said: 
Secondly, this is the other thing I forgot to say about how circumcised men can acquire it 
[HIV], if they resume sex early and in many traditionally circumcising cultures, you are 
supposed to complete the circumcision process by having sex as soon as possible with a 
woman.  In many settings there are specific women that offer this service to young men, so 
that‘s a way in which you can get infected. In the trials some of the men who resumed sex 
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early (that is why we say wait until certified healing) - became infected, because they 
resumed sex early. I mean it just makes common sense if you have a partially open wound it 
is very likely that you will be able to get infected through it.
481
  
The difficulty and concerns with the messaging of male circumcision were best explained by 
Witte and colleagues‘ discussions on implicit versus explicit fear messages. They argued that 
explicit messaging style was far more effective in delivering a message on health because 
people do not always draw out the conclusion from implicit messages.
482
 Furthermore, both 
Witte and colleagues and Panem highlighted that an important component of successful 
messaging was the need to ensure appropriate cultural colloquialisms were utilized.483 These 
factors help to explain why WHO, UNAIDS and other experts believed the partial effect of 
male circumcision was a difficult concept to deliver and could impact the overall 
effectiveness of male circumcision if people did not grasp and act on the meaning of partial. 
Another critique was provided on how the acceptability studies might have been more 
effective if they had included the community impact in addition to the individual perspective. 
Leickness Simbayi shared the potential risks associated with implementing male circumcision 
programs without community leadership and a sense of cultural legacy, he explained: 
As far as I am aware there has not been an attempt to engage with communities, particularly 
those that do not practice traditional ways of doing it, because that will be really fatal going 
for medical or clinical circumcision.  There has been no engagement with traditional 
leadership, so that they can engage. In my view, it would be much easier, if you can have the 
buy in from the traditional leaders on the benefits of male circumcision. Because that would 
be a context within which it would be much easier actually to get individuals later, than the 
other way around.  Perhaps the best way, they need to find a way to do both, talk to the 
individuals and talk to community leaders. If we don‘t I mean whilst you have these guys 
circumcised, they go into those communities where they may actually be stigmatized because 
they are circumcised, they will be marginalized, isolated, it would be counterproductive.
484
 
Professor Were supported Professor Simbayi‘s narrative and she spoke of the community and 
cultural challenges they have faced in Kenya since the trials concluded and issuing their 
National Policy on Male Circumcision. She provided an example of how stigma and culture 
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were used negatively in her country, ―in some of our communities in Kenya, circumcision is 
part of their culture so we have heard people saying that you know, they were beginning to 
point fingers, to say that people who don‘t have circumcision are going to have AIDS and all 
that, so that has been a lot of the negative conditions.‖ 485  Kenya, has also received some 
negative media attention, it was reported that the ―Luo were forcibly circumcised in the 
violence‖486 when the country was faced with political unrest.  There were also reports that ―a 
Kenyan secondary school has sent home 20 boys because they were not circumcised, saying 
it feared they would be bullied by other students because they were not circumcise.‖487 
Recognizing with any medical procedure there will have challenges to overcome, these 
findings did however support the concerns raised in the AIDS in Africa: Three scenarios to 
2025, discussed in chapter 3. Where ―the growth or erosion of unity and integrations,‖ ―the 
evolution of belief, values, and meanings‖ and ―the distribution of power and authority‖ were 
identified as three of the critical drivers that could impede future efforts or if managed 
appropriately produce positive outcomes.
488
Specific to the issue of unity, the authors asked 
―will rural communities across Africa feel integrated in national development or feel 
marginalized?,‖489which could explain Simbayi and Were‘s observations and concerns.  
The last area to substantiate the argument that acceptability studies were used primarily to 
gain support versus informing their decision, was the fact that WHO and UNAIDS believed 
any additional research on social and cultural factors could be completed after the 
endorsement. Catherine Hankins shared her thoughts: 
There are people that would argue we need more evidence about cultural meaning and so on 
and we argue that that is exactly what countries need to do now.  We need to do it from 
March 2007 - if they hadn‘t already been doing it under the first work plan, to look at cultural 
acceptability, to look at the meanings of it in their culture, what this would cause and not 
cause, what concerns there might be.
490
 
Sibongile Dludlu shared her view on waiting for additional research, 
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I think there is the question of when do you. When are you then able to say there is enough 
evidence?  I think what they did is they reviewed the evidence and decided there was enough 
evidence and decided that the evidence was compelling enough to be able to make these 
statements.  It [Montreux Recommendation] also said that there are certain research issues 
that are missing, amongst HIV positive, etc. Those particular research questions still need to 
continue, it is not - we have the evidence, you can stop.  No. There are still more questions 
that need to be answered.
491
 
Dr. Ben Chirwa, Director General of the Zambia National AIDS Council supported Hankins 
and Dludlu position. He discussed how his country had engaged in acceptability studies with 
their local university in order to prepare for the endorsement. He explained his views on 
where social and cultural research should be situated within the process: 
The initial decision about this should not be based on culture, on religion and so on, it should 
be based on scientific basis, but ultimately when you are making the program that is when 
you bring in those other sensitivities.  I think we mixed it, we started to discuss this issue 
initially on a cultural basis, on a gender basis, or on a sexual basis and therefore you gloss 
over the compelling scientific evidence. We need to separate the two issues first as a country 
we need to have our scientific community to agree, do we have compelling evidence - yes or 
no. Do we think this will make a difference - yes or no, and once you have made that decision 
then we can begin to deal with the cultural issue, the gender issue, the social issue and for us 
in Zambia that is the kind of approach we have taken.
492 
 
In response to the question did WHO and UNAIDS have enough evidence, Professor Bailey 
proclaimed: 
More than enough. You are facing three randomized control trials, over 40 epidemiological 
studies, strong biological evidence, very strong ecological evidence looking at patterns across 
populations, across Africa and the world.  There is nothing in public health, forget HIV 
prevention, there is nothing in public health with this much evidence to support an effective 
intervention. 
Other experts expressed concern over the need for additional evidence from the field of 
social sciences, Professor Moodley said, ―I think there are several gaps that have been 
identified in relating to the challenges and clearly those gaps in the knowledge have not 
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been explored or researched sufficiently.‖493  Warren Parker shared a similar view he stated, 
―I mean really something like circumcision is a 15 to 20 year project if you like.  We need 
much more research around the implications of these things the systems effects, the 
practicalities, the relevance and so forth.  I suppose they [WHO and UNAIDS] did not 
really do that, they did to some extent, they needed to emphasize much more social science 
research.‖494 Responding to the question of whether WHO and UNAIDS had enough 
research evidence, Professor Simbayi stated, ―Not when they did it, but subsequently they 
have.  Yes, not at the time, it was just put out as a medical procedure you know in isolation 
devoid of cultural settings, but subsequently over the past year there have been robust 
discussions taking place on a global level as well as regionally and within countries.‖495  
Lastly, a widely held opinion amongst those who opposed the timing and urgency of the 
endorsement, was the evidence may be compelling, however let‘s take some time to assess 
some of the challenges and concerns to ensure we get it right. One respondent shared their 
impression that ―the horse was already out the door,"496 in other words the decision had 
already been made and was not up for critical debate. Mary Crewe expressed some of the 
collective frustration,    
There was a letter sent to Peter Piot [UNAIDS executive director] from a whole range of 
organizations and social scientists saying, hey just slow down on this, we are not saying you 
should not do it, slow down, reflect more, take more cognizance of social scientists; they 
just did not do it.  They held a consultation in Durban and Montreux it was basically talking 
about a fait accompli.  They did not say okay let us put it on hold for six months while we 
commission some classy social scientific research to either support or challenge our 
views.
497
 
The apparent emphasis placed on the biomedical research versus social science research was 
discussed at various times in the literature review. However, the interviews and discussions in 
this section clearly support the arguments that the biomedical evidence dominated the 
discourse on male circumcision. During the Social Sciences consultation, the participants 
argued that ―social science seems to have been a somewhat neglected area of science in 
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relation to HIV, in contrast to biomedical science‖498 and furthermore they had not been part 
of the male circumcision process. The evidence presented in this section supports many of 
these claims and observations.  De Waal argued that a growing challenge within the context 
of AIDS was ―the premature policy consensus based on poor evidence and analysis‖ and how 
biomedicine has dominated research agendas.
499
 In the instance of male circumcisions, the 
biomedical structures do appear to have influenced the process, participants and research, 
including how acceptability studies were evaluated and interpreted. 
This section has demonstrated that the acceptability studies were viewed as an important 
source of evidence, which WHO and UNAIDS used to rationalize their endorsement. The 
evidence shows that the acceptability studies were primarily used as a resource to retain 
support from international donors, the public, and governments. Furthermore, the decision to 
endorse male circumcision was not reliant on acceptability studies but they helped in 
supporting the movement towards public policy and support.  This was supported by the 
evidence collected from the Rakai HIV-positive trial, which showed a possible risk to 
women, however additional acceptability studies were not required before issuing the 
endorsement. The last factor that supports this argument was WHO and UNAIDS own 
statements regarding the quantity, prioritization and importance of acceptability studies 
compared to the clinical evidence on male circumcision. Thus, this section concludes, the 
acceptability studies played a critical role in gaining support from international donors, the 
public, governments and the media.  
2. Consultative Process 
The evidence based research was the first reason behind WHO and UNAIDS‘ endorsement 
and the second was the consultative process modeled from the UN Work Plan for male 
circumcision. The plan provided WHO and UNAIDS with the means to coordinate, direct 
and influence the process. This included selecting participants, location of consultation sites, 
prioritization of research, media announcements, website messaging and proposed allocations 
of funds. Another theme that has emerged from the evidence collected was this sense that the 
year and a half consultative process was  used as a period to plan, coordinate, create demand 
and gain support versus critically analyzing the evidence and the feasibility of rolling out 
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male circumcision at a public health level. Lastly, the evidence supports the conclusion that 
their consultative process was closed and managed by a powerful network of male 
circumcision supporters, researchers and funders. The following evidence will support these 
positions. 
UN Work Plan 
The comprehensive chronological history of WHO and UNAIDS process was outlined in 
chapter 3. However, Catherine Hankins provided a narrative on why the Work Plan was 
originally conceived, she explained: 
The whole thing started for me really in April 2005. When Mark [Stirling] called me and said 
that he has heard a rumor that the South African Orange Farm male circumcision trial has 
been stopped.  We did not have the results, but he thought we should be doing something. So 
we agreed that we would convene a closed meeting in June in Johannesburg and we would 
invite to that meeting the researchers from the 3 trials, government counterparts in those 3 
countries, a few other countries that would be interested and some NGO‘s. We would bring to 
the table WHO, UNICEF and UNFPA from the UN family.
500
 
In addition to the UN Work Plan participants outlined in Chapter 3, Catherine Hankins 
provided a detail assessment of the types and kinds of leaders that were asked to participate 
and fund the year and a half process. 
We pulled together a steering group that was made up of both funders so ANRS, NIH, Gates 
and Clinton Foundation; and with the 4 UN partners, UNAIDS, WHO, UNFPA and UNICEF 
- and that group we added to it PEPFAR as a big funder. And that group met about every 6 
weeks by conference call and briefed each other on what was happening with the trial that 
was completed, with funding programs, with the work plan, they acted as a kind of as the 
oversight committee for the first UN Work Plan on male circumcision and HIV. I also 
convened what is called an inter agency task team on male circumcision that had 1 regional 
representative and 1 headquarter representative from the 4 UN partners.  So 8 people on the 
call which we held always a couple of days before the steering group call so that the UN 
understood, we were all briefed about what was happening and we decided what we were 
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presenting to the steering group and we could report on everything that was going on. That 
worked extremely well, extremely well.
501
  
Some observations that should be drawn from her narrative were the characteristics of the 
members that were asked to participate, they included: donors, financial supporters of the 
three trials and UN Work Plan, and lastly international biomedical health institutions. Based 
on the evidence from chapter 3 and Hankins narratives, the steering committee appeared to 
have no representation from the field of social sciences or African public health institutions. 
This evidence starts to form the basis for the argument; was UN‘s Work Plan an evaluation 
and assessment of the evidence or a process to prepare for the endorsement of male 
circumcision. Furthermore, the following account by Catherine Hankins implies the process 
may have leaned towards preparing for an endorsement. Her narrative continues, 
When it did [male circumcision trials] come in (December 2006) we had basically a one year, 
a full year funded work plan in which we had accomplished quite a number of things, 
including as I said these stakeholder meetings, a meeting on modeling, the impact of male 
circumcision, a meeting on programming, guidance for male circumcision, a couple of 
meetings and a draft manual on 3 surgical techniques under local anesthesia that could be 
done for adult male circumcision. It was great because it gave us the chance really to prepare 
all this stuff, so by the time we came to holding the meeting in March 2007 at Montreux, 
where the recommendations emerged, we had done a lot of preparation and we weren‘t just 
looking at the results of the 3 trials and saying okay now what do we do.  We also had the 
stakeholder reports from countries, which brought out a lot of rich cultural, gender issues, 
ethical issues and so on that could be discussed and debated and that‘s why when you look at 
the recommendations they are really quite rich and they stand the test of time. There still very, 
very apropos today, you know the sections on gender, the sections on what you do about HIV 
positive men, the sections on safety and behavioural issues and risk compensation and 
avoiding it and the link to HIV testing.  It is all there.
502
 
The UN Work Plan process relied heavily on various consultations and from those meetings 
reports the evidence supports the argument that the plan was used more as a preparation tool 
for an endorsement versus an assessment of the risk and feasibility of the intervention. The 
meeting report from the first consultation held November 20-21, 2006 stated the purpose of 
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the consultation was to initiate progress towards developing policies and action plans 
premised on the assumption that Kenya and Uganda, RCT‘s would produce the same results 
as Orange Farm.
503
 Furthermore, the report concluded that participants had agreed that it was 
an appropriate time to progress from ―learning of the evidence to active planning to meet 
increasing demand for safe male circumcision services.‖504 However, the evidence to explain 
what transpired during the steering group meetings and in the five country stakeholder 
meetings was not available, and posed a gap in the findings. 
WHO and UNAIDS strategy to create demand was viewed in various forms, including their 
communication strategies, UNAIDS regional website, revised funding projections and 
advocacy through the media. Press releases were often used to announce the excitement of 
the pending trials, an example was WHO 2006 Press statement: Demand for male 
circumcision rises in a bid to prevent HIV: Demand for male circumcision as a method of 
combating HIV/AIDS is likely to increase dramatically if the results from two studies, in 
Kenya and Uganda, are positive. Public health experts are warning men, however, that 
circumcision may reduce the risk of HIV infection but it does not provide full protection.505 
Within the press release, they used quotes from various leaders in African governments and 
academia, which demonstrated the strong support and movement towards circumcision, 
(chapter 3, has the quotes). In August of 2006, Nolen provided this commentary from a 
conference, he stated, ―Circumcision was the hot topic of the day at the international AIDS 
conferences yesterday, when a variety of researchers and even former U.S. President Bill 
Clinton endorsed it as an effective way to stop the spread of the disease.‖506 
Others forms of demand creation were observed in UNAIDS regional website media page 
(Table 1) which allocated a significant amount of content to the topic of male circumcision. 
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Table 1: UNAIDS Regional Website for Eastern and Southern Africa  
 
Table of Contents: Press Center – www.unaidsrstesa.org (up till April 21, 2008) 
 
Guidance on communications to support the scale-up of male circumcision programmes 
2007 AID Epidemic Report 
Special Representative 
61
st
 Session of the UN General Assembly session focused on the AIDS response 
- UN Secretary General speech at the General Assembly Review of Declaration of 
Commitment on HIV/AIDS 
- UN Secretary General‘s Progress Report 
Male Circumcision for HIV Prevention 
- Male circumcision: Africa‘s Unprecedented Opportunity 
- Press Release 
- WHO/UNAIDS-Technical Consultation Report 
- Statement on Kenyan and Ugandan Trial Findings Regarding Male Circumcision and HIV 
- Documents on Male Circumcision and Risk of HIV Acquisition 
- Epidemic Update 2006 
UNAIDS 2006 Report on the Global AIDS Epidemic- A UNAIDS 10
th
 anniversary special edition 
Launch of Media Desk 
SADC Report on the Expert Think Tank Meeting on HIV Prevention 
Treatment Access Report WHO 
25 years of HIV in Africa 
UNAIDS/WHO Statement on Data 
 
The evidence gathered from the documents also appeared to demonstrate a trend towards 
positioning male circumcision as the dominant intervention in brochures, meetings and 
statements. An example of this trend was viewed in the 2006 SADC Expert Think Tank 
Meeting on HIV Prevention in High-Prevalence Countries in Southern Africa, where male 
circumcision was presented as one of the three key drivers of the epidemic, along with 
multiple and concurrent partners and poor condom use.  Another method that appeared to 
support the movement towards isolating male circumcision was the tendency to promote it in 
a manner that was urgent or special compared to other HIV interventions.  
A recent example of this tendency was taken from a UNAIDS document, they stated ―in 
countries experiencing generalized or hyper-endemic scenarios, UNAIDS estimates of 
resource needs are very different – with a strong emphasis on youth, community 
mobilization, communication, and workplace interventions, which primarily focus on delayed 
sexual debut, decreasing multiple partnerships and condom use in casual sex, as well as the 
resources needed to bring about the most rapid feasible scale up of male circumcision in 
young adults (estimated to be 2.5 million circumcisions per year by the year 2010 in the 12 
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most highly affected countries).
507
 Another example, which appears to create an impression 
that male circumcision could be a magic bullet for HIV prevention was, ―Male circumcision, 
integrated into the spectrum of HIV prevention practices, can be compared with childhood 
immunization, which has saved millions of lives world-wide.‖508  
Numerous experts, who expressed caution over male circumcision, discussed their concerns 
over the role of the media, and the impression that ―we found sort of the golden bullet in the 
media.‖509 Gary Dowsett shared his frustration: 
Most people only have headline information about circumcision, about what these trials did 
and what they found and that‘s all anyone is interested in telling them. It‘s the press release 
and sound bite version of what these trials achieved, rather than the complexity of what these 
trials revealed, which was just how complex this issue actually is and how shaky efficacy 
actually is as a measure.
 510
 
Another view discussed in the interviews and observed in the analysis of the data was the 
tendency for WHO and UNAIDS to rely on the same researchers and authors in publications 
relating to male circumcision. This was especially evident in the published research on male 
circumcision and their own publications. Recognizing researchers commonly specialize in 
fields, the critiques were centered on WHO and UNAIDS tendency to discount or ignore 
opposing opinions or research. Dr. Sidler shared his observations, ―the other thing, which I 
find intriguing is when you read all these publications they sound all alike, they all publish 
only literature or they only reference literature, which is suitable for their own opinion and 
leave out any other literature, which is critical to their stance.‖ 511 
The evidence also showed that the UN Work Plans strategy to create demand and secure a 
massive scale up might have also influenced UNAIDS to revise their funding allocations. 
Evidence of the effects of this movement was best demonstrated in an updated 2008 Financial 
Resource Chart (Table 2), showing a 2010 budget of USD 147 million for male circumcision 
and USD 153 million for mother-to-child transmission programs, when in 2007 the number 
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forecasted for 2010 was 157 million for male circumcision and 662 million for mother-to-
child transmission.
512
  
The literature has firmly positioned women as the most at risk population in Africa and then 
children. The data has shown that only 31% of HIV-infected pregnant women received 
antiretroviral prophylaxis
513
and 90% of all the HIV infections relating to children under the 
age of 15 have come from mother-to-child transmission.
514
 In 2008, the UN reported that 
developed countries had almost completely eliminated the risk of mother-to-child HIV 
transmission
515
 and ―although the cost-effectiveness of mother-to-child HIV transmission 
prevention programmes was demonstrated in the 1990s, children still accounted for one in six 
new infections in 2007.‖516 Significantly, in 2007, Botswana achieved a 91% uptake of 
mother-to-child services resulting in only 4 % of children born to HIV-positive mothers 
becoming infected with HIV.
517
 Table 2 demonstrates how the UN Work Plan demand 
creation strategy may have indirectly affected other interventions. 
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Table 2: Financial Resources needed in 2010
518
  
 
Total resources US$ 3.26 billion 
 
When questioning Kevin De Cock on the possibility that funds allocated for male 
circumcision might have a greater impact if used on other interventions, such as mother-to 
child (PMTCT), he stated: ―I think it‘s a false dichotomy to pose these kinds of questions.  
The AIDS response needs a comprehensive response for prevention, treatment and care and 
all of the modes of transmission need to be addressed.  And to put mother-to-child 
transmission against male circumcision is just I think a completely false kind of dilemma 
both need to be done.‖ 519 Dr. Auvert responded ―I think first all maybe that‘s it‘s not the 
same money, but that‘s another problem‖ he also stated ―it [male circumcision] only has to be 
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Male circumcision 
5%
High Risk populations 
17%
PMTCT 
5%
VCT 
11%
Youth 
11%
Sti management
6%
Blood safety and other 
medical interventions 
11%
Community 
mobilization and 
communication
11%
Condoms 10%
Workplace 
13%
Male circumcision $147
High Risk populations $571
PMTCT $ 153
VCT $ 344
Community mobilization 
and communication $339
Sti management $ 178
Blood safety and other 
medical interventions $ 368
Youth $362
Condoms $ 329
Workplace $437
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done once, which is a big change in comparison to ARV and PMTCT. 520 Tomas Lundstrom 
provided his thoughts on the subject: 
Why do we have only 31 percent of pregnant women reaching any kind of PMTCT services 
in Lesotho, because there is no will or interest. If you look at that of course, you can say it 
will be a one time off. But I am saying it‘s better than nothing and I am not saying that we 
shouldn‘t focus on PMTCT to get it up, but the fact of the matter is we are not doing enough 
and we have money in these countries not being used.
521
 
Professor Leickness shared his thought on the difficulty of allocating funds for an 
intervention that may take 20 years to show any measurable gains, he explains: 
Given the fact that the effects or impact on a population level will only be seen like in 20 
years. Where there are needs today and now, people who don‘t have a meal to eat and this is 
happening worldwide now, if you‘re watching what‘s happening in terms of high cost of food 
it is going to be extremely difficult actually to find money to do this.  Even those who have 
modeled this, they said the impact is actually going to be minimal in the short term.  Again if 
it does protect anyone it‘s just men for now that is what we know, so we have no idea whether 
this will be helping women in the long run as well, that remains to be seen.
522
 
Professor Leickness observation draws attention to a possible gap in the cost analysis 
modeling. It appears from the evidence collected that little emphasis was placed on 
comparing all HIV interventions collectively - based on number of lives saved and adverted 
deaths over specific intervals of time. The modeling appeared to concentrate on male 
circumcision in isolation, with its costs and adverted deaths compared to each intervention, 
but not collectively as a group, in other words which proven interventions would have the 
greatest impact on population health in the shortest interval of time. Recognizing that funds 
and resources are not unlimited, this gap in the evidence appears to be significant. 
The final example of how the UN Work Plan influence the male circumcision agenda was 
observed through the number of news stories criticizing the efforts of African governments. 
An editorial from AllAfrica.com discussed President Museveni hesitation to proceed with 
male circumcision they reported, ―He was quoted last week saying he would not promote 
                                                 
520 Auvert, Bertran March 19, 2008. University of Versailles French Institute of Health, Director. Interview. 
521 Lundstrom, Tomas April 23 2008. UNAIDS Regional Adviser HIV Prevention. Interview 
522 Simbayi, Leickness April 14, 2008 HSRC, Social Aspects of HIV/AIDS & Health Programme, Executive Director. Interview. 
120 
 
male circumcision as a means to prevent HIV transmission unless scientific evidence on its 
effectiveness was available. What more scientific proof do you want, Mr. President?‖523  
News 24 in June of 2007 reported that Neil Martinson, WITS Prenatal HIV/AIDS Research 
Unit, stated 3 months after the endorsement ―There has been a deafening silence from policy 
people in this country, what else should we do, what else is there?.‖524 Another media source 
in 2008 discussed Activist Stephen Lewis opinion of the slow progress of male circumcision 
in South Africa: 
There is just so much more to be done. Frankly, one of the things that is inadequate is the United 
Nations agencies. Some of it is bewildering. For example, you get the Minister of Health in South 
Africa (Dr. Manto Tshabalala-Msimang) attacking and dismissing circumcision as a preventive 
technology. Here you have three determinative studies, definitive studies, we have UNAIDS and 
WHO encouraging male circumcision as a way of reducing transmission and you get an attack on 
it by the minister of health in South Africa. Where is the United Nations‘ voice? Why haven‘t they 
taken on the minister? Why haven‘t they said what should be said, which is that she‘s effectively 
dooming people to death and it need not be done? You have to have a much stronger voice of 
advocacy from the United Nations in dealing with disease and related matters‖.
525
  
Lewis critiqued both South Africa and the UN on their progress, however his theme was 
universal, for he was aware of the evidence and was advocating for action, which has been 
the historical responsibility of activists. Alternatively, however these statements may actually 
be the consequence of the international marketing campaign formed under the guidance of 
the UN Work Plan, which requested or demanded advocacy if male circumcision was to have 
any population benefits. Bertran Auvert‘s statement from a June 2007 article highlights the 
inherent power attributed to an international endorsement ―It‘s not even my opinion. It‘s now 
a WHO recommendation,‖ he said.526  
Furthermore, the literature explained that advocacy has been a critical component for getting 
governments to proceed with action in sub-Saharan Africa, which could be a reason for the 
need to create demand. However, conversely  De Waal argued that international organization 
had the potential to solidify into an ―introverted bureaucracy that soldiers on, pushing certain 
formulae on African societies‖, resulting in policies and programs that become inadequate or 
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inappropriate for combating the AIDS epidemic.
527
 Additionally Patterson suggested that 
substantive policy development should be achieved through empowering civil societies with 
the means to engage in discussions. Both De Waal and Patterson historical observations on 
why community participation has not been effective might question the principles and logic 
behind demand creation.  
Consultations 
As previously mentioned the consultations were considered a key element of why WHO and 
UNAIDS were able to act in the manner and timing they did and according to experts they 
provided the justification needed to issue an endorsement. From July to September 2006, the 
UN Work Plan group held country level consultations with five countries in sub-Saharan 
Africa (Lesotho, Kenya, Swaziland, Tanzania and Zambia).
528
  The UN group also assisted in 
coordinating four major consultations on male circumcision, which took place from 
November 2006 to March 2007.  
Catherine Hankins outlined the consultation process thus, 
It was done in a meeting with over 80 people.  It was done in a traditional consultation like 
we have all the time that weighs the evidence, the evidence is presented, people argue about 
it, they question the data and then we come up, the meeting comes up with recommendations. 
So in that meeting there were human rights‘ experts, there were gender experts, women‘s 
groups, activists, people with HIV – it was a broad range, we brought everybody who could 
have anything to say into the room including people who were completely opposed to male 
circumcision, totally opposed to it.  It is only in doing that, it is not one person that sits 
somewhere and decides something.
 529
 
Dr. Abdool Karim who attended the Montreux meeting provided a narrative of the process he 
experienced: 
The first day in Montreux we just reviewed the evidence, so we had each of the teams present 
to us in detail all their data we were able to quiz them and really hone in on it and poke every 
kind of loophole we could find and then at the end of that we had to say does this hold up to 
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scrutiny and the answer was an unequivocal yes.  When you put it under the microscope, 
these trials are all solid, you can rely on that outcome that finding is solid, and it‘s solid by 
itself, and it‘s solid in relationship to the other three trials. That makes the difference, this 
evidence is now incontrovertible, and you can‘t sit on the side now. 
The following expert opinion supported WHO and UNAIDS argument that their 
recommendation was seen as a collective decision. 
UNAIDS and WHO held many consultations with researchers, scientists, reviewed the 
evidence, talked to many different entities and didn‘t make the decisions on their own. They 
made it with lots of expert, based on the evidence we believe that this is an additional strategy 
that is important for HIV prevention.  They have never said that it is the only strategy, they 
have never said that other strategies should not pursue, they have just said it is another tool in 
the toolbox, so based on the evidence and the randomized control trials had strong results and 
they were well done trials.
530
  
However, the evidence collected from the attendees list given in each consultation report 
opposes the concept of collective and representative. The attendees for the Montreux 
consultation was not provided and the number of attendees that participated ranged from 80 
to 120, based on accounts from UNAIDS and an expert. 
Table 3: African Participants in Consultations 
 
Consultation 
 
Nairobi, Kenya 
Participants (50) 
Safe MC and HIV 
Prevention 
November 20-21, 2006 
Geneva, Switzerland  
Participants (50) 
Strategies and Approaches 
MC Programming 
December 5-6, 2006 
Durban, South Africa  
Participants (30) 
Social Science 
Perspective MC 
January 18-19, 2007 
Montreux, Switzerland   
Participants (n/a) 
Recommendation 
March 6-8, 2007 
 
Ghana  1   
Kenya 6 3 1  
Lesotho 2 1   
Malawi 1    
Mozambique 1    
Senegal  1 1  
South Africa 1 3 13  
Swaziland 3 1   
Tanzania 3 1   
Uganda  1 1  
Zambia 2 1   
Zimbabwe 1    
 20 13 16  
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The findings showed that the majority of participants were international and/or from WHO 
and UN agencies. Young argued that the ―inclusion and participation of everyone in public 
discussion and decision-making requires mechanisms for group representation, where 
differences in capacities, culture, values, and behavioral styles can be put forth without 
judgment or discrimination.
531
 Young‘s statement suggests the decision to conduct back-to-
back consultations could have limited the style and diversity of participants, through 
imposing possible constraints on participant‘s time and resources to incur such expenses. 
Furthermore, by having the final consultation in Montreux it could have limited the number 
and style of participants from sub-Saharan Africa. 
Various experts expressed concern with WHO and UNAIDS‘ consultation process. Mary 
Crewe shared her observations: 
I have been at a couple of UNAIDS consultations which actually are not really consultations. 
They are processes where you are told, that this is what UNAIDS wants to do and wants to 
recommend and you get a chance to comment, but you kind of know that unless you are 
supporting them, your views are going to be regarded as dissident.
532
 
Warren Parker also shared his experiences with the consultation process and their propensity 
to be exclusive and potentially lacking of critical thinking: 
Well I was part of those processes, it really has to do with what you might call the Geneva 
―jification‖ if that can be a word of AIDS policy. How do these discourses happen and who 
has the voice, and who is organized around having a voice in Geneva, well it sure as hell isn‘t 
people in Africa.  With that said, I injected a whole bunch of ideas into the debate when they 
had that policy discussion, but it was by virtue of having access to the mechanisms to do that 
and (a) knowing about the meeting (b) being part of it - one of the normal groups that is called 
for input and having the technology to do it. But that is certainly not a comprehensive voice 
from the region and that is really how these things are structured so they can go through a 
process, say that there was consultation and off you go.
533
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Gary Dowsett who attended the Montreux consultation supported Crewe and Parker‘s 
observations and explained how WHO and UNAIDS might benefit from this type of process. 
He explained: 
That [this kind of meeting] is what covers their backs and that‘s what allows them to move 
forward. It‘s what allows them to say to people who get up and say ‗no‘, who weren‘t 
involved in the process, that we have been through a consultation process with the world 
experts on this issue and the evidence says in their view this is the way to proceed.
534 
 
Dr. Daniel Sidler expressed the frustration he experienced when trying to present his 
concerns, he shared his thoughts: 
What has happened, which I am saying again and again is that this whole debate has become 
polarized, it is not constructive and that is one of the previous questions this is direct and a 
very negative outcome of how this discussion has happed. It should not be polarized, it should 
be constructive but critical, so that actually everybody who has got something to say is on 
board and hopefully finally one can come to a conclusion at the end and not that one labels 
each other with terminology, which is more ideological and discussed in a very polarized 
way.
535
 
Two consistent themes emerged from the literature and interviews, WHO and UNAIDS sense 
of justification based on the consultations and the practicality that they had only issued 
guidance; however, the choice remained with the governments, communities and individuals 
to decide. Dowsett, argued even though the governments may be the implied decision 
makers, ―it doesn‘t work that way, when WHO support a UNAIDS endorsement vast 
amounts of money are going to be thrown at impoverish governments to go down this path if 
they‘ll do circumcision. And, of course, they will take—well, most of them will take it, some 
of them won‘t.‖536 Dowsett‘s observation was supported by the 2006 New York Times article 
where Dr. Mark Dybul, the Executive Director of PEPFAR, said we ―will support 
implementation of safe medical male circumcision for H.I.V./AIDS prevention‖ if WHO 
recommends the intervention.537 Furthermore, in 2007 during the Montreux consultation Dr. 
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Salim Abdool Karim recalled PEPFAR stating, ―You guys tell the world you think this 
should be done, [then] PEPFAR is going to provide the money to do it.‖ 
The following two quotes provided by Kevin De Cock and Tomas Lundstrom could be 
viewed as examples of an implied assumption of choice with a subtle component of why not: 
Those are the choices society needs to make and individuals need to make and I do believe it 
is people‘s choice. But it gets back to, the early part of this discussion, what do you think are 
the obstacles the obstacles are community ownership and political ownership saying look 
AIDS is unacceptable, what it is doing in Southern Africa with its rampant epidemic of 
tuberculosis to which now we have had a drug resistance as well, this is unacceptable.
 538
 
Tomas Lundstrom explained how he viewed UNAIDS response to the endorsement, 
We tried to be careful not to say everybody should circumcise, we also said that this is mainly 
something we are pushing in hyper-endemic countries where you have more that 15% 
prevalence, where it can really have an impact. I think whenever there‘s something out there 
that‘s proven to work we need to really push it, we need to push it carefully, and I think we 
did that and that‘s why we had situational analysis and discussions in countries about how it 
works.
539 
 
Many of the principles of the consultative process used for male circumcision may conflict 
with the obstacles UNAIDS argued were crucial to overcome, if Africa‘s was to succeed in 
combating AIDS. The following aims were presented in the AIDS in Africa: Three scenarios 
to 2025 report: Ensuring the crisis is defined and backed by all players; policies should be 
shape by ensuring the inclusion of local cultures, values, and meanings if results are to be 
effective; the need to reflect on national or international capacities without the pressure for 
results, otherwise it could create an environment where the priorities of stronger voices 
prevail; no magic bullet strategies; there must be a wide range of actors in implementing and 
proposing solutions; comprehensive understanding of social, physiological and economic 
issues that impact women; and a greater understanding of the psychological impact of the 
epidemic.
540
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This section has demonstrated that the authority WHO, UNAIDS, and the steering group held 
allowed them to direct and influence the discourse on male circumcision. The evidence 
illustrates how the process was managed under the guidance of UN agencies, international 
organizations, and the financial supporters of the trials and Work Plan. Furthermore, the 
ability to engage in critical debate was highly contested by experts who questioned certain 
aspects of the endorsement. Additionally the evidence has shown how the principles of the 
Work Plan influenced, press, advocacy, and resource allocations. Lastly, the evidence cast 
doubt on the openness and participatory element of the UN Work Plan and Consultations. 
This section demonstrated that the consultative process was critical to understanding why 
WHO and UNAIDS endorsed male circumcision and suggest that their internal endorsement 
was made in April 2005, the day Catherine Hankins stated the UN Work Plan for Male 
Circumcision was established. 
3. State of the Epidemic 
The final reason for explaining why WHO and UNAIDS issued their recommendation was 
the current state of the epidemic in sub-Saharan Africa. This study has clearly outlined in 
chapter 3 and throughout this chapter that the endorsement was directed at regions with 
hyper-endemics and low levels of circumcised men. This signified that countries or regions 
located in sub-Saharan Africa were the populations targeted for mass circumcision.  
The state of the epidemic will be defined as the amount of new HIV infections, because 
experts have argued that these figures most accurately reflect current trends.
541
 In simplest 
terms, this final explanation was based on the premise that there would be no need for 
funding or mobilization of international resources for male circumcision if the epidemic were 
perceived as under control. Therefore, this section will argue that in the absence of any 
sizeable decline in new HIV infections or workable vaccines a sentiment of pessimism 
developed amongst the community of AIDS, which  influenced WHO and UNAIDS decision.  
Gary Dowsett who attended both the Social Science and Montreux consultations discussed 
the association between male circumcision and the epidemic. He explained, ―people 
advocating that circumcision be added to the list [of prevention activities], argued that none 
of the other preventions methods are working or working fast enough to make a difference, 
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and prevalence continues to rise. Therefore, there has got to be something to break the 
cycle.‖542 
In addition to the evidence presented on the current state of the epidemic in chapters 1 and 3, 
Dr. Abdool Karim explained how a sense of pessimism has emerged within the Africa AIDS 
epidemic.  
I think if you look at where we were 2 years ago, we were very excited we had all these trials 
underway, we had microbicides trials, we had vaccine trials, we had trials on herpes simplex 
virus suppression, and we had trials for diaphragms. We had just so much hope that some of 
these were going to be successful.  The reality today is very different, the reality today is that 
none of these have shown to be efficacious except for male circumcision.
543 
Another form of pessimism emerged from the social science experts, there was a sense of 
frustration that their ideas and points of views were not adequately being heard or considered. 
Gary Dowsett shared his thoughts on why the pessimism existed:  
Well I think there‘s a profound pessimism out there at the moment in my game, the social 
science game. I think we have been beaten around the ears for the last years globally in the 
rise of biomedical scientific hegemony.
544
 
Warren Parker statement merged the thoughts shared from Dr. Abdool Karim and Gary 
Dowsett; he discussed how male circumcision could potentially be a symbolic representation 
of why HIV prevention efforts have historically failed. He said: 
We are sitting in an epidemic that is severe, massive prevalence, and I am talking largely 
about the Southern Africa epidemic and you have got to ask yourself the question, what is 
pretty much an emergency situation.  We pretty much have gotten here through everyone‘s 
great ideas not working. So what do you do in that kind of context?  And the problem with 
something like circumcision it is basically saying look don‘t change the dynamics of the 
society in relation to this disease don‘t explore the implications of the fact this disease exists 
for a societal level intervention, just add a technology, which is exactly why condoms didn‘t 
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work, it is exactly why circumcision is not going to work and exactly why non bio 
technologies have actually been effective in other contexts and strategies.
545
 
The majority of experts interviewed were profoundly concerned with the current state of HIV 
prevention in sub-Saharan Africa. When asked: Why in your expert opinion did WHO and 
UNAIDS make their recommendation; the overwhelming response was situated within the 
context of the current state of the epidemic. Themes that emerged from the expert responses 
were urgency, silver bullets, emergency, pessimism and a sense that nothing else was 
working. Leickness Simbayi expressed his frustration: 
Again, it goes back to where we started talking about prevention that although certain inroads 
have been made the epidemic continues unabated, meaning that something else needs to be 
done.  So I think we have all been looking for the silver bullet, the solution to how we would 
really defeat this disease and since there is no vaccine out there. If this had been a vaccine 
with a 60% efficacy that would be good.  This is the closest that we get to anything like a 
vaccine and it has been shown to work convincingly in those three randomized controlled 
trials and there is ample evidence from other sources (ecological research that has been done) 
that it is protective against HIV.  So I think it is in this desperation to really turn the tide that 
here they had something that appeared to be the answer we have been looking for.
546
 
David Harrison shared his opinion on WHO and UNAIDS decision to proceed: 
Well I will think there are a couple reasons one is we are all desperate for the silver bullet 
were all certainly desperate to know where the next big gains are coming from. The 
desperation that there has been such limited success in terms of research, with stuff that works 
that it would be remiss of us not to try and act on positive findings.  So circumcision has been 
shown to reduce transmission therefore we need to find a way to act on it.
547
   
Dr. Bertran Auvert believed there were two important reasons for WHO and UNAIDS 
endorsement, the epidemic and the trials.
548
 Profession Moodley also concluded the key 
drivers were the trials and the epidemic; she shared her concerns over the state of prevention:  
The scientific evidence from all three trials was regarded as reliable, valid, and generalisable 
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within the sub-Saharan setting.  I also think that there‘s an incredible urgency to do 
something to prevent HIV/AIDS from escalating any further than it already has and I think 
part of their rapid response was related to the fact that they like all of us want to find 
something that is going to work, given the fact that so many other preventive methods have 
been unsuccessful or have outright failed in clinical trials.
549
  
Experts also highlighted how the state of the epidemic had the tendency to cause international 
AIDS organizations to become frustrated and promote these ―flavors of the month‖ or 
―flavors of the year‖ campaigns to combat the epidemic.550 Mary Crewe, also agreed with this 
observation, and stated: 
I think they endorsed it because again, they were looking for something, they had a lot of 
AIDS panic attacks around prevention and they believed that this is a way of getting to men 
who have been neglected traditionally in AIDS prevention work and this is a way that men 
could be brought into the whole system.  I do not think they understand a lot of the social and 
cultural implications.
551
  
The following statements from WHO and UNAIDS support the experts findings that, the 
epidemic was a critical component of why they made their decision. Kevin De Cock shared 
his perspective: 
We‘re [WHO] not forcing anybody to get circumcised, but I am saying the evidence is 
overwhelming that HIV is killing your society, it is not good for your culture to lose 20 to 30 
years of life expectancy across your population, it is not good for your infant mortality to 
have trebled (or whatever it is) or to have an epidemic of orphans.  It is not good for your 
society, now if you think that well none of that matters but my foreskin is much more 
important for my identity, those are the choices people need to make. Those are the choices 
society needs to make and individuals need to make and I do believe it is people‘s choice. 552  
Furthermore, Tomas Lundstrom shared his frustration with epidemic and the progress: 
We [UNAIDS] can create more strategies, why aren‘t people saying, I love for someone to 
come up and say listen should we do more strategies, should we have another policy, instead 
people are saying no we shouldn‘t circumcise it‘s too costly, it‘s too that, criticize the fact that 
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nothing is happening in these countries, why aren‘t governments taking gender issues 
seriously why aren‘t they doing that, that is what we should criticize.553  
This section has argued that the epidemic was the universal driver for WHO and UNAIDS 
endorsement, which was supported by the literature on HIV prevention in chapter 3 and 
throughout the interviews. Furthermore, the fact that male circumcision was targeted for 
certain regions in sub-Saharan Africa supports the argument that the state of the epidemic 
was a critical factor to explaining why the endorsement was made and with a sense of 
urgency.  
4. Why Wait 
The evidence-based research, consultative process, and the state of epidemic explained why 
WHO and UNAIDS believed they had weighed the evidence and assessed that they were 
justified in making their endorsement. However, at the start of this chapter it was argued that 
when questioned on the urgency and motivation behind their decision, WHO and UNAIDS 
maintained an attitude of ‗why wait‘.  Kevin De Cock provides an example of this position: 
Is the evidence good, yes, the evidence is very good.  It is very very strong.  It is almost a 
teaching example in terms of cause and effect and the caveats around it (which you are 
pushing very hard) they are described in our recommendations. I think WHO and UNAIDS 
have done what they have to do as far as the normative work that we do with those 
recommendations - yes. Should Southern Africa scale this up absolutely, I mean you know 
the fact you have countries with levels of prevalence of 35% or so amongst adults is 
astonishing.  I mean what more do we - I mean really you need to ask the question, in a way, I 
think you need to ask the question, how do you not justify –  how do you justify not using this 
intervention in the face of such a public health disaster.
 554
 
The rationale for engaging this concept of ‗why wait‘ was based on the evidence collected 
from the expert‘s responses to the question: In your opinion did WHO and UNAIDS have 
enough research evidence put forth on the challenges and concerns of male circumcision 
before issuing the policy statement? The group of 20 experts from diverse professions and 
regions throughout the world produced the following results:  8 experts said ‗yes‘ and the 
remaining responses ranged from ‗no‘ to ―not sure‖. The argument of ‗why wait‘, explains 
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why WHO and UNAIDS were justified in proceeding with the endorsement when concerns 
relating to risk compensation, engaging in sex before proper healing, healthcare 
infrastructures, feasibility of conducting a mass scale up,  social and cultural readiness and 
the possible risks to women, had not been fully addressed. WHO and UNAIDS argued the 
process was justified for the following reasons: the trials created demand which necessitated 
a need for safe circumcision guidelines, the intervention was just one in a comprehensive 
package of HIV prevention strategies, it would be unethical not to offer this service, we have 
already proven the effectiveness in the observational data and people are dying.  
This section will explain why WHO and UNAIDS believed they were justified in making 
their endorsement.  The first approach came from Catherine Hankins, who argued, there may 
be people who don‘t agree, however ―some people do call it a kind of best practice model of 
moving quite rapidly on emerging findings to come up with guidance for countries‖555 and 
there was a group ―that basically says we acted way too late.  Millions of infections could 
have been averted had we moved on the observational and ecological data‖556 Additionally 
when an expert from WHO was asked about some of the potential concerns raised on male 
circumcision, they stated,  
Well a lot of the concerns that people expressed, one were not evidence based and two it 
was mainly expressed from people outside of Africa and we also had concerns from groups 
these recommendation didn‘t even affect.  So for example gay men, this recommendation 
does not apply to gay men. An two if you have a lot of concerns coming out of the US or 
Australia, where these interventions are not going to be scaled up then of course one must 
listen to the concerns, but from within Africa, the African people, I really haven‘t heard the 
kind of concerns. I haven‘t heard these kind of big concerns at all personally. Also of 
course, when one is looking at concerns or suggestions there needs to be some evidence or 
some strong basis for the concern, but we haven‘t had that. So what we have done is look at 
the trials and in looking at some of the trials, for example - there was a trial at the time on 
looking at transmission from HIV positive men to women we didn‘t have enough evidence 
at the time and therefore this is something that we are now following up, now we have 
additional evidence as to whether we have sufficient evidence we can‘t say.  I think it is 
really a problem when you have a lot of outcries from people who are not at all affected by 
the prevention and they don‘t provide information to people who are directly affected 
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People need to be told of what the evidence is, people need to be cautioned about what the 
evidence does and does not say and people have to make their own decisions. because in the 
African region people have the capacity to do that, and everyone needs to recognize this as 
well.
557 
Tomas Lundstrom, UNAIDS Regional Adviser for HIV Prevention stated in response to a 
inquiry into understanding if the low levels of HIV infections in some countries were a result 
of the sexual customs of Muslims, versus the fact that they are circumcised.  Lundstrom 
responded: 
We don‘t know enough, we need to look into everything but this is a dire situation where 
people are dying like flies, and I don‘t want to sit back and say oh you know it could be this, 
but it could also be that, Muslims are you know are a different type of sexually so we 
shouldn‘t do anything here. I think it, that would be ethically, ethically wrong. If we know 
that something would could work then let‘s do it, let‘s try it, that what I would say. I am 
starving for interventions I cannot tell you one good thing to tell everybody to do.
558
 
One of the popular concerns expressed, was whether the intervention would be effective in a 
real world setting compared to the controlled environment of a RCT setting. In response to 
these concerns, Kevin De Cock provided the following argument: 
With circumcision, I wonder whether in a different situation, because I wonder whether 
paradoxically we have not had previously the real life experience already, because you know 
all of the observational data and the analytic data on male circumcision from Africa are real 
life situations where people were circumcised. The epidemiology is what it is, so in a way we 
sort of – it is a very interesting situation where in a way we did the clinical trials after we had 
a lot of real life situations.  It‘s a funny example of epidemiologically having the cart before 
the horse. Normally when you have a new intervention like a vaccine or a drug, the clinical 
trials get done and the results are wonderful and when you use it in real life, it often is not 
quite as good as you had hoped from your original clinical trials.
559 
The experts that agreed with the decision to move forward provided three primary reasons. 
First, one can never wait for everything to be perfect in the context of Africa and if we had 
waited with ARV‘s millions of lives would have been lost. Second, the epidemic justifies the 
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response.  Third, nothing else is working, so why not try it. Mark Heywood argued it was 
their ―duty to put it out‖ however the way a country integrates and operationalizes the 
intervention was a different matter.
560
 He explained, that when you do have research 
evidence, the intervention should be offered universally, because of what they learnt when 
rolling out ARV programs.
561
 Robert Bailey explained his justification for not waiting for 
additional social science research was the number of lives that would be adverted, he 
explained: 
Now of course there are challenges and potential problems, but are you going to withhold 
something that has proven effective because there are a few challenges that are before us as 
we roll out?  I mean those are going to be and should be and hopefully will be addressed as 
we roll out the services and we are going to do operational research, we are going to do 
research on risk compensation, research on the effect on women. There is going to be all that 
research that is going to take place, but if you wait another five or ten years think how many 
HIV infections could be averted in another five years of social research.
562 
David Harrison explained why the epidemic justified the action to proceed, he stated: 
Well I do not have a problem with that, I do think that in the face of such an emergency you 
go with the information that you have and it is about levels of confidence. So I don‘t have a 
problem with the outlining and programmatic implications, even if we don‘t have all the i‘s 
dots and t‘s crossed.
563
  
Another expert discussed how the lack of any other effective prevention measures influenced 
her point of view to proceed forward, she commented: 
It is like a pull back position for prevention; although it will not completely protect or prevent 
HIV acquisition, it will definitely reduce it.  In the absence of doing anything else at least, 
you are reducing the chances of halving the risk of HIV acquisition in men.  It is a single 
intervention that is durable whereas the current mechanism we have, which is condoms and 
condoms and condoms - you‘re required to have them, to put them and use them properly, 
every time you have sex and that is sometimes harder to achieve than a circumcision.
564
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Dr. Abdool Karim shared his point of view on why it was appropriate to issue the 
recommendation: 
Yes, I mean we will never have all the information and it will never be perfect, but we have 
enough information to make the decision then. If the models that we believe - I mean this 
country it will have a huge impact here.
565 
Another position that emerged from the experts who supported male circumcision was the 
rationale that that if errors or concerns did arise during rollouts then they would stop and 
correct the errors, however it should not delay the endorsement. Alan Whiteside, Director of 
HEARD share this need for urgency while premised on caution: 
Well I think for me it was a statement of, this is what we know, this is what the science is 
telling us, and this is what we would recommend.  There are all the caveats and we know 
those caveats, but on the basis of what we know, here is something that we know will work 
and therefore we would suggest you do it, as simple as that.  The other thing is that people 
have this assumption that everything we say is written in stone forever. I think it was 
endlessly debated and equally again I don‘t think, I think we all knew, we didn‘t have the 
answers, but we certainly knew enough to say that this is something that should be issued.
566
 
WHO and UNAIDS believed their positioning of the intervention as part of a comprehensive 
package of HIV prevention tools, was also a reason for moving forward. Dr. Ben Chirwa 
discussed WHO and UNAIDS integrated approach: 
Again, it has to be looked at within the framework of the recommendation.  The 
recommendation basically is that you are adding circumcision to the broad range of more 
prevention choices and that is the context that they are giving.  It is the same even when 
WHO made an earlier statement of caution was that this should not be seen as a final sphere, 
as an ultimate solution to the prevention of HIV infection.  I think their presentation has been 
consistent and that is, let‘s look at this overwhelming and compelling evidence that it should 
be done within the package of prevention services.
567
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The findings show that the ‗why wait‘ position may have created a since of polarization of 
opinions and the lack of will to enter into constructive debates or solutions. This was captured 
in Kevin De Cock‘s pronouncement: 
What I have always said to people, I said look, you make your judgment based on the 
evidence, but you take ownership of the decisions you make, of the benefits of that decision 
and the negatives. So if I recommend circumcision I will take ownership of the prevention 
benefit, but I also must take ownership of the negative things you are alluding to, the cultural 
problems, the gender sensitivity issues, etc. etc.  Am I prepared to do that?  Yes I am. If 
somebody goes and says male circumcision is wrong for HIV prevention then take ownership 
of the infections that happen, that could have been averted, take ownership of that and just 
convince yourself then that the benefit in terms of cultural identity and everything like that 
justifies those preventable HIV infections that have occurred but have not been prevented.  
Those are the sort of judgments we have to make in public health.
568 
 
Dr. De Cock‘s statement provides the framework for explaining the rationale behind the 
frustration many experts expressed when trying to engage in constructive debates.  Mary 
Crewe shared her frustration: 
There were lots of social scientist who said hey listen to us and they simple refused. [Why?] 
It would mean they would have to rethink what they were doing they would have to ponder 
on some difficult anthropological cultural, social, and political questions, they would have 
to think in difficult ways about issues around masculinity and sexuality and they didn‘t want 
to do that. They didn‘t want anything to mess up there nice streamed line approach. The 
consultations they had were heavily weighted towards the biomedical and they didn‘t really 
take the concerns of social theorist seriously or seriously enough.
569
 
Dr. Sidler asserted that WHO and UNAIDS approach was void of critical debate, which 
implied they had a magic bullet, ―Science is about hopefully coming to a solution at some 
stage and then realizing 20 years‘ down the line that that solution was the wrong one.  
Science is dynamic, one gets the feeling that these people really feel that they have found the 
golden bullet and nobody is to touch it, it is taboo, it is beyond critical analysis.‖570 
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Through defining the principles behind why WHO and UNAIDS was justified to proceed 
with the endorsement, one can start to see how these ideologies might of influenced their 
actions. Additionally the intensity of their statements may question if they were open to 
critical analysis or as some experts have argued the decision had already been made.  
Furthermore, the findings from ‗why wait‘ support the argument that the state of the epidemic 
was a decisive factor in understanding why WHO and UNAIDS made their endorsement and 
why experts supported the recommendation. 
5. Conclusion 
In conclusion this chapter has argued that the evidence-based research, consultative process 
and the state of the epidemic were the three reasons why WHO and UNAIDS endorsed male 
circumcision as a public health initiative for HIV prevention in sub-Saharan Africa. The 
comprehensive body of evidence collected over the last 20 years on male circumcision and 
HIV acquisition established the framework for WHO and UNAIDS actions. Furthermore, this 
chapter has shown why the RCT‘s, modeling, and acceptability evidence-based research each 
had substantial influence in shaping their endorsement. For, the strength and consistency of 
the three RCT‘s transitioned male circumcision from a research agenda to a policy agenda. 
This modeling studies shaped the profile for the determination of where male circumcision 
should be rolled out and to whom; established the justification and urgency for a rapid and 
massive scale up; facilitated the need to solicit international funds and support; and 
compelled activists and the media to promote and create demand for male circumcision. 
Furthermore, the findings explained how modeling studies directed public health and policy 
discourse. Thereafter, the acceptability findings gave donors, governments, media and the 
public the reassurance that male circumcision was culturally accepted, and therefore 
appropriate to endorse and rollout. 
The second reason for their endorsement was the consultative process, which was premised 
on the UN Work Plan for male circumcision and their consultations. These two events gave 
WHO and UNAIDS the resources to manage and direct a year and a half process backed by 
powerful male circumcision researchers, funders, and advocates. Furthermore, this process 
provided them with the means to control and influence research, media, participation, and 
funding; which explains how male circumcision was endorsed one month after the trial 
findings were published. The final reason for WHO and UNAIDS endorsement was the state 
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of the epidemic, which provided the necessary emotional environment to create a sense of 
urgency and attitude of ‗why not‘.  
This chapter concludes the evidence-based research, consultative process, and the state of the 
epidemic were the justification, rationale, and motivation for WHO and UNAIDS 
endorsement.  
 
  
138 
 
Chapter Five: Conclusion – Why Not Wait 
The research question ―why did WHO and UNAIDS endorse male circumcision as a public 
health initiative for HIV prevention in sub-Saharan Africa‖ was explained in chapters 3 and 
4. In summary, their decision was collectively constituted from the evidence-based research, 
their consultative process, and the state of the epidemic in sub-Saharan Africa. Furthermore 
when WHO and UNAIDS were confronted with concerns and objections, the prevailing 
consensus was ‗why wait‘.  
The evidence explained why WHO and UNAIDS made their endorsement, but it also 
clarified why the process has been contested. The findings suggest that the frustration, doubt 
and bewilderment associated with male circumcision was in part an outcome of the WHO and 
UNAIDS consultative process. Specifically, the evidence supports an argument that the 
WHO and UNAIDS consultative process (UN Work Plan and Consultations) was developed, 
designed, funded and executed with an intent to endorse male circumcision, versus a process 
to critically assess if a potentially important intervention could be effectively implemented 
within the framework of Africa‘s public health structures.  
The evidence shows that the consultative process created an environment that permitted 
international agencies, funders and universities to direct and influence research, timelines, 
participants and funds required for male circumcision. The pro-circumcision influence on 
WHO and UNAIDS consultative process established a structure that hindered and silenced 
potential opposition, dispelled the need for critical thinking and assessment, and evoked an 
impression that male circumcision was a ―magic bullet - a perfect drug to cure a disease with 
no danger of side effects.‖571 
The rationale for this conclusion starts with WHO and UNAIDS attitude ‗why wait‘ - the 
evidence was compelling, research can wait, cultures are dying, and nothing else has worked. 
Their conclusion at face value would seem plausible if it was not for the fact, the evidence 
does not support this urgency. The evidence appears to show the opposite, unless planned and 
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executed to precision, investments could be lost, with no measurable reduction in new HIV 
infections or population prevalence.  
The evidence showed that male circumcisions - required a massive scale up if population 
health benefits were to be obtained; gains would not be observable for at least 15 to 20 
years;
572
 women the most vulnerable population to the disease could be placed at risk;
573
 and 
men are the least at risk group for HIV in sub-Saharan Africa. When reviewing this list of 
‗why not wait‘ one must ask - what was so urgent that their endorsement had to be made one 
month after the RCT‘s were published and three months after the trials had been concluded?  
Moreover, the implied assumption may explain, why certain individuals and organizations 
concluded that male circumcision was the ‗magic bullet‘ of prevention. Why else would two 
organizations that consistently promote women‘s rights not take another 6 months to assess 
how this new data might affect modeling, risk assessments, acceptability, etc.. If a risk 
assessment had been completed, would it have demonstrated that a 6-month delay might have 
had little impact on the overall project. In fact, the actual benefits of a delay might have 
improved the project‘s success by 25%, who knows, for the risk assessments were not 
completed. There were no answers; however, ―why wait‘ does pose the question ―why not 
wait‖, because there was no scientific evidence proving that a delay would result in more 
deaths.
 
 
Furthermore, the modeling evidence concluded that male circumcision could not reduce 
population level HIV infections for over a decade and only then if high rates (60-80%) of 
men were circumcised in a rapid scale up.
574
 These stipulations appear significant, for they 
imply that there may be a breaking point, a point when male circumcision would no longer be 
a cost effective intervention because scale up cannot be achieved. Which questions why 
WHO and UNAIDS employed only basic cost effectiveness analysis.
575
 Furthermore, the cost 
effectiveness studies were completed by some of the same researchers involved in the RCT‘s. 
One could argue this form of analysis was sufficient if male circumcision prevented HIV and 
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a country has the infrastructure and resources to implement. However, the evidence clearly 
shows that the partial efficacy requires a massive scale up, which will conservatively take 15-
20 years and requires substantial resources to implement. Thus, one would question if these 
basic cost-effectiveness studies were adequate for the magnitude and complexity of the 
situation in sub-Saharan Africa. 
If the objective of public health remains to prevent disease and promote health, one must 
question how these isolated cost effectiveness studies even started to rationalize how millions 
of dollars would benefit a given society. Where were the cost analysis methods that compared 
various parameters across all HIV interventions, providing an unbiased approach to assessing 
which interventions would have the greatest impact on population health and for how much. 
In discussing the nature of collective analysis, The World Bank mentioned factors such as; 
ranking the interventions in broad categories, how would statistics vary in different 
demographic areas, does the interventions address the major sources of disease burden, and 
the feasibility - based on resources and experience.
576
 Furthermore, they went on to explain 
how many interventions can be effective, however it is the combination of knowledge and 
economic cost effectiveness that determine which interventions can have the greatest impact 
with a given level of resource commitment.   
These omissions point to the weakness of WHO and UNAIDS‘ consultative process, the 
attention on justifying the endorsement versus engaging the evidence to critically assess the 
feasibility of male circumcision at a public health level.
577
  Male circumcision may be an 
important and scientific breakthrough. However, whether the procedure can translate into a 
significant impact on population health and reducing the burden of disease remains 
unanswered.  Because the evidence on the correlation between costs, resources, risk, 
interventions and benefits had not been completed and therefore raises questions about why 
the endorsement was issued. 
WHO and UNAIDS argue that male circumcision should be part of a comprehensive 
approach to HIV prevention and interventions should be based on evidence-based research. 
However this study has shown that when WHO and UNAIDS were questioned on the cost 
effectiveness of male circumcision compared to other proven evidence-based interventions, 
                                                 
576 World Bank 2006:57. Priorities in health. 
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the argument became we must do them all to combat the epidemic. This argument however 
becomes a contradiction and reflects a bias towards male circumcision. Is not the question, 
what proven interventions can have the greatest impact on population health for the amount 
of resources and costs. Hypothetically, if you have 10 million dollars and cannot financially 
justify why male circumcision should have all or part of that 10 million dollars in comparison 
to other proven interventions, then one would have to question why the endorsement was 
issued.  
The decision to endorse male circumcision before these complex cost modeling studies were 
completed places governments and communities under pressure to conform and to seek 
funding irrespective if the intervention will produce the greatest reduction of illness or 
promote better health. This study has repeatedly demonstrated the negative influence and 
pressure activists, media, researchers, WHO and UNAIDS implied and/or explicitly directed 
towards Africa governments and those opposed to the rationale and logic behind the 
endorsement. Even though WHO and UNAIDS have argued that they provide guidance, the 
outcomes from their guidance remains significant and questions their authority. Male 
circumcision does not prevent HIV, which implies that male circumcision may not be the best 
solution for every community. However, if governments and communities can no longer 
make an informed decision without pressures from international and local activists and 
institutions, does that not matter. If the general public can only have one month to review 
published research, does that not matter. 
The recent developments in HIV prevention were discussed in Chapter 3, they included a few 
of these themes: changing from an emergency approach to a short and long-term strategy; 
establishing effective prevention programs vs. waiting for a ―magic bullet‖ vaccine; involving 
communities in a bottom up approach; targeting solution towards those most vulnerable; 
providing an integrated approach based on evidence; and harmonizing social sciences and 
biomedical research. This study concludes that the process used to evaluate male 
circumcision was not representative of these strategies and may reflect why HIV prevention 
efforts have failed in sub-Saharan Africa.  
The evidence suggests that the actions taken by WHO, UNAIDS, researchers, media and 
activists were not justified, undermines how public health should be administered, and was 
the direct outcome of an exclusive process that was not open to constructive debate or 
analysis and furthermore excluded public participation.  The evidence supports the notion 
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that WHO and UNAIDS consultative process and attitude of ‗why not‘ was founded on 
pessimism, double standards and elitism versus a strategy built on the principles of 
empowerment, commitment, courage, hope, critical thinking and analysis, and participation.  
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Appendix A: Guiding Questions 
Below is a list of guiding questions that were utilized during the semi-structured interviews, 
the objective was to propose questions that could assist in explaining each aim set forth in 
this research.  
I. Prevention 
 
a) What in your view is the current state of HIV Prevention in sub-Saharan Africa? 
b) How do you believe the last 27 years of knowledge, experience, successes and 
failures will alter the future of HIV prevention? 
c) What do you believe are the greatest obstacles to preventing the spread of HIV in 
sub-Saharan Africa? 
d) Please give your thought and /or opinion after listening to each quote: 
UNAIDS and WHO have argued ―the steady growth of the AIDS epidemic stems not 
from the deficiencies of available prevention strategies but rather from the world‘s 
failure to use the highly effective tools at its disposal to slow the spread of HIV‖. 
UNAIDS and WHO 2006: 124. Report on the global AIDS epidemic 2006. 
 
e) Quote 2 
―Furthermore they argued that ―for every patient who initiated antiretroviral therapy 
in 2006, six other individuals became infected with HIV‖ 
Global HIV Prevention Working Group 2007:1. Cited from UNICEF, WHO and UNAIDS 2007. Towards universal access: scaling up priority 
HIV/AIDS interventions in the health sector and UNAIDS Report on the global AIDS epidemic 
 
II. Function 
 
a) What in your experience is WHO and UNAIDS function in relation to HIV 
Prevention in sub-Saharan Africa? 
b) What do you see as the distinct qualities that differentiate the two organizations? 
c) Do you believe / think WHO and UNAIDS has been or is regarded as a successful 
leader in directing / managing AIDS in sub-Saharan Africa? 
d) Today and looking forward what do you believe is WHO and UNAIDS greatest 
challenge with HIV prevention? 
 
156 
 
III. Circumcision 
 
At the conclusion of the orange farm trial WHO and UNAIDS issued caution, 
approximately 18 months later after 2 further trials (Kenya and Uganda) were completed 
they made a commanding endorsement of male circumcision. 
a) Why in your expert opinion did WHO and UNAIDS make this recommendation? 
b) Were there any aspects of their recommendations that surprised you? 
c) What do you believe was WHO and UNAIDS intent in relation to male circumcision 
and policy? 
d) Do you believe there have been any positive/negative consequences from their 
recommendations? 
 
There has been significant literature and debates on the challenges/concerns of male 
circumcision, from medical, cost, gender, ethics, and culture many of which were 
presented in UNAIDS and WHO‘s position paper. 
 
e) Do you think any of these factors have the potential to hinder the overall forecasts 
relating to the effectiveness of male circumcision? 
f) Do you think governments in sub-Saharan Africa have the skills, budgets, and 
experience to address all the recommendations WHO and UNAIDS put forth enabling 
a successful implementation? 
g) Were concerns relating to women addressed? 
h) In your opinion did WHO and UNAIDS have enough research evidence put forth on 
the challenges and concerns of male circumcision before issuing the policy statement? 
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Appendix B: Interview Schedule 
Group 1: WHO and UNAIDS 
Invited: 15 
Completed: 6         
Name Title Organization Interview Date 
Kevin De Cock, MD Director of HIV/AIDS WHO Completed 
May 2, 2008 
5:00 SA/Geneva 
anonymous Medical Officer WHO Completed 
March 26, 2008 
10:00 SA/9:00 
Dr. Sibongile Dludlu Male Circumcision Consultant UNAIDS (RSTESA) Completed 
April 22, 2008 
Catherine Hankins, MD Chief Scientific Advisor and Associate 
Director Evidence, Monitoring, and Policy 
UNAIDS Completed 
April 22, 2008 
Tomas Lundstrom HIV Prevention Strategist UNAIDS (RSTESA) Completed 
April 22, 2008 
Mark Stirling Regional Director HIV/AIDS UNAIDS (RSTESA) 
 
Completed 
April 2, 2008 
 
No Response: 3 
Confirmed Unavailable: 6 
Name Title Organization Interview Date 
Chiweni Chimbwete Circumcision UNAIDS (RSTESA) No Response 
Kathleen Cravero Assistant Administrator UNDP Unavailable 
Deborah Landey Deputy Executive Director UNAIDS Unavailable 
 Carolyn Hannan Director for Advancement of Women 
(DAW) 
UN Unavailable 
Susan Kasedde Gender  UNAIDS (RSTESA) Unavailable 
Brian Pazvakavambwa Head of WHO Inter-country Support Team WHO (AFRO) No  Response 
Peter Piot Executive Director UNAIDS Unavailable 
Kristan Schoultz Director  UNAIDS (The Global 
Coalition on Women and 
AIDS) 
Unavailable 
Cream Wright Chief, Education Section UNICEF No Response 
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Group 2: Experts AIDS and Male Circumcision 
 
Invited: 48 
Completed: 21 
Name Title Organization Interview Date 
Bertran Auvert, MD Director University of Versailles 
French Institute of Health 
Completed 
March 19, 2008 
3:00 p.m. Johannesburg SA 
Melanie Bacon Epidemiology Branch Project Officer for Grants NIAID (Kenya and 
Uganda) 
Completed 
March 28, 2008 
3:30  p.m. SA/USA 
Robert C. Bailey Professor University of Illinois Chicago, Division of 
Epidemiology and Biostatistics 
Completed 
March 20, 2008  
1:00 p.m. SA/ Kenya 
Ben U Chirwa Director General  Zambia National AIDS Council  Completed 
April 16, 2008 
2:30 p.m. SA/Zambia 
Mary Crewe Executive Director Pretoria University, South Africa, Centre for 
Study of AIDS 
Completed 
April 15, 2008 
1:00 p.m. Pretoria SA 
George Denniston MD President Doctors Opposing Circumcision Completed 
March 31,2008 
5:00 p.m. SA/USA 
Gary Dowsett Professor, Deputy 
Director 
Australian Research Centre in Sex, Health & 
Society, Australia 
Completed 
May 9, 2008 
9:00 a.m. SA/Australia 
Glenda Gray, MD 
 
Executive Director HIVSA, South Africa Completed 
April 2, 2008 
2:00 p.m. Johannesburg, SA 
Daniel Halperin Senior Research 
Scientist and Lecturer 
Harvard Center for Population and 
Development Studies 
Completed /Partial 
May 6, 2008 
5:30 p.m. SA/USA 
David Harrison Executive Director Love Life, South Africa Completed 
April 24, 2008 
12:00 p.m. Johannesburg  SA 
Mark Heywood 
 
Executive Director AIDS Law Program South Africa  (ALP) Completed 
April 25, 2008 
10:00 a.m. Johannesburg, SA 
Salim S. Abdool Karim, 
MD 
Executive Director CAPRISA (Center for AIDS Program of 
Research South Africa)  
Completed 
March 20, 2008  
11:00 a.m. Durban SA 
Jennifer Kates VP/Director AIDS Kaiser Foundation Completed 
April 10, 2008 
3:30 p.m. SA/ USA 
Barbara Klugman Director of AIDS Ford Foundation Completed 
April 1, 2008 
8:00 p.m. SA/SA 
 Keymanthri Moodley Professor Bioethics Unit Tygerberg Division, South 
Africa 
Completed 
April 14, 2008 
12:00  p.m. Cape Town SA 
Anton A van Niekerk Department Chair and 
Director 
University of Stellenbosch, South Africa 
Center for Applied Ethics 
Completed 
April 14, 2008 
3:00 p.m. Cape Town SA 
Warren Parker Executive Director CADRE Centre for AIDS Development 
Research and Evaluation 
Completed 
March 27 2008 
1:30 p.m. Johannesburg SA 
Daniel Sidler MD Pediatric Surgeon Tygerberg Children‘s Hospital, South Africa Completed 
April 13, 2008 
12:30 p.m. Cape Town SA 
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 Leickness Simbayi Executive Director of 
HIV/AIDS, Professor 
HSRC, Human Sciences Research Council, 
Social Aspects of HIV/AIDS & Health 
Programme, South Africa 
Completed 
April 14, 2008 
9:30 a.m. Cape Town SA 
Miriam K. Were Chairperson Kenya National AIDS Council and AMREF 
Board , Co-Founder UZIMA Foundation 
Completed 
April 11, 2008 
3:00 p.m. SA/Kenya 
Alan Whiteside Executive Director, 
Professor 
HEARD, Health Economic and HIV/AIDS 
Research Division  
 Completed 
March  20, 2008 
2:00 p.m. Durban, SA 
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Appendix C: Letter of Introduction 
Date: xx, 2008 
Subject Header: Request to Participate in Research 
Dr. xxxxx, I would like to request your participation in the research I am conducting as a 
requirement for a Masters Degree in Development Studies at the University of the 
Witwatersrand (WITS) Johannesburg, South Africa.  The topic is ―Why have WHO and 
UNAIDS endorsed male circumcision as a public health initiative for HIV prevention in sub-
Saharan Africa?‖. The research will seek to address the following aims: 
 Clarify what WHO and UNAIDS function is in relation to HIV prevention in sub-
Saharan Africa. 
 Critically analyze the factors that have influenced WHO and UNAIDS to support 
male circumcision as a public health initiative. 
 Explain how WHO and UNAIDS utilized their historical findings on why social 
and behaviour factors hinder HIV prevention in sub-Saharan Africa when 
evaluating the effectiveness of male circumcision.  
 Examine the views of HIV and AIDS experts and organizations, relating to how 
they interpret why WHO and UNAIDS made their recommendations for male 
circumcision in sub-Saharan Africa. 
 Explore how WHO and UNAIDS assessed the impact of male circumcision on 
women. 
Dr. xxxxx as the leader of xxxxx I cannot emphasize enough how valuable your expertise 
would be to the proposed research. In closing, I believe this research is important for the 
reason it could provide additional insight into understanding why male circumcision has been 
recommended as a public health initiative in sub-Saharan Africa.  
If you are able to take part in my study it would be appreciated and of great value. Please 
contact me at (27) 83 500 4151 or through email if you have any questions. The attached 
letter serves as a confirmation of my studies and provides contact information for the 
University and my advisor. Thank you for your time, I hope you will consider my request and 
grant the necessary permission to be interviewed for my research.  
Sincerely, 
Tami Stainfield 
 
Enclosures 
Cc: Dr. Noor Nieftagodien 
